Gene to GO BP test for over-representation
| GOBPID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0002376 | 0.00000 | 3.22096 | 123 | 299 | 2664 | immune system process |
| GO:0051179 | 0.00000 | 2.58889 | 276 | 493 | 5950 | localization |
| GO:0006928 | 0.00000 | 3.06699 | 93 | 228 | 2014 | movement of cell or subcellular component |
| GO:0001775 | 0.00000 | 3.85195 | 51 | 157 | 1098 | cell activation |
| GO:0045321 | 0.00000 | 4.01760 | 46 | 148 | 994 | leukocyte activation |
| GO:0002682 | 0.00000 | 3.38920 | 68 | 186 | 1473 | regulation of immune system process |
| GO:0022610 | 0.00000 | 3.54207 | 61 | 173 | 1310 | biological adhesion |
| GO:0007155 | 0.00000 | 3.52605 | 60 | 171 | 1298 | cell adhesion |
| GO:0048870 | 0.00000 | 3.16762 | 74 | 190 | 1595 | cell motility |
| GO:0051674 | 0.00000 | 3.16762 | 74 | 190 | 1595 | localization of cell |
| GO:0048583 | 0.00000 | 2.40498 | 180 | 338 | 3883 | regulation of response to stimulus |
| GO:0002684 | 0.00000 | 3.66498 | 50 | 148 | 1072 | positive regulation of immune system process |
| GO:0048731 | 0.00000 | 2.29387 | 220 | 387 | 4746 | system development |
| GO:0048518 | 0.00000 | 2.18602 | 286 | 464 | 6171 | positive regulation of biological process |
| GO:0040011 | 0.00000 | 2.95988 | 84 | 203 | 1817 | locomotion |
| GO:0032879 | 0.00000 | 2.57281 | 131 | 271 | 2835 | regulation of localization |
| GO:0016477 | 0.00000 | 3.18923 | 67 | 175 | 1447 | cell migration |
| GO:0006955 | 0.00000 | 3.03575 | 77 | 190 | 1652 | immune response |
| GO:0032502 | 0.00000 | 2.14179 | 290 | 464 | 6258 | developmental process |
| GO:0048856 | 0.00000 | 2.13991 | 272 | 441 | 5871 | anatomical structure development |
| GO:0002520 | 0.00000 | 3.47425 | 48 | 137 | 1030 | immune system development |
| GO:0051239 | 0.00000 | 2.34636 | 150 | 286 | 3248 | regulation of multicellular organismal process |
| GO:0030097 | 0.00000 | 3.60072 | 43 | 127 | 921 | hemopoiesis |
| GO:0007275 | 0.00000 | 2.11250 | 248 | 407 | 5362 | multicellular organism development |
| GO:0051234 | 0.00000 | 2.17371 | 210 | 361 | 4538 | establishment of localization |
| GO:0048513 | 0.00000 | 2.28718 | 162 | 300 | 3504 | animal organ development |
| GO:0048534 | 0.00000 | 3.47885 | 45 | 130 | 972 | hematopoietic or lymphoid organ development |
| GO:0006810 | 0.00000 | 2.16684 | 204 | 351 | 4398 | transport |
| GO:0030154 | 0.00000 | 2.17778 | 195 | 340 | 4218 | cell differentiation |
| GO:0002521 | 0.00000 | 4.38830 | 26 | 94 | 567 | leukocyte differentiation |
| GO:0065009 | 0.00000 | 2.46757 | 115 | 234 | 2477 | regulation of molecular function |
| GO:0006954 | 0.00000 | 3.98059 | 32 | 105 | 691 | inflammatory response |
| GO:0050900 | 0.00000 | 5.74833 | 16 | 71 | 340 | leukocyte migration |
| GO:0065007 | 0.00000 | 2.00853 | 562 | 732 | 12135 | biological regulation |
| GO:0048869 | 0.00000 | 2.11837 | 206 | 349 | 4443 | cellular developmental process |
| GO:0098609 | 0.00000 | 3.83421 | 33 | 106 | 720 | cell-cell adhesion |
| GO:0046649 | 0.00000 | 3.57205 | 39 | 116 | 841 | lymphocyte activation |
| GO:0048522 | 0.00000 | 2.03772 | 253 | 405 | 5469 | positive regulation of cellular process |
| GO:0006952 | 0.00000 | 2.78118 | 74 | 173 | 1601 | defense response |
| GO:0002252 | 0.00000 | 3.50092 | 41 | 119 | 879 | immune effector process |
| GO:0044093 | 0.00000 | 2.87526 | 66 | 160 | 1429 | positive regulation of molecular function |
| GO:0009966 | 0.00000 | 2.32169 | 129 | 248 | 2780 | regulation of signal transduction |
| GO:0048584 | 0.00000 | 2.44244 | 106 | 217 | 2294 | positive regulation of response to stimulus |
| GO:0050776 | 0.00000 | 3.38993 | 42 | 119 | 903 | regulation of immune response |
| GO:0007166 | 0.00000 | 2.37112 | 116 | 229 | 2497 | cell surface receptor signaling pathway |
| GO:0042110 | 0.00000 | 4.45560 | 23 | 83 | 491 | T cell activation |
| GO:0010646 | 0.00000 | 2.19717 | 155 | 280 | 3338 | regulation of cell communication |
| GO:0001816 | 0.00000 | 3.62154 | 35 | 106 | 755 | cytokine production |
| GO:0048523 | 0.00000 | 2.04455 | 217 | 357 | 4687 | negative regulation of cellular process |
| GO:0023051 | 0.00000 | 2.19032 | 156 | 281 | 3360 | regulation of signaling |
| GO:0050789 | 0.00000 | 1.91904 | 534 | 696 | 11520 | regulation of biological process |
| GO:0051240 | 0.00000 | 2.53570 | 89 | 191 | 1929 | positive regulation of multicellular organismal process |
| GO:0002274 | 0.00000 | 7.03395 | 10 | 53 | 215 | myeloid leukocyte activation |
| GO:0050790 | 0.00000 | 2.53504 | 84 | 180 | 1807 | regulation of catalytic activity |
| GO:0001817 | 0.00000 | 3.67297 | 31 | 97 | 679 | regulation of cytokine production |
| GO:0002366 | 0.00000 | 5.92576 | 12 | 58 | 269 | leukocyte activation involved in immune response |
| GO:0006950 | 0.00000 | 2.09263 | 169 | 292 | 3640 | response to stress |
| GO:0035556 | 0.00000 | 2.26142 | 121 | 230 | 2608 | intracellular signal transduction |
| GO:0002697 | 0.00000 | 4.57449 | 19 | 73 | 420 | regulation of immune effector process |
| GO:0002263 | 0.00000 | 5.81446 | 13 | 58 | 273 | cell activation involved in immune response |
| GO:0030155 | 0.00000 | 3.58082 | 32 | 96 | 686 | regulation of cell adhesion |
| GO:0048519 | 0.00000 | 1.92416 | 244 | 380 | 5278 | negative regulation of biological process |
| GO:0009653 | 0.00000 | 2.18836 | 127 | 235 | 2744 | anatomical structure morphogenesis |
| GO:0051050 | 0.00000 | 2.91497 | 50 | 125 | 1081 | positive regulation of transport |
| GO:2000145 | 0.00000 | 3.06416 | 43 | 114 | 939 | regulation of cell motility |
| GO:0051049 | 0.00000 | 2.38775 | 90 | 184 | 1946 | regulation of transport |
| GO:0008283 | 0.00000 | 2.36900 | 92 | 187 | 1994 | cell proliferation |
| GO:0046903 | 0.00000 | 2.76752 | 57 | 135 | 1227 | secretion |
| GO:0006897 | 0.00000 | 3.35272 | 34 | 98 | 741 | endocytosis |
| GO:0050865 | 0.00000 | 3.44506 | 32 | 94 | 693 | regulation of cell activation |
| GO:0050794 | 0.00000 | 1.79977 | 499 | 648 | 10774 | regulation of cellular process |
| GO:0097529 | 0.00000 | 6.45985 | 10 | 48 | 207 | myeloid leukocyte migration |
| GO:0043085 | 0.00000 | 2.89196 | 49 | 121 | 1051 | positive regulation of catalytic activity |
| GO:0007159 | 0.00000 | 4.99291 | 15 | 60 | 319 | leukocyte cell-cell adhesion |
| GO:0051270 | 0.00000 | 2.90665 | 48 | 119 | 1028 | regulation of cellular component movement |
| GO:0098657 | 0.00000 | 3.08782 | 40 | 107 | 872 | import into cell |
| GO:0030098 | 0.00000 | 4.41913 | 18 | 67 | 395 | lymphocyte differentiation |
| GO:0050778 | 0.00000 | 3.27835 | 35 | 97 | 747 | positive regulation of immune response |
| GO:0030334 | 0.00000 | 3.04158 | 41 | 108 | 892 | regulation of cell migration |
| GO:0035295 | 0.00000 | 2.78968 | 52 | 125 | 1122 | tube development |
| GO:0050793 | 0.00000 | 2.13366 | 126 | 229 | 2721 | regulation of developmental process |
| GO:0002699 | 0.00000 | 5.52048 | 12 | 53 | 259 | positive regulation of immune effector process |
| GO:0002694 | 0.00000 | 3.45856 | 30 | 89 | 652 | regulation of leukocyte activation |
| GO:0050896 | 0.00000 | 1.77404 | 441 | 587 | 9531 | response to stimulus |
| GO:0002703 | 0.00000 | 5.63170 | 12 | 52 | 250 | regulation of leukocyte mediated immunity |
| GO:0023052 | 0.00000 | 1.81285 | 305 | 441 | 6579 | signaling |
| GO:0009605 | 0.00000 | 2.16958 | 116 | 216 | 2515 | response to external stimulus |
| GO:0007154 | 0.00000 | 1.80686 | 308 | 444 | 6648 | cell communication |
| GO:0035239 | 0.00000 | 2.99015 | 42 | 108 | 905 | tube morphogenesis |
| GO:0042127 | 0.00000 | 2.42460 | 76 | 160 | 1649 | regulation of cell proliferation |
| GO:0032940 | 0.00000 | 2.80209 | 50 | 120 | 1070 | secretion by cell |
| GO:0030595 | 0.00000 | 6.12507 | 10 | 47 | 211 | leukocyte chemotaxis |
| GO:2000026 | 0.00000 | 2.22915 | 101 | 194 | 2184 | regulation of multicellular organismal development |
| GO:0060326 | 0.00000 | 4.95100 | 14 | 56 | 299 | cell chemotaxis |
| GO:0009987 | 0.00000 | 1.92518 | 732 | 860 | 15803 | cellular process |
| GO:0009893 | 0.00000 | 1.98360 | 161 | 271 | 3486 | positive regulation of metabolic process |
| GO:0040012 | 0.00000 | 2.81663 | 47 | 115 | 1018 | regulation of locomotion |
| GO:1990266 | 0.00000 | 8.83454 | 6 | 35 | 119 | neutrophil migration |
| GO:1902531 | 0.00000 | 2.35975 | 79 | 162 | 1710 | regulation of intracellular signal transduction |
| GO:0030593 | 0.00000 | 9.95635 | 5 | 32 | 100 | neutrophil chemotaxis |
| GO:0030217 | 0.00000 | 5.13415 | 12 | 52 | 269 | T cell differentiation |
| GO:0050663 | 0.00000 | 5.37342 | 11 | 49 | 244 | cytokine secretion |
| GO:0010604 | 0.00000 | 1.98356 | 149 | 252 | 3212 | positive regulation of macromolecule metabolic process |
| GO:0048514 | 0.00000 | 3.35236 | 29 | 83 | 622 | blood vessel morphogenesis |
| GO:0042330 | 0.00000 | 3.39396 | 28 | 81 | 600 | taxis |
| GO:0007165 | 0.00000 | 1.77506 | 279 | 405 | 6028 | signal transduction |
| GO:0032501 | 0.00000 | 1.72462 | 381 | 516 | 8233 | multicellular organismal process |
| GO:0001819 | 0.00000 | 3.85561 | 21 | 68 | 449 | positive regulation of cytokine production |
| GO:0032101 | 0.00000 | 3.04174 | 36 | 94 | 770 | regulation of response to external stimulus |
| GO:0010562 | 0.00000 | 2.65024 | 52 | 119 | 1112 | positive regulation of phosphorus metabolic process |
| GO:0045937 | 0.00000 | 2.65024 | 52 | 119 | 1112 | positive regulation of phosphate metabolic process |
| GO:0006935 | 0.00000 | 3.36195 | 28 | 80 | 597 | chemotaxis |
| GO:0097530 | 0.00000 | 7.20300 | 7 | 37 | 146 | granulocyte migration |
| GO:0019220 | 0.00000 | 2.29518 | 78 | 157 | 1692 | regulation of phosphate metabolic process |
| GO:0002443 | 0.00000 | 3.58098 | 23 | 72 | 507 | leukocyte mediated immunity |
| GO:0051174 | 0.00000 | 2.29357 | 78 | 157 | 1693 | regulation of phosphorus metabolic process |
| GO:0022407 | 0.00000 | 4.00714 | 18 | 62 | 395 | regulation of cell-cell adhesion |
| GO:0002250 | 0.00000 | 3.35092 | 27 | 78 | 583 | adaptive immune response |
| GO:0016043 | 0.00000 | 1.74466 | 282 | 404 | 6083 | cellular component organization |
| GO:0072358 | 0.00000 | 2.98462 | 35 | 92 | 765 | cardiovascular system development |
| GO:0001944 | 0.00000 | 3.00440 | 35 | 91 | 752 | vasculature development |
| GO:0006468 | 0.00000 | 2.23354 | 84 | 164 | 1815 | protein phosphorylation |
| GO:0042327 | 0.00000 | 2.64887 | 48 | 112 | 1043 | positive regulation of phosphorylation |
| GO:0050670 | 0.00000 | 5.32888 | 10 | 45 | 225 | regulation of lymphocyte proliferation |
| GO:0001568 | 0.00000 | 3.03847 | 33 | 88 | 719 | blood vessel development |
| GO:0001934 | 0.00000 | 2.69440 | 46 | 108 | 989 | positive regulation of protein phosphorylation |
| GO:0001932 | 0.00000 | 2.39357 | 65 | 137 | 1410 | regulation of protein phosphorylation |
| GO:0051716 | 0.00000 | 1.69524 | 362 | 490 | 7810 | cellular response to stimulus |
| GO:0051247 | 0.00000 | 2.28670 | 76 | 152 | 1639 | positive regulation of protein metabolic process |
| GO:0033036 | 0.00000 | 1.97169 | 134 | 229 | 2901 | macromolecule localization |
| GO:0009967 | 0.00000 | 2.34197 | 70 | 143 | 1504 | positive regulation of signal transduction |
| GO:0032944 | 0.00000 | 5.26984 | 11 | 45 | 227 | regulation of mononuclear cell proliferation |
| GO:0071621 | 0.00000 | 7.75736 | 6 | 33 | 123 | granulocyte chemotaxis |
| GO:0031325 | 0.00000 | 1.92607 | 148 | 246 | 3201 | positive regulation of cellular metabolic process |
| GO:0070663 | 0.00000 | 5.10902 | 11 | 46 | 238 | regulation of leukocyte proliferation |
| GO:0048646 | 0.00000 | 2.52995 | 54 | 119 | 1157 | anatomical structure formation involved in morphogenesis |
| GO:0072359 | 0.00000 | 2.53942 | 53 | 118 | 1143 | circulatory system development |
| GO:0002790 | 0.00000 | 3.12420 | 30 | 82 | 652 | peptide secretion |
| GO:0016310 | 0.00000 | 2.09979 | 100 | 184 | 2166 | phosphorylation |
| GO:0042325 | 0.00000 | 2.31018 | 71 | 144 | 1533 | regulation of phosphorylation |
| GO:0050715 | 0.00000 | 6.69297 | 7 | 36 | 150 | positive regulation of cytokine secretion |
| GO:1902533 | 0.00000 | 2.64435 | 47 | 108 | 1005 | positive regulation of intracellular signal transduction |
| GO:0051246 | 0.00000 | 1.98857 | 124 | 215 | 2687 | regulation of protein metabolic process |
| GO:0009306 | 0.00000 | 3.20777 | 28 | 78 | 605 | protein secretion |
| GO:0002706 | 0.00000 | 5.65966 | 9 | 41 | 195 | regulation of lymphocyte mediated immunity |
| GO:1903532 | 0.00000 | 3.56631 | 22 | 67 | 472 | positive regulation of secretion by cell |
| GO:0048585 | 0.00000 | 2.27550 | 73 | 146 | 1576 | negative regulation of response to stimulus |
| GO:0050764 | 0.00000 | 8.44402 | 5 | 30 | 105 | regulation of phagocytosis |
| GO:0016192 | 0.00000 | 2.30608 | 70 | 141 | 1501 | vesicle-mediated transport |
| GO:0002064 | 0.00000 | 4.87825 | 11 | 46 | 247 | epithelial cell development |
| GO:0070661 | 0.00000 | 4.17348 | 15 | 54 | 331 | leukocyte proliferation |
| GO:0045785 | 0.00000 | 3.74439 | 19 | 61 | 411 | positive regulation of cell adhesion |
| GO:0046631 | 0.00000 | 6.30377 | 7 | 36 | 157 | alpha-beta T cell activation |
| GO:0006811 | 0.00000 | 2.25467 | 72 | 144 | 1565 | ion transport |
| GO:0006796 | 0.00000 | 1.92200 | 136 | 227 | 2933 | phosphate-containing compound metabolic process |
| GO:0030100 | 0.00000 | 4.39466 | 14 | 50 | 293 | regulation of endocytosis |
| GO:0050707 | 0.00000 | 5.22233 | 10 | 42 | 213 | regulation of cytokine secretion |
| GO:0071840 | 0.00000 | 1.69255 | 290 | 407 | 6266 | cellular component organization or biogenesis |
| GO:1902105 | 0.00000 | 4.37645 | 14 | 50 | 294 | regulation of leukocyte differentiation |
| GO:0006793 | 0.00000 | 1.91579 | 137 | 228 | 2955 | phosphorus metabolic process |
| GO:2000147 | 0.00000 | 3.23171 | 26 | 73 | 561 | positive regulation of cell motility |
| GO:0030855 | 0.00000 | 3.08185 | 29 | 78 | 626 | epithelial cell differentiation |
| GO:0051047 | 0.00000 | 3.30396 | 24 | 70 | 527 | positive regulation of secretion |
| GO:0046651 | 0.00000 | 4.23979 | 14 | 51 | 308 | lymphocyte proliferation |
| GO:0060429 | 0.00000 | 2.44027 | 54 | 117 | 1172 | epithelium development |
| GO:0070887 | 0.00000 | 1.89617 | 140 | 231 | 3023 | cellular response to chemical stimulus |
| GO:0002793 | 0.00000 | 4.07728 | 15 | 53 | 331 | positive regulation of peptide secretion |
| GO:0002822 | 0.00000 | 5.51747 | 9 | 39 | 189 | regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains |
| GO:0032943 | 0.00000 | 4.20667 | 14 | 51 | 310 | mononuclear cell proliferation |
| GO:0051173 | 0.00000 | 1.88921 | 142 | 233 | 3061 | positive regulation of nitrogen compound metabolic process |
| GO:0010647 | 0.00000 | 2.12690 | 86 | 161 | 1854 | positive regulation of cell communication |
| GO:0051222 | 0.00000 | 3.57086 | 20 | 62 | 435 | positive regulation of protein transport |
| GO:0008219 | 0.00000 | 2.06742 | 96 | 174 | 2065 | cell death |
| GO:0051094 | 0.00000 | 2.23758 | 71 | 141 | 1540 | positive regulation of developmental process |
| GO:0031399 | 0.00000 | 2.15505 | 82 | 155 | 1760 | regulation of protein modification process |
| GO:0050867 | 0.00000 | 3.46623 | 21 | 64 | 461 | positive regulation of cell activation |
| GO:0023056 | 0.00000 | 2.11876 | 86 | 161 | 1860 | positive regulation of signaling |
| GO:0050714 | 0.00000 | 4.23597 | 14 | 50 | 302 | positive regulation of protein secretion |
| GO:0031401 | 0.00000 | 2.40100 | 56 | 119 | 1210 | positive regulation of protein modification process |
| GO:0050863 | 0.00000 | 4.20223 | 14 | 50 | 304 | regulation of T cell activation |
| GO:0008104 | 0.00000 | 1.94958 | 119 | 204 | 2578 | protein localization |
| GO:0002285 | 0.00000 | 5.37318 | 9 | 39 | 193 | lymphocyte activation involved in immune response |
| GO:0051046 | 0.00000 | 2.63069 | 42 | 98 | 911 | regulation of secretion |
| GO:0030335 | 0.00000 | 3.21764 | 25 | 70 | 539 | positive regulation of cell migration |
| GO:0050708 | 0.00000 | 3.34940 | 23 | 66 | 490 | regulation of protein secretion |
| GO:1904951 | 0.00000 | 3.46197 | 21 | 63 | 454 | positive regulation of establishment of protein localization |
| GO:1903530 | 0.00000 | 2.70971 | 38 | 92 | 831 | regulation of secretion by cell |
| GO:0002705 | 0.00000 | 5.64070 | 8 | 37 | 176 | positive regulation of leukocyte mediated immunity |
| GO:0002791 | 0.00000 | 3.23186 | 25 | 69 | 529 | regulation of peptide secretion |
| GO:0051272 | 0.00000 | 3.10787 | 27 | 73 | 580 | positive regulation of cellular component movement |
| GO:0040017 | 0.00000 | 3.07897 | 27 | 74 | 593 | positive regulation of locomotion |
| GO:0012501 | 0.00000 | 2.08840 | 88 | 163 | 1908 | programmed cell death |
| GO:0002819 | 0.00000 | 5.14595 | 9 | 40 | 205 | regulation of adaptive immune response |
| GO:0051241 | 0.00000 | 2.30464 | 62 | 127 | 1343 | negative regulation of multicellular organismal process |
| GO:0045595 | 0.00000 | 2.08711 | 88 | 163 | 1909 | regulation of cell differentiation |
| GO:0018108 | 0.00000 | 4.06373 | 15 | 51 | 319 | peptidyl-tyrosine phosphorylation |
| GO:0051128 | 0.00000 | 1.94252 | 118 | 202 | 2558 | regulation of cellular component organization |
| GO:0048017 | 0.00000 | 5.92577 | 7 | 35 | 160 | inositol lipid-mediated signaling |
| GO:0030099 | 0.00000 | 3.62335 | 19 | 58 | 401 | myeloid cell differentiation |
| GO:0002683 | 0.00000 | 3.36268 | 22 | 64 | 473 | negative regulation of immune system process |
| GO:0018212 | 0.00000 | 4.01819 | 15 | 51 | 322 | peptidyl-tyrosine modification |
| GO:0031347 | 0.00000 | 2.95626 | 30 | 77 | 640 | regulation of defense response |
| GO:0001525 | 0.00000 | 3.23235 | 24 | 67 | 513 | angiogenesis |
| GO:0051223 | 0.00000 | 2.83733 | 33 | 82 | 708 | regulation of protein transport |
| GO:0008284 | 0.00000 | 2.53157 | 45 | 101 | 972 | positive regulation of cell proliferation |
| GO:0090087 | 0.00000 | 2.77631 | 35 | 85 | 749 | regulation of peptide transport |
| GO:0032270 | 0.00000 | 2.19132 | 71 | 138 | 1532 | positive regulation of cellular protein metabolic process |
| GO:0006915 | 0.00000 | 2.07596 | 86 | 159 | 1867 | apoptotic process |
| GO:0042221 | 0.00000 | 1.74791 | 192 | 289 | 4136 | response to chemical |
| GO:0043067 | 0.00000 | 2.18296 | 71 | 138 | 1537 | regulation of programmed cell death |
| GO:0043410 | 0.00000 | 3.18856 | 24 | 67 | 519 | positive regulation of MAPK cascade |
| GO:0031323 | 0.00000 | 1.67727 | 250 | 356 | 5401 | regulation of cellular metabolic process |
| GO:0009888 | 0.00000 | 2.04363 | 91 | 164 | 1956 | tissue development |
| GO:0048468 | 0.00000 | 1.94311 | 111 | 191 | 2406 | cell development |
| GO:0048015 | 0.00000 | 5.84497 | 7 | 34 | 157 | phosphatidylinositol-mediated signaling |
| GO:1903037 | 0.00000 | 4.17098 | 13 | 47 | 287 | regulation of leukocyte cell-cell adhesion |
| GO:0070201 | 0.00000 | 2.73524 | 34 | 83 | 740 | regulation of establishment of protein localization |
| GO:0032880 | 0.00000 | 2.43122 | 48 | 104 | 1038 | regulation of protein localization |
| GO:1903706 | 0.00000 | 3.48511 | 19 | 57 | 407 | regulation of hemopoiesis |
| GO:0010941 | 0.00000 | 2.10320 | 78 | 146 | 1685 | regulation of cell death |
| GO:0032635 | 0.00000 | 5.61538 | 8 | 34 | 162 | interleukin-6 production |
| GO:0032675 | 0.00000 | 5.81010 | 7 | 33 | 153 | regulation of interleukin-6 production |
| GO:0051336 | 0.00000 | 2.46270 | 46 | 100 | 985 | regulation of hydrolase activity |
| GO:0002696 | 0.00000 | 3.33071 | 21 | 60 | 446 | positive regulation of leukocyte activation |
| GO:0022409 | 0.00000 | 4.45920 | 11 | 42 | 242 | positive regulation of cell-cell adhesion |
| GO:0019222 | 0.00000 | 1.63894 | 276 | 382 | 5953 | regulation of metabolic process |
| GO:0022603 | 0.00000 | 2.38687 | 50 | 106 | 1076 | regulation of anatomical structure morphogenesis |
| GO:0046634 | 0.00000 | 7.38037 | 5 | 27 | 104 | regulation of alpha-beta T cell activation |
| GO:0032268 | 0.00000 | 1.89902 | 116 | 194 | 2494 | regulation of cellular protein metabolic process |
| GO:1903039 | 0.00000 | 4.87923 | 9 | 38 | 203 | positive regulation of leukocyte cell-cell adhesion |
| GO:0007010 | 0.00000 | 2.24435 | 60 | 121 | 1305 | cytoskeleton organization |
| GO:0010648 | 0.00000 | 2.24235 | 60 | 121 | 1306 | negative regulation of cell communication |
| GO:0002764 | 0.00000 | 3.25226 | 21 | 61 | 463 | immune response-regulating signaling pathway |
| GO:0023057 | 0.00000 | 2.23438 | 61 | 121 | 1310 | negative regulation of signaling |
| GO:0042981 | 0.00000 | 2.13840 | 70 | 134 | 1516 | regulation of apoptotic process |
| GO:0051249 | 0.00000 | 3.00171 | 26 | 68 | 555 | regulation of lymphocyte activation |
| GO:0002573 | 0.00000 | 4.67008 | 10 | 39 | 216 | myeloid leukocyte differentiation |
| GO:0031349 | 0.00000 | 3.56928 | 17 | 53 | 370 | positive regulation of defense response |
| GO:0030888 | 0.00000 | 9.81867 | 3 | 22 | 69 | regulation of B cell proliferation |
| GO:0045087 | 0.00000 | 2.56311 | 39 | 89 | 842 | innate immune response |
| GO:0001818 | 0.00000 | 4.22820 | 12 | 43 | 259 | negative regulation of cytokine production |
| GO:0050766 | 0.00000 | 8.93999 | 4 | 23 | 77 | positive regulation of phagocytosis |
| GO:0060255 | 0.00000 | 1.63397 | 254 | 355 | 5486 | regulation of macromolecule metabolic process |
| GO:0065008 | 0.00000 | 1.70633 | 188 | 279 | 4051 | regulation of biological quality |
| GO:0032103 | 0.00000 | 3.77318 | 14 | 47 | 312 | positive regulation of response to external stimulus |
| GO:0045807 | 0.00000 | 5.09464 | 8 | 34 | 175 | positive regulation of endocytosis |
| GO:0006909 | 0.00000 | 3.63562 | 16 | 49 | 336 | phagocytosis |
| GO:0045597 | 0.00000 | 2.30713 | 51 | 105 | 1097 | positive regulation of cell differentiation |
| GO:0009968 | 0.00000 | 2.25518 | 54 | 110 | 1175 | negative regulation of signal transduction |
| GO:0080090 | 0.00000 | 1.63109 | 243 | 341 | 5248 | regulation of primary metabolic process |
| GO:0000165 | 0.00000 | 2.56154 | 37 | 84 | 793 | MAPK cascade |
| GO:0002286 | 0.00000 | 6.60531 | 5 | 27 | 113 | T cell activation involved in immune response |
| GO:0051345 | 0.00000 | 3.02045 | 24 | 63 | 510 | positive regulation of hydrolase activity |
| GO:0050870 | 0.00000 | 4.86719 | 9 | 35 | 187 | positive regulation of T cell activation |
| GO:0023014 | 0.00000 | 2.53549 | 38 | 85 | 810 | signal transduction by protein phosphorylation |
| GO:0002824 | 0.00000 | 5.74815 | 6 | 30 | 140 | positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains |
| GO:0002253 | 0.00000 | 2.96965 | 24 | 64 | 526 | activation of immune response |
| GO:0002757 | 0.00000 | 3.16330 | 21 | 58 | 450 | immune response-activating signal transduction |
| GO:0080134 | 0.00000 | 2.15977 | 62 | 120 | 1337 | regulation of response to stress |
| GO:0001909 | 0.00000 | 5.69611 | 7 | 30 | 141 | leukocyte mediated cytotoxicity |
| GO:0045859 | 0.00000 | 2.70899 | 31 | 74 | 662 | regulation of protein kinase activity |
| GO:0060627 | 0.00000 | 2.87021 | 26 | 67 | 568 | regulation of vesicle-mediated transport |
| GO:0045576 | 0.00000 | 9.16799 | 3 | 21 | 69 | mast cell activation |
| GO:0046635 | 0.00000 | 9.16799 | 3 | 21 | 69 | positive regulation of alpha-beta T cell activation |
| GO:0071702 | 0.00000 | 1.83807 | 116 | 190 | 2505 | organic substance transport |
| GO:0002708 | 0.00000 | 5.54545 | 7 | 30 | 144 | positive regulation of lymphocyte mediated immunity |
| GO:0043408 | 0.00000 | 2.58890 | 34 | 79 | 737 | regulation of MAPK cascade |
| GO:0014065 | 0.00000 | 5.95263 | 6 | 28 | 127 | phosphatidylinositol 3-kinase signaling |
| GO:0043549 | 0.00000 | 2.58596 | 34 | 78 | 728 | regulation of kinase activity |
| GO:0002821 | 0.00000 | 5.40253 | 7 | 30 | 147 | positive regulation of adaptive immune response |
| GO:0002449 | 0.00000 | 3.17190 | 20 | 55 | 425 | lymphocyte mediated immunity |
| GO:0030029 | 0.00000 | 2.55290 | 35 | 79 | 746 | actin filament-based process |
| GO:0033674 | 0.00000 | 3.02442 | 22 | 59 | 476 | positive regulation of kinase activity |
| GO:0045860 | 0.00000 | 3.12946 | 20 | 56 | 438 | positive regulation of protein kinase activity |
| GO:0002460 | 0.00000 | 3.10465 | 20 | 56 | 441 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains |
| GO:0050730 | 0.00000 | 3.91392 | 12 | 41 | 263 | regulation of peptidyl-tyrosine phosphorylation |
| GO:0001906 | 0.00000 | 4.76979 | 8 | 33 | 179 | cell killing |
| GO:0044092 | 0.00000 | 2.28715 | 47 | 96 | 1006 | negative regulation of molecular function |
| GO:0051347 | 0.00000 | 2.81396 | 26 | 64 | 551 | positive regulation of transferase activity |
| GO:0051171 | 0.00000 | 1.59593 | 236 | 328 | 5104 | regulation of nitrogen compound metabolic process |
| GO:0045216 | 0.00000 | 5.26267 | 7 | 29 | 145 | cell-cell junction organization |
| GO:0042098 | 0.00000 | 4.34827 | 9 | 35 | 205 | T cell proliferation |
| GO:0030001 | 0.00000 | 2.40030 | 39 | 84 | 839 | metal ion transport |
| GO:0045765 | 0.00000 | 3.54917 | 14 | 44 | 307 | regulation of angiogenesis |
| GO:0002275 | 0.00000 | 7.31974 | 4 | 22 | 85 | myeloid cell activation involved in immune response |
| GO:1903555 | 0.00000 | 4.83894 | 8 | 31 | 166 | regulation of tumor necrosis factor superfamily cytokine production |
| GO:0042113 | 0.00000 | 3.13654 | 19 | 52 | 405 | B cell activation |
| GO:0002709 | 0.00000 | 6.79419 | 4 | 23 | 94 | regulation of T cell mediated immunity |
| GO:1902107 | 0.00000 | 4.76786 | 8 | 31 | 168 | positive regulation of leukocyte differentiation |
| GO:0002292 | 0.00000 | 8.20890 | 3 | 20 | 71 | T cell differentiation involved in immune response |
| GO:0046632 | 0.00000 | 6.03394 | 5 | 25 | 112 | alpha-beta T cell differentiation |
| GO:0015833 | 0.00000 | 1.91652 | 83 | 144 | 1797 | peptide transport |
| GO:0071706 | 0.00000 | 4.69883 | 8 | 31 | 170 | tumor necrosis factor superfamily cytokine production |
| GO:0002685 | 0.00000 | 4.29638 | 9 | 34 | 201 | regulation of leukocyte migration |
| GO:0042592 | 0.00000 | 1.88839 | 87 | 149 | 1887 | homeostatic process |
| GO:0045184 | 0.00000 | 1.89326 | 86 | 147 | 1856 | establishment of protein localization |
| GO:0031589 | 0.00000 | 3.33248 | 16 | 46 | 339 | cell-substrate adhesion |
| GO:0002237 | 0.00000 | 3.17520 | 17 | 49 | 377 | response to molecule of bacterial origin |
| GO:0000902 | 0.00000 | 2.16769 | 51 | 100 | 1100 | cell morphogenesis |
| GO:1901342 | 0.00000 | 3.30958 | 16 | 46 | 341 | regulation of vasculature development |
| GO:0032989 | 0.00000 | 2.10571 | 56 | 107 | 1211 | cellular component morphogenesis |
| GO:1904018 | 0.00000 | 4.21998 | 9 | 34 | 204 | positive regulation of vasculature development |
| GO:0042886 | 0.00000 | 1.89176 | 84 | 144 | 1817 | amide transport |
| GO:0032680 | 0.00000 | 4.71349 | 8 | 30 | 164 | regulation of tumor necrosis factor production |
| GO:0050731 | 0.00000 | 4.29557 | 9 | 33 | 195 | positive regulation of peptidyl-tyrosine phosphorylation |
| GO:0030030 | 0.00000 | 1.95540 | 73 | 129 | 1572 | cell projection organization |
| GO:0030036 | 0.00000 | 2.53025 | 31 | 70 | 663 | actin cytoskeleton organization |
| GO:0051707 | 0.00000 | 2.11274 | 54 | 104 | 1172 | response to other organism |
| GO:0050671 | 0.00000 | 5.20609 | 6 | 27 | 136 | positive regulation of lymphocyte proliferation |
| GO:0070374 | 0.00000 | 4.03699 | 10 | 35 | 218 | positive regulation of ERK1 and ERK2 cascade |
| GO:0043207 | 0.00000 | 2.10859 | 54 | 104 | 1174 | response to external biotic stimulus |
| GO:0035710 | 0.00000 | 6.26307 | 5 | 23 | 100 | CD4-positive, alpha-beta T cell activation |
| GO:0072511 | 0.00000 | 2.84826 | 22 | 56 | 475 | divalent inorganic cation transport |
| GO:0002456 | 0.00000 | 5.15853 | 6 | 27 | 137 | T cell mediated immunity |
| GO:0009607 | 0.00000 | 2.08786 | 56 | 106 | 1208 | response to biotic stimulus |
| GO:0032640 | 0.00000 | 4.60965 | 8 | 30 | 167 | tumor necrosis factor production |
| GO:0051093 | 0.00000 | 2.15713 | 50 | 97 | 1070 | negative regulation of developmental process |
| GO:0032946 | 0.00000 | 5.11182 | 6 | 27 | 138 | positive regulation of mononuclear cell proliferation |
| GO:0043299 | 0.00000 | 7.94725 | 3 | 19 | 69 | leukocyte degranulation |
| GO:0051338 | 0.00000 | 2.32032 | 39 | 81 | 832 | regulation of transferase activity |
| GO:0042129 | 0.00000 | 4.51025 | 8 | 30 | 170 | regulation of T cell proliferation |
| GO:0070372 | 0.00000 | 3.36832 | 14 | 42 | 306 | regulation of ERK1 and ERK2 cascade |
| GO:0015031 | 0.00000 | 1.88009 | 81 | 138 | 1746 | protein transport |
| GO:0045619 | 0.00000 | 4.32306 | 8 | 31 | 182 | regulation of lymphocyte differentiation |
| GO:0070838 | 0.00000 | 2.80832 | 22 | 55 | 472 | divalent metal ion transport |
| GO:0006812 | 0.00000 | 2.11335 | 51 | 98 | 1101 | cation transport |
| GO:0007162 | 0.00000 | 3.46733 | 13 | 40 | 284 | negative regulation of cell adhesion |
| GO:0030031 | 0.00000 | 2.73542 | 23 | 57 | 501 | cell projection assembly |
| GO:0090022 | 0.00000 | 15.04086 | 1 | 13 | 31 | regulation of neutrophil chemotaxis |
| GO:0045766 | 0.00000 | 4.23826 | 9 | 31 | 185 | positive regulation of angiogenesis |
| GO:0002687 | 0.00000 | 4.84836 | 7 | 27 | 144 | positive regulation of leukocyte migration |
| GO:0070371 | 0.00000 | 3.25223 | 15 | 43 | 323 | ERK1 and ERK2 cascade |
| GO:0007229 | 0.00000 | 6.46566 | 4 | 21 | 89 | integrin-mediated signaling pathway |
| GO:0042107 | 0.00000 | 5.24643 | 6 | 25 | 125 | cytokine metabolic process |
| GO:0033627 | 0.00000 | 8.00306 | 3 | 18 | 65 | cell adhesion mediated by integrin |
| GO:0043367 | 0.00000 | 6.86007 | 4 | 20 | 81 | CD4-positive, alpha-beta T cell differentiation |
| GO:0070665 | 0.00000 | 4.80705 | 7 | 27 | 145 | positive regulation of leukocyte proliferation |
| GO:1903708 | 0.00000 | 3.97412 | 10 | 33 | 208 | positive regulation of hemopoiesis |
| GO:0032663 | 0.00000 | 8.65872 | 3 | 17 | 58 | regulation of interleukin-2 production |
| GO:0071900 | 0.00000 | 2.88218 | 20 | 51 | 427 | regulation of protein serine/threonine kinase activity |
| GO:0032623 | 0.00000 | 7.83597 | 3 | 18 | 66 | interleukin-2 production |
| GO:0051091 | 0.00000 | 3.65261 | 11 | 36 | 244 | positive regulation of DNA-binding transcription factor activity |
| GO:0120192 | 0.00000 | 10.42689 | 2 | 15 | 45 | tight junction assembly |
| GO:0001910 | 0.00000 | 5.60535 | 5 | 23 | 109 | regulation of leukocyte mediated cytotoxicity |
| GO:0042035 | 0.00000 | 5.60535 | 5 | 23 | 109 | regulation of cytokine biosynthetic process |
| GO:0006898 | 0.00000 | 3.81281 | 10 | 34 | 222 | receptor-mediated endocytosis |
| GO:0050801 | 0.00000 | 2.28106 | 38 | 78 | 812 | ion homeostasis |
| GO:0051092 | 0.00000 | 5.09293 | 6 | 25 | 128 | positive regulation of NF-kappaB transcription factor activity |
| GO:0051090 | 0.00000 | 2.92610 | 18 | 48 | 396 | regulation of DNA-binding transcription factor activity |
| GO:0042089 | 0.00000 | 5.18811 | 6 | 24 | 121 | cytokine biosynthetic process |
| GO:0098771 | 0.00000 | 2.32333 | 35 | 73 | 746 | inorganic ion homeostasis |
| GO:0032496 | 0.00000 | 3.03613 | 17 | 45 | 359 | response to lipopolysaccharide |
| GO:0043269 | 0.00000 | 2.33572 | 34 | 72 | 732 | regulation of ion transport |
| GO:0031341 | 0.00000 | 4.94811 | 6 | 25 | 131 | regulation of cell killing |
| GO:0051130 | 0.00000 | 1.97982 | 60 | 108 | 1290 | positive regulation of cellular component organization |
| GO:0042100 | 0.00000 | 5.41567 | 5 | 23 | 112 | B cell proliferation |
| GO:0071705 | 0.00000 | 1.75878 | 99 | 158 | 2133 | nitrogen compound transport |
| GO:0032609 | 0.00000 | 5.13493 | 6 | 24 | 122 | interferon-gamma production |
| GO:0043547 | 0.00000 | 3.77818 | 10 | 33 | 217 | positive regulation of GTPase activity |
| GO:0006464 | 0.00000 | 1.60659 | 160 | 231 | 3453 | cellular protein modification process |
| GO:0036211 | 0.00000 | 1.60659 | 160 | 231 | 3453 | protein modification process |
| GO:0007399 | 0.00000 | 1.72148 | 108 | 169 | 2333 | nervous system development |
| GO:0046330 | 0.00000 | 4.66434 | 7 | 26 | 143 | positive regulation of JNK cascade |
| GO:0014066 | 0.00000 | 5.86034 | 4 | 21 | 96 | regulation of phosphatidylinositol 3-kinase signaling |
| GO:0042093 | 0.00000 | 7.71581 | 3 | 17 | 63 | T-helper cell differentiation |
| GO:0014068 | 0.00000 | 7.09513 | 3 | 18 | 71 | positive regulation of phosphatidylinositol 3-kinase signaling |
| GO:0071902 | 0.00000 | 3.32899 | 13 | 38 | 279 | positive regulation of protein serine/threonine kinase activity |
| GO:0002444 | 0.00000 | 5.78297 | 4 | 21 | 97 | myeloid leukocyte mediated immunity |
| GO:0060099 | 0.00000 | 23.08399 | 1 | 10 | 19 | regulation of phagocytosis, engulfment |
| GO:0050727 | 0.00000 | 3.00460 | 16 | 44 | 354 | regulation of inflammatory response |
| GO:1902622 | 0.00000 | 10.41800 | 2 | 14 | 42 | regulation of neutrophil migration |
| GO:0051251 | 0.00000 | 2.87073 | 18 | 47 | 394 | positive regulation of lymphocyte activation |
| GO:0002294 | 0.00000 | 7.55130 | 3 | 17 | 64 | CD4-positive, alpha-beta T cell differentiation involved in immune response |
| GO:0042102 | 0.00000 | 5.70761 | 5 | 21 | 98 | positive regulation of T cell proliferation |
| GO:0120036 | 0.00000 | 1.87137 | 71 | 121 | 1526 | plasma membrane bounded cell projection organization |
| GO:0002293 | 0.00000 | 7.39365 | 3 | 17 | 65 | alpha-beta T cell differentiation involved in immune response |
| GO:0150076 | 0.00000 | 7.39365 | 3 | 17 | 65 | neuroinflammatory response |
| GO:0120193 | 0.00000 | 8.93531 | 2 | 15 | 50 | tight junction organization |
| GO:0002700 | 0.00000 | 4.47216 | 7 | 26 | 148 | regulation of production of molecular mediator of immune response |
| GO:0032649 | 0.00000 | 5.29474 | 5 | 22 | 109 | regulation of interferon-gamma production |
| GO:0071310 | 0.00000 | 1.68670 | 113 | 173 | 2433 | cellular response to organic substance |
| GO:0090023 | 0.00000 | 16.33532 | 1 | 11 | 25 | positive regulation of neutrophil chemotaxis |
| GO:1905153 | 0.00000 | 20.77465 | 1 | 10 | 20 | regulation of membrane invagination |
| GO:0002287 | 0.00000 | 7.24243 | 3 | 17 | 66 | alpha-beta T cell activation involved in immune response |
| GO:0009617 | 0.00000 | 2.13302 | 42 | 82 | 907 | response to bacterium |
| GO:0043086 | 0.00000 | 2.32585 | 32 | 67 | 682 | negative regulation of catalytic activity |
| GO:0045580 | 0.00000 | 4.39963 | 7 | 26 | 150 | regulation of T cell differentiation |
| GO:0070830 | 0.00000 | 9.72259 | 2 | 14 | 44 | bicellular tight junction assembly |
| GO:0002768 | 0.00000 | 2.99978 | 16 | 42 | 338 | immune response-regulating cell surface receptor signaling pathway |
| GO:0001763 | 0.00000 | 3.47680 | 11 | 34 | 240 | morphogenesis of a branching structure |
| GO:0006801 | 0.00000 | 7.09726 | 3 | 17 | 67 | superoxide metabolic process |
| GO:0022607 | 0.00000 | 1.63412 | 130 | 193 | 2807 | cellular component assembly |
| GO:0051641 | 0.00000 | 1.65630 | 120 | 181 | 2592 | cellular localization |
| GO:0055080 | 0.00000 | 2.25926 | 34 | 70 | 732 | cation homeostasis |
| GO:0060100 | 0.00000 | 26.68882 | 1 | 9 | 16 | positive regulation of phagocytosis, engulfment |
| GO:1905155 | 0.00000 | 26.68882 | 1 | 9 | 16 | positive regulation of membrane invagination |
| GO:0120031 | 0.00000 | 2.58699 | 23 | 53 | 488 | plasma membrane bounded cell projection assembly |
| GO:0018193 | 0.00000 | 1.98699 | 53 | 96 | 1137 | peptidyl-amino acid modification |
| GO:0010033 | 0.00000 | 1.60530 | 142 | 207 | 3070 | response to organic substance |
| GO:0034330 | 0.00000 | 3.35238 | 12 | 35 | 255 | cell junction organization |
| GO:0006816 | 0.00000 | 2.71205 | 20 | 48 | 423 | calcium ion transport |
| GO:0055065 | 0.00000 | 2.31382 | 31 | 65 | 664 | metal ion homeostasis |
| GO:0043069 | 0.00000 | 2.07991 | 43 | 83 | 939 | negative regulation of programmed cell death |
| GO:0043087 | 0.00000 | 3.11946 | 14 | 38 | 295 | regulation of GTPase activity |
| GO:0008285 | 0.00000 | 2.28886 | 32 | 66 | 681 | negative regulation of cell proliferation |
| GO:0071624 | 0.00000 | 14.29212 | 1 | 11 | 27 | positive regulation of granulocyte chemotaxis |
| GO:0002761 | 0.00000 | 4.72265 | 6 | 23 | 125 | regulation of myeloid leukocyte differentiation |
| GO:0002711 | 0.00000 | 6.57035 | 3 | 17 | 71 | positive regulation of T cell mediated immunity |
| GO:0032760 | 0.00000 | 5.36080 | 5 | 20 | 98 | positive regulation of tumor necrosis factor production |
| GO:1902624 | 0.00000 | 11.34679 | 2 | 12 | 34 | positive regulation of neutrophil migration |
| GO:0030183 | 0.00000 | 4.22638 | 7 | 25 | 149 | B cell differentiation |
| GO:0032755 | 0.00000 | 5.29270 | 5 | 20 | 99 | positive regulation of interleukin-6 production |
| GO:1903557 | 0.00000 | 5.29270 | 5 | 20 | 99 | positive regulation of tumor necrosis factor superfamily cytokine production |
| GO:0045088 | 0.00000 | 3.09536 | 13 | 37 | 289 | regulation of innate immune response |
| GO:0032874 | 0.00000 | 3.93446 | 8 | 27 | 171 | positive regulation of stress-activated MAPK cascade |
| GO:2000514 | 0.00000 | 6.95216 | 3 | 16 | 64 | regulation of CD4-positive, alpha-beta T cell activation |
| GO:2000379 | 0.00000 | 4.99167 | 5 | 21 | 109 | positive regulation of reactive oxygen species metabolic process |
| GO:0043412 | 0.00000 | 1.54211 | 168 | 235 | 3634 | macromolecule modification |
| GO:0070304 | 0.00000 | 3.90715 | 8 | 27 | 172 | positive regulation of stress-activated protein kinase signaling cascade |
| GO:0002702 | 0.00000 | 5.22630 | 5 | 20 | 100 | positive regulation of production of molecular mediator of immune response |
| GO:0019882 | 0.00000 | 4.93536 | 5 | 21 | 110 | antigen processing and presentation |
| GO:0042119 | 0.00000 | 12.70296 | 1 | 11 | 29 | neutrophil activation |
| GO:0045089 | 0.00000 | 3.36491 | 11 | 32 | 232 | positive regulation of innate immune response |
| GO:0050729 | 0.00000 | 4.26074 | 7 | 24 | 142 | positive regulation of inflammatory response |
| GO:0007169 | 0.00000 | 2.39262 | 26 | 56 | 553 | transmembrane receptor protein tyrosine kinase signaling pathway |
| GO:0032715 | 0.00000 | 8.09996 | 2 | 14 | 50 | negative regulation of interleukin-6 production |
| GO:0033003 | 0.00000 | 8.09996 | 2 | 14 | 50 | regulation of mast cell activation |
| GO:0061138 | 0.00000 | 3.42960 | 10 | 31 | 221 | morphogenesis of a branching epithelium |
| GO:0043405 | 0.00000 | 3.02254 | 14 | 37 | 295 | regulation of MAP kinase activity |
| GO:0042116 | 0.00000 | 5.36393 | 4 | 19 | 93 | macrophage activation |
| GO:0006887 | 0.00000 | 2.73632 | 17 | 43 | 375 | exocytosis |
| GO:0002224 | 0.00000 | 5.03672 | 5 | 20 | 103 | toll-like receptor signaling pathway |
| GO:0030853 | 0.00000 | 48.35331 | 0 | 7 | 10 | negative regulation of granulocyte differentiation |
| GO:0007167 | 0.00000 | 2.05443 | 41 | 78 | 890 | enzyme linked receptor protein signaling pathway |
| GO:0048871 | 0.00000 | 2.48451 | 23 | 51 | 486 | multicellular organismal homeostasis |
| GO:0060548 | 0.00000 | 1.96447 | 49 | 88 | 1049 | negative regulation of cell death |
| GO:0032613 | 0.00000 | 7.10474 | 3 | 15 | 59 | interleukin-10 production |
| GO:0050920 | 0.00000 | 3.44372 | 10 | 30 | 213 | regulation of chemotaxis |
| GO:0042554 | 0.00000 | 9.98382 | 2 | 12 | 37 | superoxide anion generation |
| GO:0046637 | 0.00000 | 6.41621 | 3 | 16 | 68 | regulation of alpha-beta T cell differentiation |
| GO:0034154 | 0.00000 | 124.23199 | 0 | 6 | 7 | toll-like receptor 7 signaling pathway |
| GO:0007204 | 0.00000 | 2.85564 | 15 | 39 | 327 | positive regulation of cytosolic calcium ion concentration |
| GO:0050866 | 0.00000 | 3.49920 | 9 | 29 | 203 | negative regulation of cell activation |
| GO:0072507 | 0.00000 | 2.40092 | 24 | 53 | 521 | divalent inorganic cation homeostasis |
| GO:0001774 | 0.00000 | 8.45513 | 2 | 13 | 45 | microglial cell activation |
| GO:0002269 | 0.00000 | 8.45513 | 2 | 13 | 45 | leukocyte activation involved in inflammatory response |
| GO:0002221 | 0.00000 | 4.22323 | 6 | 23 | 137 | pattern recognition receptor signaling pathway |
| GO:0006873 | 0.00000 | 2.22338 | 30 | 62 | 655 | cellular ion homeostasis |
| GO:0048771 | 0.00000 | 3.56088 | 9 | 28 | 193 | tissue remodeling |
| GO:0061900 | 0.00000 | 7.47587 | 2 | 14 | 53 | glial cell activation |
| GO:0009611 | 0.00000 | 2.43314 | 23 | 51 | 495 | response to wounding |
| GO:0002695 | 0.00000 | 3.65341 | 8 | 27 | 182 | negative regulation of leukocyte activation |
| GO:0050673 | 0.00000 | 2.56615 | 20 | 46 | 425 | epithelial cell proliferation |
| GO:0007043 | 0.00000 | 4.80427 | 5 | 20 | 107 | cell-cell junction assembly |
| GO:0043066 | 0.00000 | 2.00582 | 43 | 79 | 921 | negative regulation of apoptotic process |
| GO:0051051 | 0.00000 | 2.35597 | 25 | 54 | 540 | negative regulation of transport |
| GO:0002758 | 0.00000 | 4.15003 | 6 | 23 | 139 | innate immune response-activating signal transduction |
| GO:0045621 | 0.00000 | 4.74946 | 5 | 20 | 108 | positive regulation of lymphocyte differentiation |
| GO:0048878 | 0.00000 | 1.87706 | 55 | 95 | 1182 | chemical homeostasis |
| GO:0043297 | 0.00000 | 7.28864 | 3 | 14 | 54 | apical junction assembly |
| GO:0007264 | 0.00000 | 2.43342 | 22 | 50 | 485 | small GTPase mediated signal transduction |
| GO:0045596 | 0.00000 | 2.07945 | 37 | 71 | 799 | negative regulation of cell differentiation |
| GO:0043406 | 0.00000 | 3.31579 | 10 | 30 | 220 | positive regulation of MAP kinase activity |
| GO:0032653 | 0.00000 | 7.11055 | 3 | 14 | 55 | regulation of interleukin-10 production |
| GO:0031343 | 0.00000 | 4.89883 | 5 | 19 | 100 | positive regulation of cell killing |
| GO:0055074 | 0.00000 | 2.41080 | 23 | 50 | 489 | calcium ion homeostasis |
| GO:0022408 | 0.00000 | 3.53844 | 9 | 27 | 187 | negative regulation of cell-cell adhesion |
| GO:0098542 | 0.00000 | 2.17807 | 31 | 62 | 667 | defense response to other organism |
| GO:0002688 | 0.00000 | 4.59226 | 5 | 20 | 111 | regulation of leukocyte chemotaxis |
| GO:0046328 | 0.00000 | 3.51630 | 9 | 27 | 188 | regulation of JNK cascade |
| GO:0048608 | 0.00000 | 2.47171 | 21 | 47 | 449 | reproductive structure development |
| GO:0002762 | 0.00000 | 7.72935 | 2 | 13 | 48 | negative regulation of myeloid leukocyte differentiation |
| GO:0045408 | 0.00000 | 12.21651 | 1 | 10 | 27 | regulation of interleukin-6 biosynthetic process |
| GO:0002429 | 0.00000 | 2.77974 | 15 | 38 | 326 | immune response-activating cell surface receptor signaling pathway |
| GO:0072593 | 0.00000 | 2.91073 | 13 | 35 | 288 | reactive oxygen species metabolic process |
| GO:0019221 | 0.00000 | 2.72152 | 16 | 39 | 341 | cytokine-mediated signaling pathway |
| GO:0006875 | 0.00000 | 2.25768 | 27 | 56 | 582 | cellular metal ion homeostasis |
| GO:0045123 | 0.00000 | 6.25047 | 3 | 15 | 65 | cellular extravasation |
| GO:0002009 | 0.00000 | 2.29321 | 26 | 54 | 553 | morphogenesis of an epithelium |
| GO:0042108 | 0.00000 | 5.75090 | 3 | 16 | 74 | positive regulation of cytokine biosynthetic process |
| GO:0007254 | 0.00000 | 3.37531 | 9 | 28 | 202 | JNK cascade |
| GO:0061458 | 0.00000 | 2.44691 | 21 | 47 | 453 | reproductive system development |
| GO:0050854 | 0.00000 | 6.77921 | 3 | 14 | 57 | regulation of antigen receptor-mediated signaling pathway |
| GO:0046638 | 0.00000 | 7.51431 | 2 | 13 | 49 | positive regulation of alpha-beta T cell differentiation |
| GO:0072503 | 0.00000 | 2.36678 | 23 | 50 | 497 | cellular divalent inorganic cation homeostasis |
| GO:0045637 | 0.00000 | 3.27166 | 10 | 29 | 215 | regulation of myeloid cell differentiation |
| GO:0042226 | 0.00000 | 11.53730 | 1 | 10 | 28 | interleukin-6 biosynthetic process |
| GO:0044085 | 0.00000 | 1.53203 | 141 | 198 | 3041 | cellular component biogenesis |
| GO:0032612 | 0.00000 | 4.66745 | 5 | 19 | 104 | interleukin-1 production |
| GO:0046641 | 0.00000 | 14.36701 | 1 | 9 | 22 | positive regulation of alpha-beta T cell proliferation |
| GO:0002440 | 0.00000 | 2.68545 | 16 | 39 | 345 | production of molecular mediator of immune response |
| GO:0002831 | 0.00000 | 3.88088 | 7 | 23 | 147 | regulation of response to biotic stimulus |
| GO:0036230 | 0.00000 | 9.52463 | 2 | 11 | 35 | granulocyte activation |
| GO:0043370 | 0.00000 | 7.31089 | 2 | 13 | 50 | regulation of CD4-positive, alpha-beta T cell differentiation |
| GO:0071622 | 0.00000 | 7.31089 | 2 | 13 | 50 | regulation of granulocyte chemotaxis |
| GO:0045582 | 0.00000 | 4.87835 | 4 | 18 | 95 | positive regulation of T cell differentiation |
| GO:0006874 | 0.00000 | 2.38749 | 22 | 48 | 473 | cellular calcium ion homeostasis |
| GO:0050852 | 0.00000 | 4.18027 | 6 | 21 | 126 | T cell receptor signaling pathway |
| GO:0001912 | 0.00000 | 5.13852 | 4 | 17 | 86 | positive regulation of leukocyte mediated cytotoxicity |
| GO:0032611 | 0.00000 | 5.13852 | 4 | 17 | 86 | interleukin-1 beta production |
| GO:0051403 | 0.00000 | 2.98762 | 12 | 32 | 257 | stress-activated MAPK cascade |
| GO:0032735 | 0.00000 | 9.14323 | 2 | 11 | 36 | positive regulation of interleukin-12 production |
| GO:2000516 | 0.00000 | 9.14323 | 2 | 11 | 36 | positive regulation of CD4-positive, alpha-beta T cell activation |
| GO:0038061 | 0.00000 | 4.50772 | 5 | 19 | 107 | NIK/NF-kappaB signaling |
| GO:0030003 | 0.00000 | 2.15052 | 30 | 59 | 641 | cellular cation homeostasis |
| GO:0010959 | 0.00000 | 2.46304 | 19 | 44 | 421 | regulation of metal ion transport |
| GO:0051056 | 0.00000 | 2.96103 | 12 | 32 | 259 | regulation of small GTPase mediated signal transduction |
| GO:0034220 | 0.00000 | 1.96134 | 41 | 74 | 878 | ion transmembrane transport |
| GO:0050921 | 0.00000 | 3.89826 | 6 | 22 | 140 | positive regulation of chemotaxis |
| GO:0030316 | 0.00000 | 4.45686 | 5 | 19 | 108 | osteoclast differentiation |
| GO:0032642 | 0.00000 | 4.99332 | 4 | 17 | 88 | regulation of chemokine production |
| GO:0003158 | 0.00000 | 4.21964 | 6 | 20 | 119 | endothelium development |
| GO:0032673 | 0.00000 | 10.38263 | 1 | 10 | 30 | regulation of interleukin-4 production |
| GO:0043372 | 0.00000 | 10.38263 | 1 | 10 | 30 | positive regulation of CD4-positive, alpha-beta T cell differentiation |
| GO:0032633 | 0.00000 | 8.79117 | 2 | 11 | 37 | interleukin-4 production |
| GO:0022008 | 0.00000 | 1.66212 | 82 | 127 | 1778 | neurogenesis |
| GO:0060284 | 0.00000 | 1.84945 | 51 | 87 | 1093 | regulation of cell development |
| GO:0048729 | 0.00000 | 2.10152 | 31 | 61 | 677 | tissue morphogenesis |
| GO:0002218 | 0.00000 | 3.58760 | 8 | 24 | 164 | activation of innate immune response |
| GO:0034113 | 0.00000 | 6.76165 | 2 | 13 | 53 | heterotypic cell-cell adhesion |
| GO:1901700 | 0.00000 | 1.69672 | 74 | 116 | 1589 | response to oxygen-containing compound |
| GO:0030890 | 0.00000 | 7.56076 | 2 | 12 | 45 | positive regulation of B cell proliferation |
| GO:0010942 | 0.00000 | 2.07901 | 32 | 62 | 695 | positive regulation of cell death |
| GO:0032753 | 0.00000 | 12.45028 | 1 | 9 | 24 | positive regulation of interleukin-4 production |
| GO:0009891 | 0.00000 | 1.62933 | 90 | 136 | 1943 | positive regulation of biosynthetic process |
| GO:0031098 | 0.00000 | 2.79136 | 13 | 34 | 290 | stress-activated protein kinase signaling cascade |
| GO:2000116 | 0.00000 | 3.08743 | 10 | 29 | 226 | regulation of cysteine-type endopeptidase activity |
| GO:0010628 | 0.00000 | 1.62158 | 92 | 138 | 1981 | positive regulation of gene expression |
| GO:0007265 | 0.00000 | 2.44429 | 19 | 43 | 414 | Ras protein signal transduction |
| GO:0010563 | 0.00000 | 2.22678 | 25 | 52 | 546 | negative regulation of phosphorus metabolic process |
| GO:0045936 | 0.00000 | 2.22678 | 25 | 52 | 546 | negative regulation of phosphate metabolic process |
| GO:0009889 | 0.00000 | 1.47493 | 164 | 222 | 3542 | regulation of biosynthetic process |
| GO:1901222 | 0.00000 | 4.52447 | 5 | 18 | 101 | regulation of NIK/NF-kappaB signaling |
| GO:0003382 | 0.00000 | 7.33806 | 2 | 12 | 46 | epithelial cell morphogenesis |
| GO:0034097 | 0.00000 | 1.87274 | 47 | 81 | 1004 | response to cytokine |
| GO:0034121 | 0.00000 | 5.94749 | 3 | 14 | 63 | regulation of toll-like receptor signaling pathway |
| GO:0051704 | 0.00000 | 1.56161 | 111 | 160 | 2389 | multi-organism process |
| GO:0002367 | 0.00000 | 4.47040 | 5 | 18 | 102 | cytokine production involved in immune response |
| GO:0032602 | 0.00000 | 4.72615 | 4 | 17 | 92 | chemokine production |
| GO:0030852 | 0.00000 | 15.07983 | 1 | 8 | 19 | regulation of granulocyte differentiation |
| GO:0045076 | 0.00000 | 15.07983 | 1 | 8 | 19 | regulation of interleukin-2 biosynthetic process |
| GO:0032655 | 0.00000 | 6.43909 | 3 | 13 | 55 | regulation of interleukin-12 production |
| GO:0009620 | 0.00000 | 8.16249 | 2 | 11 | 39 | response to fungus |
| GO:0042063 | 0.00000 | 2.63765 | 15 | 36 | 323 | gliogenesis |
| GO:0032743 | 0.00000 | 9.43790 | 1 | 10 | 32 | positive regulation of interleukin-2 production |
| GO:0001894 | 0.00000 | 2.99536 | 11 | 29 | 232 | tissue homeostasis |
| GO:0032872 | 0.00000 | 2.99536 | 11 | 29 | 232 | regulation of stress-activated MAPK cascade |
| GO:0000904 | 0.00000 | 1.96334 | 37 | 68 | 804 | cell morphogenesis involved in differentiation |
| GO:0031326 | 0.00000 | 1.46803 | 161 | 217 | 3470 | regulation of cellular biosynthetic process |
| GO:0048732 | 0.00000 | 2.30569 | 22 | 46 | 467 | gland development |
| GO:0046633 | 0.00000 | 7.88067 | 2 | 11 | 40 | alpha-beta T cell proliferation |
| GO:0043303 | 0.00000 | 6.92976 | 2 | 12 | 48 | mast cell degranulation |
| GO:0033993 | 0.00000 | 1.94762 | 38 | 69 | 822 | response to lipid |
| GO:0071216 | 0.00000 | 2.64594 | 14 | 35 | 313 | cellular response to biotic stimulus |
| GO:0070302 | 0.00000 | 2.96586 | 11 | 29 | 234 | regulation of stress-activated protein kinase signaling cascade |
| GO:0055082 | 0.00000 | 1.94692 | 38 | 68 | 810 | cellular chemical homeostasis |
| GO:0044267 | 0.00000 | 1.41350 | 212 | 273 | 4569 | cellular protein metabolic process |
| GO:0002279 | 0.00000 | 6.74216 | 2 | 12 | 49 | mast cell activation involved in immune response |
| GO:0002448 | 0.00000 | 6.74216 | 2 | 12 | 49 | mast cell mediated immunity |
| GO:0033628 | 0.00000 | 7.61764 | 2 | 11 | 41 | regulation of cell adhesion mediated by integrin |
| GO:0051271 | 0.00000 | 2.61734 | 15 | 35 | 316 | negative regulation of cellular component movement |
| GO:0050678 | 0.00000 | 2.49810 | 17 | 38 | 358 | regulation of epithelial cell proliferation |
| GO:0032615 | 0.00000 | 6.00900 | 3 | 13 | 58 | interleukin-12 production |
| GO:0071219 | 0.00000 | 2.69601 | 13 | 33 | 290 | cellular response to molecule of bacterial origin |
| GO:0001936 | 0.00000 | 3.83078 | 6 | 20 | 129 | regulation of endothelial cell proliferation |
| GO:0050864 | 0.00000 | 2.79119 | 12 | 31 | 264 | regulation of B cell activation |
| GO:0090322 | 0.00000 | 8.65063 | 2 | 10 | 34 | regulation of superoxide metabolic process |
| GO:0051250 | 0.00000 | 3.53649 | 7 | 22 | 152 | negative regulation of lymphocyte activation |
| GO:0045638 | 0.00000 | 4.42976 | 4 | 17 | 97 | negative regulation of myeloid cell differentiation |
| GO:0032729 | 0.00000 | 5.03796 | 4 | 15 | 77 | positive regulation of interferon-gamma production |
| GO:0051480 | 0.00000 | 2.44972 | 17 | 39 | 374 | regulation of cytosolic calcium ion concentration |
| GO:0002690 | 0.00000 | 4.69515 | 4 | 16 | 87 | positive regulation of leukocyte chemotaxis |
| GO:2000106 | 0.00000 | 4.17124 | 5 | 18 | 108 | regulation of leukocyte apoptotic process |
| GO:0048002 | 0.00000 | 5.39557 | 3 | 14 | 68 | antigen processing and presentation of peptide antigen |
| GO:0010720 | 0.00000 | 2.04342 | 31 | 58 | 659 | positive regulation of cell development |
| GO:0046777 | 0.00000 | 2.88074 | 11 | 29 | 240 | protein autophosphorylation |
| GO:0032930 | 0.00000 | 12.75871 | 1 | 8 | 21 | positive regulation of superoxide anion generation |
| GO:0042094 | 0.00000 | 12.75871 | 1 | 8 | 21 | interleukin-2 biosynthetic process |
| GO:0098742 | 0.00000 | 3.09241 | 9 | 26 | 202 | cell-cell adhesion via plasma-membrane adhesion molecules |
| GO:0048568 | 0.00000 | 2.22336 | 23 | 47 | 493 | embryonic organ development |
| GO:0031328 | 0.00000 | 1.59469 | 88 | 131 | 1903 | positive regulation of cellular biosynthetic process |
| GO:0001935 | 0.00000 | 3.59499 | 7 | 21 | 143 | endothelial cell proliferation |
| GO:0032733 | 0.00000 | 8.30423 | 2 | 10 | 35 | positive regulation of interleukin-10 production |
| GO:0051248 | 0.00000 | 1.79275 | 50 | 83 | 1070 | negative regulation of protein metabolic process |
| GO:0045055 | 0.00000 | 2.78304 | 12 | 30 | 256 | regulated exocytosis |
| GO:0003341 | 0.00000 | 5.20240 | 3 | 14 | 70 | cilium movement |
| GO:0007249 | 0.00000 | 3.11324 | 9 | 25 | 193 | I-kappaB kinase/NF-kappaB signaling |
| GO:0002283 | 0.00000 | 16.11340 | 1 | 7 | 16 | neutrophil activation involved in immune response |
| GO:0045624 | 0.00000 | 11.84683 | 1 | 8 | 22 | positive regulation of T-helper cell differentiation |
| GO:0051924 | 0.00000 | 2.69755 | 13 | 31 | 272 | regulation of calcium ion transport |
| GO:0055085 | 0.00000 | 1.71390 | 59 | 94 | 1266 | transmembrane transport |
| GO:0032652 | 0.00000 | 4.44394 | 4 | 16 | 91 | regulation of interleukin-1 production |
| GO:0010876 | 0.00000 | 2.40648 | 17 | 38 | 370 | lipid localization |
| GO:0007266 | 0.00000 | 3.07633 | 9 | 25 | 195 | Rho protein signal transduction |
| GO:0035023 | 0.00000 | 3.62992 | 6 | 20 | 135 | regulation of Rho protein signal transduction |
| GO:0002437 | 0.00000 | 5.51747 | 3 | 13 | 62 | inflammatory response to antigenic stimulus |
| GO:1902106 | 0.00000 | 4.16824 | 5 | 17 | 102 | negative regulation of leukocyte differentiation |
| GO:2000520 | 0.00000 | Inf | 0 | 4 | 4 | regulation of immunological synapse formation |
| GO:0044057 | 0.00000 | 2.06214 | 28 | 53 | 596 | regulation of system process |
| GO:0046640 | 0.00000 | 7.68840 | 2 | 10 | 37 | regulation of alpha-beta T cell proliferation |
| GO:0051129 | 0.00000 | 1.92903 | 35 | 63 | 755 | negative regulation of cellular component organization |
| GO:0019538 | 0.00000 | 1.37002 | 248 | 309 | 5344 | protein metabolic process |
| GO:0032722 | 0.00001 | 5.40687 | 3 | 13 | 63 | positive regulation of chemokine production |
| GO:0001914 | 0.00001 | 5.93818 | 3 | 12 | 54 | regulation of T cell mediated cytotoxicity |
| GO:0034762 | 0.00001 | 2.08255 | 26 | 51 | 568 | regulation of transmembrane transport |
| GO:0042060 | 0.00001 | 2.40712 | 17 | 37 | 360 | wound healing |
| GO:0034765 | 0.00001 | 2.18971 | 22 | 45 | 478 | regulation of ion transmembrane transport |
| GO:0008360 | 0.00001 | 3.39884 | 7 | 21 | 150 | regulation of cell shape |
| GO:0072604 | 0.00001 | 6.52793 | 2 | 11 | 46 | interleukin-6 secretion |
| GO:0031324 | 0.00001 | 1.50424 | 113 | 159 | 2449 | negative regulation of cellular metabolic process |
| GO:0042267 | 0.00001 | 5.30062 | 3 | 13 | 64 | natural killer cell mediated cytotoxicity |
| GO:0043900 | 0.00001 | 2.32959 | 18 | 39 | 391 | regulation of multi-organism process |
| GO:0006996 | 0.00001 | 1.42640 | 165 | 218 | 3568 | organelle organization |
| GO:0030851 | 0.00001 | 7.41348 | 2 | 10 | 38 | granulocyte differentiation |
| GO:0032945 | 0.00001 | 4.52543 | 4 | 15 | 84 | negative regulation of mononuclear cell proliferation |
| GO:0034103 | 0.00001 | 4.52543 | 4 | 15 | 84 | regulation of tissue remodeling |
| GO:0050672 | 0.00001 | 4.52543 | 4 | 15 | 84 | negative regulation of lymphocyte proliferation |
| GO:0032651 | 0.00001 | 4.85470 | 3 | 14 | 74 | regulation of interleukin-1 beta production |
| GO:1901224 | 0.00001 | 4.85470 | 3 | 14 | 74 | positive regulation of NIK/NF-kappaB signaling |
| GO:0070925 | 0.00001 | 1.88438 | 37 | 65 | 796 | organelle assembly |
| GO:0043281 | 0.00001 | 2.97064 | 9 | 25 | 201 | regulation of cysteine-type endopeptidase activity involved in apoptotic process |
| GO:0045086 | 0.00001 | 20.70065 | 1 | 6 | 12 | positive regulation of interleukin-2 biosynthetic process |
| GO:0071639 | 0.00001 | 20.70065 | 1 | 6 | 12 | positive regulation of monocyte chemotactic protein-1 production |
| GO:0048699 | 0.00001 | 1.59976 | 77 | 116 | 1672 | generation of neurons |
| GO:0045446 | 0.00001 | 3.98018 | 5 | 17 | 106 | endothelial cell differentiation |
| GO:0002886 | 0.00001 | 5.19845 | 3 | 13 | 65 | regulation of myeloid leukocyte mediated immunity |
| GO:0043068 | 0.00001 | 1.99686 | 30 | 55 | 637 | positive regulation of programmed cell death |
| GO:0050702 | 0.00001 | 6.34631 | 2 | 11 | 47 | interleukin-1 beta secretion |
| GO:0010557 | 0.00001 | 1.57717 | 83 | 123 | 1799 | positive regulation of macromolecule biosynthetic process |
| GO:0050851 | 0.00001 | 2.55152 | 14 | 32 | 295 | antigen receptor-mediated signaling pathway |
| GO:0052548 | 0.00001 | 2.43299 | 16 | 35 | 337 | regulation of endopeptidase activity |
| GO:0060562 | 0.00001 | 2.33505 | 18 | 38 | 380 | epithelial tube morphogenesis |
| GO:0032732 | 0.00001 | 5.66775 | 3 | 12 | 56 | positive regulation of interleukin-1 production |
| GO:0046578 | 0.00001 | 2.81141 | 11 | 27 | 228 | regulation of Ras protein signal transduction |
| GO:0050830 | 0.00001 | 3.60257 | 6 | 19 | 129 | defense response to Gram-positive bacterium |
| GO:0032928 | 0.00001 | 10.36504 | 1 | 8 | 24 | regulation of superoxide anion generation |
| GO:0008015 | 0.00001 | 2.15919 | 22 | 45 | 484 | blood circulation |
| GO:0010556 | 0.00001 | 1.43438 | 153 | 204 | 3311 | regulation of macromolecule biosynthetic process |
| GO:0071222 | 0.00001 | 2.58889 | 13 | 31 | 282 | cellular response to lipopolysaccharide |
| GO:0090132 | 0.00001 | 2.58889 | 13 | 31 | 282 | epithelium migration |
| GO:0052547 | 0.00001 | 2.26717 | 19 | 40 | 411 | regulation of peptidase activity |
| GO:0002228 | 0.00001 | 5.10013 | 3 | 13 | 66 | natural killer cell mediated immunity |
| GO:1901701 | 0.00001 | 1.69844 | 56 | 89 | 1206 | cellular response to oxygen-containing compound |
| GO:0007160 | 0.00001 | 2.92046 | 9 | 25 | 204 | cell-matrix adhesion |
| GO:0090130 | 0.00001 | 2.56819 | 13 | 31 | 284 | tissue migration |
| GO:0032731 | 0.00001 | 6.17451 | 2 | 11 | 48 | positive regulation of interleukin-1 beta production |
| GO:0038066 | 0.00001 | 6.17451 | 2 | 11 | 48 | p38MAPK cascade |
| GO:0044782 | 0.00001 | 2.43474 | 15 | 34 | 327 | cilium organization |
| GO:0060271 | 0.00001 | 2.51283 | 14 | 32 | 299 | cilium assembly |
| GO:0002446 | 0.00001 | 8.11681 | 1 | 9 | 32 | neutrophil mediated immunity |
| GO:0045577 | 0.00001 | 8.11681 | 1 | 9 | 32 | regulation of B cell differentiation |
| GO:0030225 | 0.00001 | 6.91862 | 2 | 10 | 40 | macrophage differentiation |
| GO:0046456 | 0.00001 | 6.91862 | 2 | 10 | 40 | icosanoid biosynthetic process |
| GO:0001885 | 0.00001 | 5.00546 | 3 | 13 | 67 | endothelial cell development |
| GO:0043113 | 0.00001 | 5.00546 | 3 | 13 | 67 | receptor clustering |
| GO:0015711 | 0.00001 | 2.24258 | 19 | 40 | 415 | organic anion transport |
| GO:0034329 | 0.00001 | 2.88792 | 10 | 25 | 206 | cell junction assembly |
| GO:0007017 | 0.00001 | 1.88249 | 35 | 62 | 759 | microtubule-based process |
| GO:0048872 | 0.00001 | 2.45419 | 15 | 33 | 315 | homeostasis of number of cells |
| GO:0002474 | 0.00001 | 6.01175 | 2 | 11 | 49 | antigen processing and presentation of peptide antigen via MHC class I |
| GO:0043300 | 0.00001 | 6.01175 | 2 | 11 | 49 | regulation of leukocyte degranulation |
| GO:0001889 | 0.00001 | 3.64262 | 6 | 18 | 121 | liver development |
| GO:0033077 | 0.00001 | 4.27669 | 4 | 15 | 88 | T cell differentiation in thymus |
| GO:0070664 | 0.00001 | 4.27669 | 4 | 15 | 88 | negative regulation of leukocyte proliferation |
| GO:0043065 | 0.00001 | 1.97255 | 29 | 54 | 632 | positive regulation of apoptotic process |
| GO:0045921 | 0.00001 | 4.01415 | 5 | 16 | 99 | positive regulation of exocytosis |
| GO:0035082 | 0.00001 | 4.91423 | 3 | 13 | 68 | axoneme assembly |
| GO:0045834 | 0.00001 | 3.22287 | 7 | 21 | 157 | positive regulation of lipid metabolic process |
| GO:0007018 | 0.00001 | 2.56498 | 13 | 30 | 275 | microtubule-based movement |
| GO:0021700 | 0.00001 | 2.43668 | 15 | 33 | 317 | developmental maturation |
| GO:0002526 | 0.00001 | 3.60743 | 6 | 18 | 122 | acute inflammatory response |
| GO:0038083 | 0.00001 | 6.69514 | 2 | 10 | 41 | peptidyl-tyrosine autophosphorylation |
| GO:1900744 | 0.00001 | 6.69514 | 2 | 10 | 41 | regulation of p38MAPK cascade |
| GO:0002244 | 0.00001 | 3.19920 | 7 | 21 | 158 | hematopoietic progenitor cell differentiation |
| GO:1903707 | 0.00001 | 3.19920 | 7 | 21 | 158 | negative regulation of hemopoiesis |
| GO:0002698 | 0.00001 | 3.44516 | 6 | 19 | 134 | negative regulation of immune effector process |
| GO:0040013 | 0.00001 | 2.39334 | 15 | 34 | 332 | negative regulation of locomotion |
| GO:0003013 | 0.00001 | 2.10534 | 23 | 45 | 495 | circulatory system process |
| GO:0071605 | 0.00001 | 12.08341 | 1 | 7 | 19 | monocyte chemotactic protein-1 production |
| GO:0071637 | 0.00001 | 12.08341 | 1 | 7 | 19 | regulation of monocyte chemotactic protein-1 production |
| GO:0001578 | 0.00001 | 3.96619 | 5 | 16 | 100 | microtubule bundle formation |
| GO:0032637 | 0.00001 | 4.82625 | 3 | 13 | 69 | interleukin-8 production |
| GO:0048754 | 0.00001 | 2.98398 | 9 | 23 | 184 | branching morphogenesis of an epithelial tube |
| GO:0031668 | 0.00002 | 2.76012 | 10 | 26 | 223 | cellular response to extracellular stimulus |
| GO:0060249 | 0.00002 | 2.25465 | 18 | 38 | 392 | anatomical structure homeostasis |
| GO:0031532 | 0.00002 | 3.91935 | 5 | 16 | 101 | actin cytoskeleton reorganization |
| GO:0042326 | 0.00002 | 2.15439 | 21 | 42 | 452 | negative regulation of phosphorylation |
| GO:1904062 | 0.00002 | 2.33873 | 16 | 35 | 349 | regulation of cation transmembrane transport |
| GO:0051668 | 0.00002 | 2.96542 | 9 | 23 | 185 | localization within membrane |
| GO:0061008 | 0.00002 | 3.53905 | 6 | 18 | 124 | hepaticobiliary system development |
| GO:0098660 | 0.00002 | 1.93203 | 30 | 55 | 656 | inorganic ion transmembrane transport |
| GO:0070727 | 0.00002 | 1.56804 | 78 | 115 | 1686 | cellular macromolecule localization |
| GO:0032269 | 0.00002 | 1.74048 | 46 | 76 | 1003 | negative regulation of cellular protein metabolic process |
| GO:0001773 | 0.00002 | 7.46679 | 2 | 9 | 34 | myeloid dendritic cell activation |
| GO:0032102 | 0.00002 | 2.36121 | 16 | 34 | 336 | negative regulation of response to external stimulus |
| GO:0046683 | 0.00002 | 4.10731 | 4 | 15 | 91 | response to organophosphorus |
| GO:0009887 | 0.00002 | 1.70618 | 50 | 81 | 1090 | animal organ morphogenesis |
| GO:0010631 | 0.00002 | 2.51311 | 13 | 30 | 280 | epithelial cell migration |
| GO:0098655 | 0.00002 | 1.90196 | 32 | 57 | 690 | cation transmembrane transport |
| GO:1903522 | 0.00002 | 2.66420 | 11 | 27 | 239 | regulation of blood circulation |
| GO:1903307 | 0.00002 | 5.08826 | 3 | 12 | 61 | positive regulation of regulated secretory pathway |
| GO:2000377 | 0.00002 | 2.84910 | 9 | 24 | 200 | regulation of reactive oxygen species metabolic process |
| GO:2000146 | 0.00002 | 2.50298 | 13 | 30 | 281 | negative regulation of cell motility |
| GO:0019216 | 0.00002 | 2.34546 | 16 | 34 | 338 | regulation of lipid metabolic process |
| GO:0009892 | 0.00002 | 1.43940 | 132 | 177 | 2843 | negative regulation of metabolic process |
| GO:0006691 | 0.00002 | 11.15341 | 1 | 7 | 20 | leukotriene metabolic process |
| GO:0022612 | 0.00002 | 3.20890 | 7 | 20 | 150 | gland morphogenesis |
| GO:0060008 | 0.00002 | 8.72727 | 1 | 8 | 27 | Sertoli cell differentiation |
| GO:0030336 | 0.00002 | 2.54000 | 12 | 29 | 268 | negative regulation of cell migration |
| GO:0034613 | 0.00002 | 1.56242 | 78 | 114 | 1676 | cellular protein localization |
| GO:0098662 | 0.00002 | 1.95477 | 28 | 52 | 613 | inorganic cation transmembrane transport |
| GO:0010693 | 0.00002 | 82.66667 | 0 | 4 | 5 | negative regulation of alkaline phosphatase activity |
| GO:0002718 | 0.00002 | 4.28200 | 4 | 14 | 82 | regulation of cytokine production involved in immune response |
| GO:2001187 | 0.00002 | 25.85397 | 0 | 5 | 9 | positive regulation of CD8-positive, alpha-beta T cell activation |
| GO:0051817 | 0.00002 | 4.00163 | 4 | 15 | 93 | modification of morphology or physiology of other organism involved in symbiotic interaction |
| GO:0050709 | 0.00003 | 3.15999 | 7 | 20 | 152 | negative regulation of protein secretion |
| GO:0002720 | 0.00003 | 5.43822 | 2 | 11 | 53 | positive regulation of cytokine production involved in immune response |
| GO:0050878 | 0.00003 | 2.31458 | 16 | 34 | 342 | regulation of body fluid levels |
| GO:0019725 | 0.00003 | 1.75155 | 43 | 71 | 930 | cellular homeostasis |
| GO:0050918 | 0.00003 | 6.10356 | 2 | 10 | 44 | positive chemotaxis |
| GO:0010468 | 0.00003 | 1.37945 | 179 | 229 | 3860 | regulation of gene expression |
| GO:2001141 | 0.00003 | 1.43409 | 130 | 174 | 2801 | regulation of RNA biosynthetic process |
| GO:0045670 | 0.00003 | 4.50369 | 3 | 13 | 73 | regulation of osteoclast differentiation |
| GO:0002712 | 0.00003 | 4.88827 | 3 | 12 | 63 | regulation of B cell mediated immunity |
| GO:0002889 | 0.00003 | 4.88827 | 3 | 12 | 63 | regulation of immunoglobulin mediated immune response |
| GO:0032677 | 0.00003 | 4.88827 | 3 | 12 | 63 | regulation of interleukin-8 production |
| GO:0033043 | 0.00003 | 1.64260 | 58 | 89 | 1242 | regulation of organelle organization |
| GO:0072539 | 0.00003 | 8.29053 | 1 | 8 | 28 | T-helper 17 cell differentiation |
| GO:1900745 | 0.00003 | 8.29053 | 1 | 8 | 28 | positive regulation of p38MAPK cascade |
| GO:0002920 | 0.00003 | 6.91307 | 2 | 9 | 36 | regulation of humoral immune response |
| GO:1903034 | 0.00003 | 2.92471 | 8 | 22 | 179 | regulation of response to wounding |
| GO:0051960 | 0.00003 | 1.69053 | 50 | 79 | 1071 | regulation of nervous system development |
| GO:0002888 | 0.00003 | 5.92891 | 2 | 10 | 45 | positive regulation of myeloid leukocyte mediated immunity |
| GO:0061028 | 0.00003 | 5.92891 | 2 | 10 | 45 | establishment of endothelial barrier |
| GO:0002763 | 0.00003 | 4.79405 | 3 | 12 | 64 | positive regulation of myeloid leukocyte differentiation |
| GO:0014074 | 0.00003 | 3.65993 | 5 | 16 | 107 | response to purine-containing compound |
| GO:0001667 | 0.00003 | 2.16748 | 19 | 38 | 406 | ameboidal-type cell migration |
| GO:0001771 | 0.00003 | 13.79857 | 1 | 6 | 15 | immunological synapse formation |
| GO:0043129 | 0.00003 | 13.79857 | 1 | 6 | 15 | surfactant homeostasis |
| GO:0050868 | 0.00003 | 3.47086 | 6 | 17 | 119 | negative regulation of T cell activation |
| GO:0050767 | 0.00003 | 1.72567 | 44 | 72 | 956 | regulation of neurogenesis |
| GO:0002675 | 0.00004 | 6.66587 | 2 | 9 | 37 | positive regulation of acute inflammatory response |
| GO:0007596 | 0.00004 | 3.06649 | 7 | 20 | 156 | blood coagulation |
| GO:0045058 | 0.00004 | 5.19055 | 3 | 11 | 55 | T cell selection |
| GO:0050701 | 0.00004 | 5.19055 | 3 | 11 | 55 | interleukin-1 secretion |
| GO:0001933 | 0.00004 | 2.15557 | 19 | 38 | 408 | negative regulation of protein phosphorylation |
| GO:0002381 | 0.00004 | 4.70338 | 3 | 12 | 65 | immunoglobulin production involved in immunoglobulin mediated immune response |
| GO:0032757 | 0.00004 | 5.76395 | 2 | 10 | 46 | positive regulation of interleukin-8 production |
| GO:0071887 | 0.00004 | 3.28950 | 6 | 18 | 132 | leukocyte apoptotic process |
| GO:0051640 | 0.00004 | 1.92879 | 28 | 50 | 596 | organelle localization |
| GO:0006355 | 0.00004 | 1.42369 | 129 | 172 | 2784 | regulation of transcription, DNA-templated |
| GO:0002374 | 0.00004 | 9.66542 | 1 | 7 | 22 | cytokine secretion involved in immune response |
| GO:0050857 | 0.00004 | 9.66542 | 1 | 7 | 22 | positive regulation of antigen receptor-mediated signaling pathway |
| GO:0060009 | 0.00004 | 9.66542 | 1 | 7 | 22 | Sertoli cell development |
| GO:0001913 | 0.00004 | 4.28864 | 4 | 13 | 76 | T cell mediated cytotoxicity |
| GO:0034763 | 0.00004 | 3.26075 | 6 | 18 | 133 | negative regulation of transmembrane transport |
| GO:0002704 | 0.00004 | 5.07498 | 3 | 11 | 56 | negative regulation of leukocyte mediated immunity |
| GO:0010692 | 0.00004 | 20.68224 | 0 | 5 | 10 | regulation of alkaline phosphatase activity |
| GO:0032621 | 0.00004 | 20.68224 | 0 | 5 | 10 | interleukin-18 production |
| GO:1902563 | 0.00004 | 20.68224 | 0 | 5 | 10 | regulation of neutrophil activation |
| GO:0043270 | 0.00004 | 2.31111 | 15 | 32 | 322 | positive regulation of ion transport |
| GO:0007599 | 0.00004 | 3.02177 | 7 | 20 | 158 | hemostasis |
| GO:0050777 | 0.00004 | 3.02177 | 7 | 20 | 158 | negative regulation of immune response |
| GO:0043271 | 0.00005 | 2.92021 | 8 | 21 | 171 | negative regulation of ion transport |
| GO:0002475 | 0.00005 | 6.43572 | 2 | 9 | 38 | antigen processing and presentation via MHC class Ib |
| GO:0016339 | 0.00005 | 6.43572 | 2 | 9 | 38 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules |
| GO:0045622 | 0.00005 | 6.43572 | 2 | 9 | 38 | regulation of T-helper cell differentiation |
| GO:0048010 | 0.00005 | 5.60792 | 2 | 10 | 47 | vascular endothelial growth factor receptor signaling pathway |
| GO:0010810 | 0.00005 | 2.68017 | 10 | 24 | 211 | regulation of cell-substrate adhesion |
| GO:1903506 | 0.00005 | 1.41876 | 129 | 172 | 2792 | regulation of nucleic acid-templated transcription |
| GO:0050817 | 0.00005 | 2.99990 | 7 | 20 | 159 | coagulation |
| GO:0042742 | 0.00005 | 2.10443 | 20 | 39 | 428 | defense response to bacterium |
| GO:0048469 | 0.00005 | 2.74351 | 9 | 23 | 198 | cell maturation |
| GO:0030193 | 0.00005 | 4.22144 | 4 | 13 | 77 | regulation of blood coagulation |
| GO:0045639 | 0.00005 | 3.71479 | 5 | 15 | 99 | positive regulation of myeloid cell differentiation |
| GO:0050710 | 0.00005 | 4.53194 | 3 | 12 | 67 | negative regulation of cytokine secretion |
| GO:0016322 | 0.00005 | 12.41815 | 1 | 6 | 16 | neuron remodeling |
| GO:0033631 | 0.00005 | 12.41815 | 1 | 6 | 16 | cell-cell adhesion mediated by integrin |
| GO:0046629 | 0.00005 | 12.41815 | 1 | 6 | 16 | gamma-delta T cell activation |
| GO:0050679 | 0.00005 | 2.72780 | 9 | 23 | 199 | positive regulation of epithelial cell proliferation |
| GO:0035821 | 0.00005 | 2.97833 | 7 | 20 | 160 | modification of morphology or physiology of other organism |
| GO:0043491 | 0.00005 | 2.79898 | 9 | 22 | 186 | protein kinase B signaling |
| GO:0032774 | 0.00006 | 1.40750 | 134 | 177 | 2896 | RNA biosynthetic process |
| GO:1900046 | 0.00006 | 4.15631 | 4 | 13 | 78 | regulation of hemostasis |
| GO:0010035 | 0.00006 | 2.00787 | 23 | 43 | 493 | response to inorganic substance |
| GO:1905954 | 0.00006 | 3.88112 | 4 | 14 | 89 | positive regulation of lipid localization |
| GO:0002714 | 0.00006 | 5.46009 | 2 | 10 | 48 | positive regulation of B cell mediated immunity |
| GO:0002891 | 0.00006 | 5.46009 | 2 | 10 | 48 | positive regulation of immunoglobulin mediated immune response |
| GO:0009991 | 0.00006 | 2.13197 | 19 | 37 | 401 | response to extracellular stimulus |
| GO:0043123 | 0.00006 | 3.46852 | 5 | 16 | 112 | positive regulation of I-kappaB kinase/NF-kappaB signaling |
| GO:0051346 | 0.00006 | 2.12603 | 19 | 37 | 402 | negative regulation of hydrolase activity |
| GO:0045862 | 0.00006 | 2.26364 | 15 | 32 | 328 | positive regulation of proteolysis |
| GO:0043302 | 0.00006 | 7.20818 | 1 | 8 | 31 | positive regulation of leukocyte degranulation |
| GO:0050718 | 0.00006 | 7.20818 | 1 | 8 | 31 | positive regulation of interleukin-1 beta secretion |
| GO:0002792 | 0.00006 | 2.93612 | 8 | 20 | 162 | negative regulation of peptide secretion |
| GO:1902532 | 0.00006 | 1.96267 | 24 | 45 | 527 | negative regulation of intracellular signal transduction |
| GO:0014004 | 0.00006 | 41.33147 | 0 | 4 | 6 | microglia differentiation |
| GO:0060341 | 0.00007 | 1.69402 | 44 | 71 | 958 | regulation of cellular localization |
| GO:0090287 | 0.00007 | 2.40930 | 13 | 28 | 271 | regulation of cellular response to growth factor stimulus |
| GO:0071345 | 0.00007 | 1.71402 | 42 | 68 | 907 | cellular response to cytokine stimulus |
| GO:0032956 | 0.00007 | 2.22239 | 16 | 33 | 344 | regulation of actin cytoskeleton organization |
| GO:0001916 | 0.00007 | 5.31985 | 2 | 10 | 49 | positive regulation of T cell mediated cytotoxicity |
| GO:0019218 | 0.00007 | 3.58621 | 5 | 15 | 102 | regulation of steroid metabolic process |
| GO:0046849 | 0.00007 | 3.58621 | 5 | 15 | 102 | bone remodeling |
| GO:0002369 | 0.00007 | 6.01997 | 2 | 9 | 40 | T cell cytokine production |
| GO:0050706 | 0.00007 | 6.01997 | 2 | 9 | 40 | regulation of interleukin-1 beta secretion |
| GO:0001938 | 0.00007 | 3.77997 | 4 | 14 | 91 | positive regulation of endothelial cell proliferation |
| GO:0071695 | 0.00007 | 2.73184 | 9 | 22 | 190 | anatomical structure maturation |
| GO:0044260 | 0.00007 | 1.28704 | 329 | 386 | 7099 | cellular macromolecule metabolic process |
| GO:0002923 | 0.00008 | 17.23442 | 1 | 5 | 11 | regulation of humoral immune response mediated by circulating immunoglobulin |
| GO:0006351 | 0.00008 | 1.39964 | 133 | 175 | 2875 | transcription, DNA-templated |
| GO:0032878 | 0.00008 | 8.52754 | 1 | 7 | 24 | regulation of establishment or maintenance of cell polarity |
| GO:0045410 | 0.00008 | 11.28872 | 1 | 6 | 17 | positive regulation of interleukin-6 biosynthetic process |
| GO:0048875 | 0.00008 | 11.28872 | 1 | 6 | 17 | chemical homeostasis within a tissue |
| GO:0050855 | 0.00008 | 11.28872 | 1 | 6 | 17 | regulation of B cell receptor signaling pathway |
| GO:2001185 | 0.00008 | 11.28872 | 1 | 6 | 17 | regulation of CD8-positive, alpha-beta T cell activation |
| GO:0051252 | 0.00008 | 1.38898 | 141 | 184 | 3049 | regulation of RNA metabolic process |
| GO:0050769 | 0.00008 | 1.89790 | 27 | 48 | 580 | positive regulation of neurogenesis |
| GO:0045944 | 0.00008 | 1.60145 | 57 | 86 | 1226 | positive regulation of transcription by RNA polymerase II |
| GO:0002486 | 0.00008 | 6.90753 | 1 | 8 | 32 | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent |
| GO:0072538 | 0.00008 | 6.90753 | 1 | 8 | 32 | T-helper 17 type immune response |
| GO:0046661 | 0.00008 | 2.97646 | 7 | 19 | 152 | male sex differentiation |
| GO:1903531 | 0.00008 | 2.52220 | 11 | 25 | 232 | negative regulation of secretion by cell |
| GO:0019915 | 0.00008 | 4.29695 | 3 | 12 | 70 | lipid storage |
| GO:0043122 | 0.00008 | 2.87498 | 8 | 20 | 165 | regulation of I-kappaB kinase/NF-kappaB signaling |
| GO:0044087 | 0.00008 | 1.68632 | 44 | 70 | 948 | regulation of cellular component biogenesis |
| GO:0031663 | 0.00008 | 5.18662 | 2 | 10 | 50 | lipopolysaccharide-mediated signaling pathway |
| GO:1902930 | 0.00008 | 5.18662 | 2 | 10 | 50 | regulation of alcohol biosynthetic process |
| GO:0006820 | 0.00008 | 1.92252 | 25 | 46 | 549 | anion transport |
| GO:0032970 | 0.00008 | 2.11367 | 18 | 36 | 393 | regulation of actin filament-based process |
| GO:0051172 | 0.00008 | 1.44255 | 105 | 143 | 2271 | negative regulation of nitrogen compound metabolic process |
| GO:0050818 | 0.00008 | 3.97240 | 4 | 13 | 81 | regulation of coagulation |
| GO:0046850 | 0.00008 | 4.65985 | 3 | 11 | 60 | regulation of bone remodeling |
| GO:0044089 | 0.00009 | 1.93394 | 25 | 45 | 534 | positive regulation of cellular component biogenesis |
| GO:0044237 | 0.00009 | 1.26916 | 434 | 494 | 9374 | cellular metabolic process |
| GO:0002040 | 0.00009 | 3.32918 | 5 | 16 | 116 | sprouting angiogenesis |
| GO:0097659 | 0.00009 | 1.39493 | 134 | 175 | 2883 | nucleic acid-templated transcription |
| GO:0009719 | 0.00009 | 1.55506 | 65 | 96 | 1409 | response to endogenous stimulus |
| GO:1901564 | 0.00010 | 1.29207 | 289 | 343 | 6234 | organonitrogen compound metabolic process |
| GO:0030162 | 0.00010 | 1.78815 | 33 | 56 | 716 | regulation of proteolysis |
| GO:0034766 | 0.00010 | 3.46619 | 5 | 15 | 105 | negative regulation of ion transmembrane transport |
| GO:0043266 | 0.00010 | 3.46619 | 5 | 15 | 105 | regulation of potassium ion transport |
| GO:0051591 | 0.00010 | 4.56645 | 3 | 11 | 61 | response to cAMP |
| GO:0051649 | 0.00010 | 1.47477 | 88 | 123 | 1906 | establishment of localization in cell |
| GO:0051962 | 0.00010 | 1.82754 | 30 | 52 | 651 | positive regulation of nervous system development |
| GO:0002476 | 0.00010 | 6.63093 | 2 | 8 | 33 | antigen processing and presentation of endogenous peptide antigen via MHC class Ib |
| GO:0002484 | 0.00010 | 6.63093 | 2 | 8 | 33 | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway |
| GO:0021591 | 0.00010 | 6.63093 | 2 | 8 | 33 | ventricular system development |
| GO:0034123 | 0.00010 | 8.05342 | 1 | 7 | 25 | positive regulation of toll-like receptor signaling pathway |
| GO:0051235 | 0.00010 | 2.22895 | 15 | 31 | 322 | maintenance of location |
| GO:0001570 | 0.00011 | 3.63772 | 4 | 14 | 94 | vasculogenesis |
| GO:0071674 | 0.00011 | 3.85856 | 4 | 13 | 83 | mononuclear cell migration |
| GO:0019722 | 0.00011 | 2.57997 | 10 | 23 | 209 | calcium-mediated signaling |
| GO:0034138 | 0.00011 | 10.34752 | 1 | 6 | 18 | toll-like receptor 3 signaling pathway |
| GO:0038093 | 0.00011 | 10.34752 | 1 | 6 | 18 | Fc receptor signaling pathway |
| GO:0040007 | 0.00011 | 1.62120 | 51 | 78 | 1097 | growth |
| GO:0070588 | 0.00012 | 2.32230 | 13 | 28 | 280 | calcium ion transmembrane transport |
| GO:1901570 | 0.00012 | 4.93919 | 2 | 10 | 52 | fatty acid derivative biosynthetic process |
| GO:1903038 | 0.00012 | 3.10381 | 6 | 17 | 131 | negative regulation of leukocyte cell-cell adhesion |
| GO:0002065 | 0.00012 | 2.97459 | 7 | 18 | 144 | columnar/cuboidal epithelial cell differentiation |
| GO:0002637 | 0.00012 | 4.08507 | 3 | 12 | 73 | regulation of immunoglobulin production |
| GO:0051851 | 0.00012 | 4.08507 | 3 | 12 | 73 | modification by host of symbiont morphology or physiology |
| GO:0033004 | 0.00013 | 14.77170 | 1 | 5 | 12 | negative regulation of mast cell activation |
| GO:0033632 | 0.00013 | 14.77170 | 1 | 5 | 12 | regulation of cell-cell adhesion mediated by integrin |
| GO:0043312 | 0.00013 | 14.77170 | 1 | 5 | 12 | neutrophil degranulation |
| GO:0072608 | 0.00013 | 14.77170 | 1 | 5 | 12 | interleukin-10 secretion |
| GO:0002428 | 0.00013 | 6.37560 | 2 | 8 | 34 | antigen processing and presentation of peptide antigen via MHC class Ib |
| GO:0050716 | 0.00013 | 6.37560 | 2 | 8 | 34 | positive regulation of interleukin-1 secretion |
| GO:0050869 | 0.00013 | 6.37560 | 2 | 8 | 34 | negative regulation of B cell activation |
| GO:0003006 | 0.00013 | 1.73086 | 37 | 60 | 791 | developmental process involved in reproduction |
| GO:0010632 | 0.00013 | 2.49190 | 10 | 24 | 225 | regulation of epithelial cell migration |
| GO:0010721 | 0.00013 | 2.08262 | 18 | 35 | 387 | negative regulation of cell development |
| GO:0008584 | 0.00013 | 3.20055 | 6 | 16 | 120 | male gonad development |
| GO:1903556 | 0.00013 | 4.39042 | 3 | 11 | 63 | negative regulation of tumor necrosis factor superfamily cytokine production |
| GO:0019219 | 0.00014 | 1.35870 | 155 | 198 | 3352 | regulation of nucleobase-containing compound metabolic process |
| GO:0043542 | 0.00014 | 2.60672 | 9 | 22 | 198 | endothelial cell migration |
| GO:0030048 | 0.00014 | 3.35393 | 5 | 15 | 108 | actin filament-based movement |
| GO:0045453 | 0.00014 | 4.01900 | 3 | 12 | 74 | bone resorption |
| GO:0002291 | 0.00014 | 27.55307 | 0 | 4 | 7 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell |
| GO:0050861 | 0.00014 | 27.55307 | 0 | 4 | 7 | positive regulation of B cell receptor signaling pathway |
| GO:0060558 | 0.00014 | 27.55307 | 0 | 4 | 7 | regulation of calcidiol 1-monooxygenase activity |
| GO:2000048 | 0.00014 | 27.55307 | 0 | 4 | 7 | negative regulation of cell-cell adhesion mediated by cadherin |
| GO:0045893 | 0.00014 | 1.51332 | 71 | 102 | 1536 | positive regulation of transcription, DNA-templated |
| GO:0010605 | 0.00015 | 1.39979 | 120 | 158 | 2584 | negative regulation of macromolecule metabolic process |
| GO:0046546 | 0.00015 | 3.16993 | 6 | 16 | 121 | development of primary male sexual characteristics |
| GO:0009913 | 0.00015 | 2.52519 | 10 | 23 | 213 | epidermal cell differentiation |
| GO:0031400 | 0.00015 | 1.86556 | 26 | 46 | 564 | negative regulation of protein modification process |
| GO:0061098 | 0.00016 | 5.33101 | 2 | 9 | 44 | positive regulation of protein tyrosine kinase activity |
| GO:0002643 | 0.00016 | 9.55113 | 1 | 6 | 19 | regulation of tolerance induction |
| GO:0002726 | 0.00016 | 9.55113 | 1 | 6 | 19 | positive regulation of T cell cytokine production |
| GO:0030889 | 0.00016 | 9.55113 | 1 | 6 | 19 | negative regulation of B cell proliferation |
| GO:0032656 | 0.00016 | 9.55113 | 1 | 6 | 19 | regulation of interleukin-13 production |
| GO:2000114 | 0.00016 | 9.55113 | 1 | 6 | 19 | regulation of establishment of cell polarity |
| GO:0032388 | 0.00016 | 2.57720 | 9 | 22 | 200 | positive regulation of intracellular transport |
| GO:0034122 | 0.00016 | 6.13919 | 2 | 8 | 35 | negative regulation of toll-like receptor signaling pathway |
| GO:0045940 | 0.00016 | 6.13919 | 2 | 8 | 35 | positive regulation of steroid metabolic process |
| GO:1903508 | 0.00016 | 1.50881 | 71 | 102 | 1540 | positive regulation of nucleic acid-templated transcription |
| GO:0008406 | 0.00016 | 2.51185 | 10 | 23 | 214 | gonad development |
| GO:0030856 | 0.00016 | 2.90502 | 7 | 18 | 147 | regulation of epithelial cell differentiation |
| GO:0032418 | 0.00016 | 3.95502 | 3 | 12 | 75 | lysosome localization |
| GO:0061097 | 0.00016 | 3.95502 | 3 | 12 | 75 | regulation of protein tyrosine kinase activity |
| GO:0006869 | 0.00016 | 2.16852 | 15 | 31 | 330 | lipid transport |
| GO:0086001 | 0.00016 | 4.71426 | 3 | 10 | 54 | cardiac muscle cell action potential |
| GO:1902680 | 0.00016 | 1.50769 | 71 | 102 | 1541 | positive regulation of RNA biosynthetic process |
| GO:0006690 | 0.00017 | 3.28302 | 5 | 15 | 110 | icosanoid metabolic process |
| GO:0010893 | 0.00018 | 7.24743 | 1 | 7 | 27 | positive regulation of steroid biosynthetic process |
| GO:0036037 | 0.00018 | 7.24743 | 1 | 7 | 27 | CD8-positive, alpha-beta T cell activation |
| GO:0045061 | 0.00018 | 7.24743 | 1 | 7 | 27 | thymic T cell selection |
| GO:0048305 | 0.00018 | 7.24743 | 1 | 7 | 27 | immunoglobulin secretion |
| GO:0007163 | 0.00018 | 2.48560 | 10 | 23 | 216 | establishment or maintenance of cell polarity |
| GO:0032965 | 0.00019 | 5.18269 | 2 | 9 | 45 | regulation of collagen biosynthetic process |
| GO:0050732 | 0.00019 | 4.60929 | 3 | 10 | 55 | negative regulation of peptidyl-tyrosine phosphorylation |
| GO:0006357 | 0.00019 | 1.44135 | 92 | 126 | 1993 | regulation of transcription by RNA polymerase II |
| GO:0002861 | 0.00020 | 5.91967 | 2 | 8 | 36 | regulation of inflammatory response to antigenic stimulus |
| GO:0071320 | 0.00020 | 5.91967 | 2 | 8 | 36 | cellular response to cAMP |
| GO:2000112 | 0.00020 | 1.35419 | 149 | 190 | 3219 | regulation of cellular macromolecule biosynthetic process |
| GO:0001660 | 0.00020 | 12.92465 | 1 | 5 | 13 | fever generation |
| GO:0019370 | 0.00020 | 12.92465 | 1 | 5 | 13 | leukotriene biosynthetic process |
| GO:0032494 | 0.00020 | 12.92465 | 1 | 5 | 13 | response to peptidoglycan |
| GO:0038094 | 0.00020 | 12.92465 | 1 | 5 | 13 | Fc-gamma receptor signaling pathway |
| GO:0042492 | 0.00020 | 12.92465 | 1 | 5 | 13 | gamma-delta T cell differentiation |
| GO:0051493 | 0.00020 | 1.86958 | 25 | 44 | 538 | regulation of cytoskeleton organization |
| GO:0034341 | 0.00020 | 2.94782 | 6 | 17 | 137 | response to interferon-gamma |
| GO:0001892 | 0.00020 | 3.21504 | 5 | 15 | 112 | embryonic placenta development |
| GO:0051224 | 0.00021 | 2.52009 | 9 | 22 | 204 | negative regulation of protein transport |
| GO:0045137 | 0.00021 | 2.45988 | 10 | 23 | 218 | development of primary sexual characteristics |
| GO:0022604 | 0.00021 | 1.87977 | 24 | 43 | 523 | regulation of cell morphogenesis |
| GO:0051048 | 0.00021 | 2.30980 | 12 | 26 | 261 | negative regulation of secretion |
| GO:0007219 | 0.00021 | 2.65379 | 8 | 20 | 177 | Notch signaling pathway |
| GO:0033630 | 0.00022 | 8.86850 | 1 | 6 | 20 | positive regulation of cell adhesion mediated by integrin |
| GO:0070633 | 0.00022 | 8.86850 | 1 | 6 | 20 | transepithelial transport |
| GO:0016311 | 0.00022 | 2.07347 | 17 | 33 | 366 | dephosphorylation |
| GO:0002707 | 0.00022 | 5.04239 | 2 | 9 | 46 | negative regulation of lymphocyte mediated immunity |
| GO:0031345 | 0.00022 | 2.50621 | 9 | 22 | 205 | negative regulation of cell projection organization |
| GO:1904063 | 0.00022 | 3.55297 | 4 | 13 | 89 | negative regulation of cation transmembrane transport |
| GO:0001945 | 0.00023 | 6.90200 | 1 | 7 | 28 | lymph vessel development |
| GO:0002507 | 0.00023 | 6.90200 | 1 | 7 | 28 | tolerance induction |
| GO:0045671 | 0.00023 | 6.90200 | 1 | 7 | 28 | negative regulation of osteoclast differentiation |
| GO:0086005 | 0.00023 | 6.90200 | 1 | 7 | 28 | ventricular cardiac muscle cell action potential |
| GO:0045935 | 0.00023 | 1.45324 | 85 | 117 | 1833 | positive regulation of nucleobase-containing compound metabolic process |
| GO:0032147 | 0.00023 | 2.33953 | 11 | 25 | 248 | activation of protein kinase activity |
| GO:0008152 | 0.00023 | 1.24689 | 486 | 542 | 10485 | metabolic process |
| GO:0043170 | 0.00023 | 1.25262 | 393 | 448 | 8488 | macromolecule metabolic process |
| GO:0043507 | 0.00024 | 3.77474 | 4 | 12 | 78 | positive regulation of JUN kinase activity |
| GO:0061515 | 0.00024 | 3.77474 | 4 | 12 | 78 | myeloid cell development |
| GO:0031623 | 0.00024 | 3.02515 | 6 | 16 | 126 | receptor internalization |
| GO:1903524 | 0.00025 | 3.50666 | 4 | 13 | 90 | positive regulation of blood circulation |
| GO:1901362 | 0.00026 | 1.33394 | 163 | 204 | 3510 | organic cyclic compound biosynthetic process |
| GO:0050704 | 0.00026 | 4.90947 | 2 | 9 | 47 | regulation of interleukin-1 secretion |
| GO:0051702 | 0.00027 | 3.71823 | 4 | 12 | 79 | interaction with symbiont |
| GO:0034109 | 0.00027 | 4.00439 | 3 | 11 | 68 | homotypic cell-cell adhesion |
| GO:0007507 | 0.00027 | 1.77803 | 29 | 49 | 628 | heart development |
| GO:0071346 | 0.00028 | 3.11816 | 5 | 15 | 115 | cellular response to interferon-gamma |
| GO:0000185 | 0.00028 | 20.66387 | 0 | 4 | 8 | activation of MAPKKK activity |
| GO:0032661 | 0.00028 | 20.66387 | 0 | 4 | 8 | regulation of interleukin-18 production |
| GO:0035425 | 0.00028 | 20.66387 | 0 | 4 | 8 | autocrine signaling |
| GO:0043313 | 0.00028 | 20.66387 | 0 | 4 | 8 | regulation of neutrophil degranulation |
| GO:0045743 | 0.00028 | 20.66387 | 0 | 4 | 8 | positive regulation of fibroblast growth factor receptor signaling pathway |
| GO:0097368 | 0.00028 | 20.66387 | 0 | 4 | 8 | establishment of Sertoli cell barrier |
| GO:0051254 | 0.00028 | 1.47114 | 76 | 106 | 1638 | positive regulation of RNA metabolic process |
| GO:0006366 | 0.00028 | 1.42228 | 95 | 128 | 2049 | transcription by RNA polymerase II |
| GO:0031295 | 0.00029 | 6.58797 | 1 | 7 | 29 | T cell costimulation |
| GO:0043552 | 0.00029 | 6.58797 | 1 | 7 | 29 | positive regulation of phosphatidylinositol 3-kinase activity |
| GO:0061041 | 0.00029 | 2.85221 | 7 | 17 | 141 | regulation of wound healing |
| GO:0002863 | 0.00029 | 8.27689 | 1 | 6 | 21 | positive regulation of inflammatory response to antigenic stimulus |
| GO:0015732 | 0.00029 | 8.27689 | 1 | 6 | 21 | prostaglandin transport |
| GO:0032693 | 0.00029 | 8.27689 | 1 | 6 | 21 | negative regulation of interleukin-10 production |
| GO:0043267 | 0.00029 | 5.52452 | 2 | 8 | 38 | negative regulation of potassium ion transport |
| GO:1904950 | 0.00029 | 2.45215 | 10 | 22 | 209 | negative regulation of establishment of protein localization |
| GO:0032604 | 0.00030 | 11.48806 | 1 | 5 | 14 | granulocyte macrophage colony-stimulating factor production |
| GO:0032645 | 0.00030 | 11.48806 | 1 | 5 | 14 | regulation of granulocyte macrophage colony-stimulating factor production |
| GO:0045060 | 0.00030 | 11.48806 | 1 | 5 | 14 | negative thymic T cell selection |
| GO:0070486 | 0.00030 | 11.48806 | 1 | 5 | 14 | leukocyte aggregation |
| GO:0030182 | 0.00030 | 1.49016 | 69 | 98 | 1494 | neuron differentiation |
| GO:0050850 | 0.00031 | 4.78337 | 2 | 9 | 48 | positive regulation of calcium-mediated signaling |
| GO:0070848 | 0.00031 | 1.77786 | 28 | 48 | 615 | response to growth factor |
| GO:0007417 | 0.00032 | 1.63721 | 41 | 64 | 888 | central nervous system development |
| GO:0019438 | 0.00032 | 1.33301 | 157 | 197 | 3386 | aromatic compound biosynthetic process |
| GO:0034654 | 0.00033 | 1.33511 | 153 | 193 | 3310 | nucleobase-containing compound biosynthetic process |
| GO:0032412 | 0.00033 | 2.27760 | 12 | 25 | 254 | regulation of ion transmembrane transporter activity |
| GO:0045806 | 0.00035 | 4.23225 | 3 | 10 | 59 | negative regulation of endocytosis |
| GO:0043506 | 0.00035 | 3.37471 | 4 | 13 | 93 | regulation of JUN kinase activity |
| GO:0002483 | 0.00035 | 5.34607 | 2 | 8 | 39 | antigen processing and presentation of endogenous peptide antigen |
| GO:0019885 | 0.00035 | 5.34607 | 2 | 8 | 39 | antigen processing and presentation of endogenous peptide antigen via MHC class I |
| GO:0043551 | 0.00035 | 5.34607 | 2 | 8 | 39 | regulation of phosphatidylinositol 3-kinase activity |
| GO:0044331 | 0.00035 | 5.34607 | 2 | 8 | 39 | cell-cell adhesion mediated by cadherin |
| GO:0002724 | 0.00036 | 6.30125 | 1 | 7 | 30 | regulation of T cell cytokine production |
| GO:0033005 | 0.00036 | 6.30125 | 1 | 7 | 30 | positive regulation of mast cell activation |
| GO:0042533 | 0.00036 | 6.30125 | 1 | 7 | 30 | tumor necrosis factor biosynthetic process |
| GO:0042534 | 0.00036 | 6.30125 | 1 | 7 | 30 | regulation of tumor necrosis factor biosynthetic process |
| GO:0071496 | 0.00036 | 2.18459 | 13 | 27 | 285 | cellular response to external stimulus |
| GO:0010594 | 0.00036 | 2.69480 | 7 | 18 | 157 | regulation of endothelial cell migration |
| GO:0007267 | 0.00038 | 1.46509 | 74 | 103 | 1596 | cell-cell signaling |
| GO:0042493 | 0.00038 | 1.62492 | 41 | 64 | 894 | response to drug |
| GO:0001802 | 0.00038 | 61.94216 | 0 | 3 | 4 | type III hypersensitivity |
| GO:0001803 | 0.00038 | 61.94216 | 0 | 3 | 4 | regulation of type III hypersensitivity |
| GO:0001805 | 0.00038 | 61.94216 | 0 | 3 | 4 | positive regulation of type III hypersensitivity |
| GO:0002351 | 0.00038 | 61.94216 | 0 | 3 | 4 | serotonin production involved in inflammatory response |
| GO:0002442 | 0.00038 | 61.94216 | 0 | 3 | 4 | serotonin secretion involved in inflammatory response |
| GO:0002835 | 0.00038 | 61.94216 | 0 | 3 | 4 | negative regulation of response to tumor cell |
| GO:0002838 | 0.00038 | 61.94216 | 0 | 3 | 4 | negative regulation of immune response to tumor cell |
| GO:0043315 | 0.00038 | 61.94216 | 0 | 3 | 4 | positive regulation of neutrophil degranulation |
| GO:0071896 | 0.00038 | 61.94216 | 0 | 3 | 4 | protein localization to adherens junction |
| GO:0106015 | 0.00038 | 61.94216 | 0 | 3 | 4 | negative regulation of inflammatory response to wounding |
| GO:1902565 | 0.00038 | 61.94216 | 0 | 3 | 4 | positive regulation of neutrophil activation |
| GO:0002834 | 0.00038 | 7.75924 | 1 | 6 | 22 | regulation of response to tumor cell |
| GO:0002837 | 0.00038 | 7.75924 | 1 | 6 | 22 | regulation of immune response to tumor cell |
| GO:0031649 | 0.00038 | 7.75924 | 1 | 6 | 22 | heat generation |
| GO:0032616 | 0.00038 | 7.75924 | 1 | 6 | 22 | interleukin-13 production |
| GO:0033209 | 0.00040 | 4.14742 | 3 | 10 | 60 | tumor necrosis factor-mediated signaling pathway |
| GO:0032409 | 0.00040 | 2.20541 | 13 | 26 | 272 | regulation of transporter activity |
| GO:0033673 | 0.00041 | 2.38775 | 10 | 22 | 214 | negative regulation of kinase activity |
| GO:0045124 | 0.00043 | 4.54963 | 2 | 9 | 50 | regulation of bone resorption |
| GO:0007548 | 0.00043 | 2.15919 | 13 | 27 | 288 | sex differentiation |
| GO:0034162 | 0.00043 | 10.33879 | 1 | 5 | 15 | toll-like receptor 9 signaling pathway |
| GO:0043383 | 0.00043 | 10.33879 | 1 | 5 | 15 | negative T cell selection |
| GO:0031294 | 0.00044 | 6.03843 | 1 | 7 | 31 | lymphocyte costimulation |
| GO:0032967 | 0.00044 | 6.03843 | 1 | 7 | 31 | positive regulation of collagen biosynthetic process |
| GO:0140029 | 0.00048 | 3.25229 | 4 | 13 | 96 | exocytic process |
| GO:0001767 | 0.00048 | 16.53035 | 0 | 4 | 9 | establishment of lymphocyte polarity |
| GO:0001768 | 0.00048 | 16.53035 | 0 | 4 | 9 | establishment of T cell polarity |
| GO:0016338 | 0.00048 | 16.53035 | 0 | 4 | 9 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules |
| GO:0042590 | 0.00048 | 16.53035 | 0 | 4 | 9 | antigen processing and presentation of exogenous peptide antigen via MHC class I |
| GO:0045586 | 0.00048 | 16.53035 | 0 | 4 | 9 | regulation of gamma-delta T cell differentiation |
| GO:0046643 | 0.00048 | 16.53035 | 0 | 4 | 9 | regulation of gamma-delta T cell activation |
| GO:0060556 | 0.00048 | 16.53035 | 0 | 4 | 9 | regulation of vitamin D biosynthetic process |
| GO:0032411 | 0.00048 | 2.94086 | 6 | 15 | 121 | positive regulation of transporter activity |
| GO:0071495 | 0.00049 | 1.51941 | 57 | 82 | 1223 | cellular response to endogenous stimulus |
| GO:0018130 | 0.00049 | 1.32132 | 156 | 195 | 3374 | heterocycle biosynthetic process |
| GO:0090066 | 0.00049 | 1.78451 | 26 | 44 | 561 | regulation of anatomical structure size |
| GO:0031334 | 0.00049 | 2.25402 | 11 | 24 | 246 | positive regulation of protein complex assembly |
| GO:0001911 | 0.00050 | 7.30248 | 1 | 6 | 23 | negative regulation of leukocyte mediated cytotoxicity |
| GO:0035743 | 0.00050 | 7.30248 | 1 | 6 | 23 | CD4-positive, alpha-beta T cell cytokine production |
| GO:0050765 | 0.00050 | 7.30248 | 1 | 6 | 23 | negative regulation of phagocytosis |
| GO:0051353 | 0.00050 | 4.44110 | 2 | 9 | 51 | positive regulation of oxidoreductase activity |
| GO:0006953 | 0.00050 | 5.02161 | 2 | 8 | 41 | acute-phase response |
| GO:0050856 | 0.00050 | 5.02161 | 2 | 8 | 41 | regulation of T cell receptor signaling pathway |
| GO:0099084 | 0.00050 | 5.02161 | 2 | 8 | 41 | postsynaptic specialization organization |
| GO:0043902 | 0.00051 | 2.53497 | 8 | 19 | 175 | positive regulation of multi-organism process |
| GO:0071396 | 0.00051 | 1.74545 | 28 | 47 | 612 | cellular response to lipid |
| GO:0050810 | 0.00051 | 3.68062 | 3 | 11 | 73 | regulation of steroid biosynthetic process |
| GO:0003231 | 0.00051 | 2.69894 | 7 | 17 | 148 | cardiac ventricle development |
| GO:0007015 | 0.00052 | 1.94261 | 19 | 34 | 400 | actin filament organization |
| GO:0032720 | 0.00052 | 3.98754 | 3 | 10 | 62 | negative regulation of tumor necrosis factor production |
| GO:0022898 | 0.00053 | 2.19992 | 12 | 25 | 262 | regulation of transmembrane transporter activity |
| GO:0051341 | 0.00053 | 3.41169 | 4 | 12 | 85 | regulation of oxidoreductase activity |
| GO:0001666 | 0.00054 | 2.39002 | 9 | 21 | 204 | response to hypoxia |
| GO:0030947 | 0.00055 | 5.79663 | 1 | 7 | 32 | regulation of vascular endothelial growth factor receptor signaling pathway |
| GO:0032689 | 0.00055 | 5.79663 | 1 | 7 | 32 | negative regulation of interferon-gamma production |
| GO:0097242 | 0.00055 | 5.79663 | 1 | 7 | 32 | amyloid-beta clearance |
| GO:0007156 | 0.00056 | 3.02924 | 5 | 14 | 110 | homophilic cell adhesion via plasma membrane adhesion molecules |
| GO:0043588 | 0.00056 | 2.11812 | 14 | 27 | 293 | skin development |
| GO:0030324 | 0.00056 | 2.32662 | 10 | 22 | 219 | lung development |
| GO:2001056 | 0.00057 | 2.77180 | 6 | 16 | 136 | positive regulation of cysteine-type endopeptidase activity |
| GO:0043112 | 0.00057 | 2.37692 | 9 | 21 | 205 | receptor metabolic process |
| GO:0002066 | 0.00057 | 3.62203 | 3 | 11 | 74 | columnar/cuboidal epithelial cell development |
| GO:0002532 | 0.00057 | 3.62203 | 3 | 11 | 74 | production of molecular mediator involved in inflammatory response |
| GO:0010712 | 0.00058 | 4.33762 | 2 | 9 | 52 | regulation of collagen metabolic process |
| GO:0050808 | 0.00059 | 1.87018 | 21 | 37 | 451 | synapse organization |
| GO:0072659 | 0.00059 | 2.14370 | 13 | 26 | 279 | protein localization to plasma membrane |
| GO:0035904 | 0.00060 | 3.91213 | 3 | 10 | 63 | aorta development |
| GO:0019883 | 0.00060 | 4.87370 | 2 | 8 | 42 | antigen processing and presentation of endogenous antigen |
| GO:0032768 | 0.00060 | 4.87370 | 2 | 8 | 42 | regulation of monooxygenase activity |
| GO:0000122 | 0.00060 | 1.61270 | 40 | 61 | 857 | negative regulation of transcription by RNA polymerase II |
| GO:0015718 | 0.00060 | 2.65812 | 7 | 17 | 150 | monocarboxylic acid transport |
| GO:0002281 | 0.00060 | 9.39847 | 1 | 5 | 16 | macrophage activation involved in immune response |
| GO:0034134 | 0.00060 | 9.39847 | 1 | 5 | 16 | toll-like receptor 2 signaling pathway |
| GO:0072672 | 0.00060 | 9.39847 | 1 | 5 | 16 | neutrophil extravasation |
| GO:0021782 | 0.00061 | 2.99787 | 5 | 14 | 111 | glial cell development |
| GO:0002418 | 0.00064 | 6.89648 | 1 | 6 | 24 | immune response to tumor cell |
| GO:0002693 | 0.00064 | 6.89648 | 1 | 6 | 24 | positive regulation of cellular extravasation |
| GO:0034104 | 0.00064 | 6.89648 | 1 | 6 | 24 | negative regulation of tissue remodeling |
| GO:0071363 | 0.00065 | 1.73500 | 28 | 46 | 602 | cellular response to growth factor stimulus |
| GO:2000117 | 0.00066 | 3.32041 | 4 | 12 | 87 | negative regulation of cysteine-type endopeptidase activity |
| GO:0060541 | 0.00066 | 2.20387 | 12 | 24 | 251 | respiratory system development |
| GO:0010573 | 0.00066 | 5.57343 | 2 | 7 | 33 | vascular endothelial growth factor production |
| GO:0090218 | 0.00066 | 5.57343 | 2 | 7 | 33 | positive regulation of lipid kinase activity |
| GO:0030010 | 0.00067 | 2.72611 | 6 | 16 | 138 | establishment of cell polarity |
| GO:0034767 | 0.00067 | 2.47115 | 8 | 19 | 179 | positive regulation of ion transmembrane transport |
| GO:0042269 | 0.00067 | 4.23885 | 2 | 9 | 53 | regulation of natural killer cell mediated cytotoxicity |
| GO:0055010 | 0.00067 | 4.23885 | 2 | 9 | 53 | ventricular cardiac muscle tissue morphogenesis |
| GO:0016525 | 0.00067 | 2.96715 | 5 | 14 | 112 | negative regulation of angiogenesis |
| GO:0030323 | 0.00067 | 2.29141 | 10 | 22 | 222 | respiratory tube development |
| GO:0071704 | 0.00068 | 1.22471 | 464 | 515 | 10008 | organic substance metabolic process |
| GO:0048246 | 0.00070 | 4.73423 | 2 | 8 | 43 | macrophage chemotaxis |
| GO:0070232 | 0.00070 | 4.73423 | 2 | 8 | 43 | regulation of T cell apoptotic process |
| GO:0086002 | 0.00070 | 4.73423 | 2 | 8 | 43 | cardiac muscle cell action potential involved in contraction |
| GO:0006469 | 0.00071 | 2.39266 | 9 | 20 | 194 | negative regulation of protein kinase activity |
| GO:0097190 | 0.00072 | 1.72545 | 28 | 46 | 605 | apoptotic signaling pathway |
| GO:0006809 | 0.00072 | 3.51027 | 4 | 11 | 76 | nitric oxide biosynthetic process |
| GO:0055008 | 0.00072 | 3.51027 | 4 | 11 | 76 | cardiac muscle tissue morphogenesis |
| GO:0070228 | 0.00072 | 3.51027 | 4 | 11 | 76 | regulation of lymphocyte apoptotic process |
| GO:0008544 | 0.00073 | 2.01789 | 15 | 29 | 329 | epidermis development |
| GO:1904019 | 0.00073 | 2.93704 | 5 | 14 | 113 | epithelial cell apoptotic process |
| GO:2000177 | 0.00073 | 2.93704 | 5 | 14 | 113 | regulation of neural precursor cell proliferation |
| GO:0010950 | 0.00075 | 2.59913 | 7 | 17 | 153 | positive regulation of endopeptidase activity |
| GO:0051961 | 0.00076 | 1.96202 | 17 | 31 | 361 | negative regulation of nervous system development |
| GO:0033689 | 0.00077 | 13.77467 | 0 | 4 | 10 | negative regulation of osteoblast proliferation |
| GO:0034145 | 0.00077 | 13.77467 | 0 | 4 | 10 | positive regulation of toll-like receptor 4 signaling pathway |
| GO:2001179 | 0.00077 | 13.77467 | 0 | 4 | 10 | regulation of interleukin-10 secretion |
| GO:0002715 | 0.00077 | 4.14447 | 3 | 9 | 54 | regulation of natural killer cell mediated immunity |
| GO:0032964 | 0.00077 | 4.14447 | 3 | 9 | 54 | collagen biosynthetic process |
| GO:0010001 | 0.00077 | 2.21860 | 11 | 23 | 239 | glial cell differentiation |
| GO:0010038 | 0.00078 | 2.13612 | 12 | 25 | 269 | response to metal ion |
| GO:0034446 | 0.00078 | 3.06680 | 5 | 13 | 101 | substrate adhesion-dependent cell spreading |
| GO:0050848 | 0.00078 | 3.06680 | 5 | 13 | 101 | regulation of calcium-mediated signaling |
| GO:0043062 | 0.00079 | 2.03583 | 15 | 28 | 315 | extracellular structure organization |
| GO:0010811 | 0.00080 | 2.78256 | 6 | 15 | 127 | positive regulation of cell-substrate adhesion |
| GO:0032414 | 0.00080 | 2.90754 | 5 | 14 | 114 | positive regulation of ion transmembrane transporter activity |
| GO:0010714 | 0.00080 | 5.36676 | 2 | 7 | 34 | positive regulation of collagen metabolic process |
| GO:0010737 | 0.00080 | 5.36676 | 2 | 7 | 34 | protein kinase A signaling |
| GO:0010575 | 0.00081 | 6.53321 | 1 | 6 | 25 | positive regulation of vascular endothelial growth factor production |
| GO:0032703 | 0.00081 | 6.53321 | 1 | 6 | 25 | negative regulation of interleukin-2 production |
| GO:0050832 | 0.00081 | 6.53321 | 1 | 6 | 25 | defense response to fungus |
| GO:0014015 | 0.00081 | 3.23388 | 4 | 12 | 89 | positive regulation of gliogenesis |
| GO:0046907 | 0.00081 | 1.44571 | 70 | 96 | 1502 | intracellular transport |
| GO:0002922 | 0.00082 | 8.61488 | 1 | 5 | 17 | positive regulation of humoral immune response |
| GO:0032310 | 0.00082 | 8.61488 | 1 | 5 | 17 | prostaglandin secretion |
| GO:0048739 | 0.00082 | 8.61488 | 1 | 5 | 17 | cardiac muscle fiber development |
| GO:0050755 | 0.00082 | 8.61488 | 1 | 5 | 17 | chemokine metabolic process |
| GO:0019932 | 0.00083 | 1.86667 | 20 | 35 | 427 | second-messenger-mediated signaling |
| GO:0031344 | 0.00083 | 1.62290 | 36 | 56 | 781 | regulation of cell projection organization |
| GO:0007346 | 0.00085 | 1.79775 | 23 | 39 | 493 | regulation of mitotic cell cycle |
| GO:1901343 | 0.00087 | 2.75781 | 6 | 15 | 128 | negative regulation of vasculature development |
| GO:0051896 | 0.00087 | 2.56122 | 7 | 17 | 155 | regulation of protein kinase B signaling |
| GO:0061351 | 0.00087 | 2.41044 | 8 | 19 | 183 | neural precursor cell proliferation |
| GO:0002833 | 0.00088 | 4.05418 | 3 | 9 | 55 | positive regulation of response to biotic stimulus |
| GO:0002238 | 0.00092 | 30.96968 | 0 | 3 | 5 | response to molecule of fungal origin |
| GO:0014005 | 0.00092 | 30.96968 | 0 | 3 | 5 | microglia development |
| GO:0042091 | 0.00092 | 30.96968 | 0 | 3 | 5 | interleukin-10 biosynthetic process |
| GO:0045074 | 0.00092 | 30.96968 | 0 | 3 | 5 | regulation of interleukin-10 biosynthetic process |
| GO:0051025 | 0.00092 | 30.96968 | 0 | 3 | 5 | negative regulation of immunoglobulin secretion |
| GO:0060298 | 0.00092 | 30.96968 | 0 | 3 | 5 | positive regulation of sarcomere organization |
| GO:0106014 | 0.00092 | 30.96968 | 0 | 3 | 5 | regulation of inflammatory response to wounding |
| GO:0001890 | 0.00094 | 2.46287 | 8 | 18 | 170 | placenta development |
| GO:2000181 | 0.00095 | 2.85027 | 5 | 14 | 116 | negative regulation of blood vessel morphogenesis |
| GO:0043304 | 0.00096 | 5.17486 | 2 | 7 | 35 | regulation of mast cell degranulation |
| GO:0060441 | 0.00096 | 5.17486 | 2 | 7 | 35 | epithelial tube branching involved in lung morphogenesis |
| GO:0097106 | 0.00096 | 5.17486 | 2 | 7 | 35 | postsynaptic density organization |
| GO:1902895 | 0.00096 | 5.17486 | 2 | 7 | 35 | positive regulation of pri-miRNA transcription by RNA polymerase II |
| GO:0002673 | 0.00098 | 3.63693 | 3 | 10 | 67 | regulation of acute inflammatory response |
| GO:0040008 | 0.00098 | 1.64111 | 33 | 52 | 717 | regulation of growth |
| GO:0010634 | 0.00098 | 2.61819 | 7 | 16 | 143 | positive regulation of epithelial cell migration |
| GO:0048589 | 0.00099 | 1.60913 | 36 | 56 | 787 | developmental growth |
| GO:0003208 | 0.00101 | 3.35495 | 4 | 11 | 79 | cardiac ventricle morphogenesis |
| GO:0050858 | 0.00101 | 6.20627 | 1 | 6 | 26 | negative regulation of antigen receptor-mediated signaling pathway |
| GO:1901380 | 0.00101 | 6.20627 | 1 | 6 | 26 | negative regulation of potassium ion transmembrane transport |
| GO:0017157 | 0.00103 | 2.16791 | 11 | 23 | 244 | regulation of exocytosis |
| GO:0030101 | 0.00103 | 2.96529 | 5 | 13 | 104 | natural killer cell activation |
| GO:0032674 | 0.00109 | 7.95183 | 1 | 5 | 18 | regulation of interleukin-5 production |
| GO:0045428 | 0.00110 | 3.57407 | 3 | 10 | 68 | regulation of nitric oxide biosynthetic process |
| GO:0006629 | 0.00111 | 1.47173 | 58 | 82 | 1258 | lipid metabolic process |
| GO:0002312 | 0.00112 | 3.30617 | 4 | 11 | 80 | B cell activation involved in immune response |
| GO:0043154 | 0.00112 | 3.30617 | 4 | 11 | 80 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic process |
| GO:0046209 | 0.00112 | 3.30617 | 4 | 11 | 80 | nitric oxide metabolic process |
| GO:1903727 | 0.00112 | 4.35989 | 2 | 8 | 46 | positive regulation of phospholipid metabolic process |
| GO:0043254 | 0.00113 | 1.81342 | 21 | 36 | 451 | regulation of protein complex assembly |
| GO:1905952 | 0.00114 | 2.57736 | 7 | 16 | 145 | regulation of lipid localization |
| GO:0000226 | 0.00115 | 1.71508 | 26 | 43 | 568 | microtubule cytoskeleton organization |
| GO:0033006 | 0.00115 | 4.99619 | 2 | 7 | 36 | regulation of mast cell activation involved in immune response |
| GO:0045601 | 0.00115 | 4.99619 | 2 | 7 | 36 | regulation of endothelial cell differentiation |
| GO:0051181 | 0.00115 | 4.99619 | 2 | 7 | 36 | cofactor transport |
| GO:0098751 | 0.00115 | 4.99619 | 2 | 7 | 36 | bone cell development |
| GO:0033554 | 0.00116 | 1.39722 | 82 | 109 | 1763 | cellular response to stress |
| GO:0002468 | 0.00116 | 11.80632 | 1 | 4 | 11 | dendritic cell antigen processing and presentation |
| GO:0042368 | 0.00116 | 11.80632 | 1 | 4 | 11 | vitamin D biosynthetic process |
| GO:1902260 | 0.00116 | 11.80632 | 1 | 4 | 11 | negative regulation of delayed rectifier potassium channel activity |
| GO:0032370 | 0.00123 | 3.51333 | 3 | 10 | 69 | positive regulation of lipid transport |
| GO:2000107 | 0.00123 | 3.51333 | 3 | 10 | 69 | negative regulation of leukocyte apoptotic process |
| GO:1903169 | 0.00124 | 2.47111 | 7 | 17 | 160 | regulation of calcium ion transmembrane transport |
| GO:0003018 | 0.00124 | 2.27405 | 9 | 20 | 203 | vascular process in circulatory system |
| GO:0002347 | 0.00125 | 5.91046 | 1 | 6 | 27 | response to tumor cell |
| GO:0031342 | 0.00125 | 5.91046 | 1 | 6 | 27 | negative regulation of cell killing |
| GO:0045730 | 0.00125 | 5.91046 | 1 | 6 | 27 | respiratory burst |
| GO:0050901 | 0.00125 | 5.91046 | 1 | 6 | 27 | leukocyte tethering or rolling |
| GO:0060713 | 0.00125 | 5.91046 | 1 | 6 | 27 | labyrinthine layer morphogenesis |
| GO:0071402 | 0.00125 | 5.91046 | 1 | 6 | 27 | cellular response to lipoprotein particle stimulus |
| GO:1903827 | 0.00125 | 1.74356 | 24 | 40 | 520 | regulation of cellular protein localization |
| GO:0045930 | 0.00128 | 2.17086 | 11 | 22 | 233 | negative regulation of mitotic cell cycle |
| GO:1901568 | 0.00129 | 2.64035 | 6 | 15 | 133 | fatty acid derivative metabolic process |
| GO:0002639 | 0.00130 | 4.24790 | 2 | 8 | 47 | positive regulation of immunoglobulin production |
| GO:0045429 | 0.00130 | 4.24790 | 2 | 8 | 47 | positive regulation of nitric oxide biosynthetic process |
| GO:0098900 | 0.00131 | 3.80545 | 3 | 9 | 58 | regulation of action potential |
| GO:0031175 | 0.00132 | 1.49988 | 50 | 72 | 1083 | neuron projection development |
| GO:0045746 | 0.00136 | 4.82943 | 2 | 7 | 37 | negative regulation of Notch signaling pathway |
| GO:0061756 | 0.00136 | 4.82943 | 2 | 7 | 37 | leukocyte adhesion to vascular endothelial cell |
| GO:0097028 | 0.00136 | 4.82943 | 2 | 7 | 37 | dendritic cell differentiation |
| GO:0042130 | 0.00138 | 3.45462 | 3 | 10 | 70 | negative regulation of T cell proliferation |
| GO:1903725 | 0.00138 | 3.45462 | 3 | 10 | 70 | regulation of phospholipid metabolic process |
| GO:1990868 | 0.00138 | 3.45462 | 3 | 10 | 70 | response to chemokine |
| GO:1990869 | 0.00138 | 3.45462 | 3 | 10 | 70 | cellular response to chemokine |
| GO:0002262 | 0.00140 | 2.36869 | 8 | 18 | 176 | myeloid cell homeostasis |
| GO:0010952 | 0.00142 | 2.43680 | 8 | 17 | 162 | positive regulation of peptidase activity |
| GO:0031348 | 0.00142 | 2.19626 | 10 | 21 | 220 | negative regulation of defense response |
| GO:0002043 | 0.00143 | 7.38351 | 1 | 5 | 19 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis |
| GO:0031664 | 0.00143 | 7.38351 | 1 | 5 | 19 | regulation of lipopolysaccharide-mediated signaling pathway |
| GO:0032634 | 0.00143 | 7.38351 | 1 | 5 | 19 | interleukin-5 production |
| GO:0060088 | 0.00143 | 7.38351 | 1 | 5 | 19 | auditory receptor cell stereocilium organization |
| GO:0046717 | 0.00144 | 2.71646 | 6 | 14 | 121 | acid secretion |
| GO:1903409 | 0.00144 | 2.71646 | 6 | 14 | 121 | reactive oxygen species biosynthetic process |
| GO:1903829 | 0.00148 | 1.99967 | 14 | 26 | 297 | positive regulation of cellular protein localization |
| GO:1903078 | 0.00148 | 3.72917 | 3 | 9 | 59 | positive regulation of protein localization to plasma membrane |
| GO:0043550 | 0.00149 | 4.14152 | 2 | 8 | 48 | regulation of lipid kinase activity |
| GO:1904407 | 0.00149 | 4.14152 | 2 | 8 | 48 | positive regulation of nitric oxide metabolic process |
| GO:0007088 | 0.00152 | 2.42000 | 8 | 17 | 163 | regulation of mitotic nuclear division |
| GO:0035162 | 0.00153 | 5.64155 | 1 | 6 | 28 | embryonic hemopoiesis |
| GO:0060445 | 0.00153 | 5.64155 | 1 | 6 | 28 | branching involved in salivary gland morphogenesis |
| GO:1902932 | 0.00153 | 5.64155 | 1 | 6 | 28 | positive regulation of alcohol biosynthetic process |
| GO:0032413 | 0.00154 | 3.39783 | 3 | 10 | 71 | negative regulation of ion transmembrane transporter activity |
| GO:0072657 | 0.00155 | 1.70874 | 25 | 41 | 543 | protein localization to membrane |
| GO:0002377 | 0.00157 | 2.09141 | 12 | 23 | 252 | immunoglobulin production |
| GO:0007200 | 0.00159 | 2.96345 | 4 | 12 | 96 | phospholipase C-activating G protein-coupled receptor signaling pathway |
| GO:0030279 | 0.00159 | 2.96345 | 4 | 12 | 96 | negative regulation of ossification |
| GO:0032963 | 0.00159 | 2.81021 | 5 | 13 | 109 | collagen metabolic process |
| GO:0014002 | 0.00160 | 4.67343 | 2 | 7 | 38 | astrocyte development |
| GO:0006970 | 0.00168 | 3.12445 | 4 | 11 | 84 | response to osmotic stress |
| GO:1901379 | 0.00168 | 3.12445 | 4 | 11 | 84 | regulation of potassium ion transmembrane transport |
| GO:2001057 | 0.00168 | 3.12445 | 4 | 11 | 84 | reactive nitrogen species metabolic process |
| GO:0032725 | 0.00168 | 10.33007 | 1 | 4 | 12 | positive regulation of granulocyte macrophage colony-stimulating factor production |
| GO:0032754 | 0.00168 | 10.33007 | 1 | 4 | 12 | positive regulation of interleukin-5 production |
| GO:1900165 | 0.00168 | 10.33007 | 1 | 4 | 12 | negative regulation of interleukin-6 secretion |
| GO:0010921 | 0.00169 | 2.66638 | 6 | 14 | 123 | regulation of phosphatase activity |
| GO:0035690 | 0.00172 | 1.85359 | 18 | 31 | 380 | cellular response to drug |
| GO:0001776 | 0.00173 | 2.78112 | 5 | 13 | 110 | leukocyte homeostasis |
| GO:0072676 | 0.00174 | 2.92845 | 4 | 12 | 97 | lymphocyte migration |
| GO:0044238 | 0.00174 | 1.20443 | 437 | 484 | 9443 | primary metabolic process |
| GO:0002925 | 0.00178 | 20.64552 | 0 | 3 | 6 | positive regulation of humoral immune response mediated by circulating immunoglobulin |
| GO:0008228 | 0.00178 | 20.64552 | 0 | 3 | 6 | opsonization |
| GO:0038033 | 0.00178 | 20.64552 | 0 | 3 | 6 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway |
| GO:0045588 | 0.00178 | 20.64552 | 0 | 3 | 6 | positive regulation of gamma-delta T cell differentiation |
| GO:0046645 | 0.00178 | 20.64552 | 0 | 3 | 6 | positive regulation of gamma-delta T cell activation |
| GO:0070339 | 0.00178 | 20.64552 | 0 | 3 | 6 | response to bacterial lipopeptide |
| GO:0071220 | 0.00178 | 20.64552 | 0 | 3 | 6 | cellular response to bacterial lipoprotein |
| GO:0071221 | 0.00178 | 20.64552 | 0 | 3 | 6 | cellular response to bacterial lipopeptide |
| GO:0071224 | 0.00178 | 20.64552 | 0 | 3 | 6 | cellular response to peptidoglycan |
| GO:2000321 | 0.00178 | 20.64552 | 0 | 3 | 6 | positive regulation of T-helper 17 cell differentiation |
| GO:2001181 | 0.00178 | 20.64552 | 0 | 3 | 6 | positive regulation of interleukin-10 secretion |
| GO:0046942 | 0.00178 | 1.97022 | 14 | 26 | 301 | carboxylic acid transport |
| GO:0009615 | 0.00180 | 2.03189 | 13 | 24 | 270 | response to virus |
| GO:0060560 | 0.00180 | 2.03189 | 13 | 24 | 270 | developmental growth involved in morphogenesis |
| GO:0001946 | 0.00183 | 6.89097 | 1 | 5 | 20 | lymphangiogenesis |
| GO:0002523 | 0.00183 | 6.89097 | 1 | 5 | 20 | leukocyte migration involved in inflammatory response |
| GO:0002755 | 0.00183 | 6.89097 | 1 | 5 | 20 | MyD88-dependent toll-like receptor signaling pathway |
| GO:0035855 | 0.00183 | 6.89097 | 1 | 5 | 20 | megakaryocyte development |
| GO:0045649 | 0.00183 | 6.89097 | 1 | 5 | 20 | regulation of macrophage differentiation |
| GO:0048143 | 0.00183 | 6.89097 | 1 | 5 | 20 | astrocyte activation |
| GO:0060252 | 0.00183 | 6.89097 | 1 | 5 | 20 | positive regulation of glial cell proliferation |
| GO:0033687 | 0.00185 | 5.39602 | 1 | 6 | 29 | osteoblast proliferation |
| GO:0051783 | 0.00185 | 2.24486 | 9 | 19 | 195 | regulation of nuclear division |
| GO:0015849 | 0.00187 | 1.96299 | 14 | 26 | 302 | organic acid transport |
| GO:0045840 | 0.00188 | 3.58542 | 3 | 9 | 61 | positive regulation of mitotic nuclear division |
| GO:1903428 | 0.00188 | 3.58542 | 3 | 9 | 61 | positive regulation of reactive oxygen species biosynthetic process |
| GO:0030198 | 0.00189 | 2.02357 | 13 | 24 | 271 | extracellular matrix organization |
| GO:0042491 | 0.00196 | 3.94395 | 2 | 8 | 50 | inner ear auditory receptor cell differentiation |
| GO:0060322 | 0.00196 | 1.60659 | 32 | 49 | 688 | head development |
| GO:0035303 | 0.00197 | 2.35504 | 8 | 17 | 167 | regulation of dephosphorylation |
| GO:0008593 | 0.00203 | 3.04085 | 4 | 11 | 86 | regulation of Notch signaling pathway |
| GO:0015908 | 0.00203 | 3.04085 | 4 | 11 | 86 | fatty acid transport |
| GO:0010466 | 0.00207 | 2.08120 | 11 | 22 | 242 | negative regulation of peptidase activity |
| GO:0051607 | 0.00209 | 2.12095 | 11 | 21 | 227 | defense response to virus |
| GO:0003229 | 0.00211 | 3.51761 | 3 | 9 | 62 | ventricular cardiac muscle tissue development |
| GO:0097327 | 0.00212 | 3.23812 | 3 | 10 | 74 | response to antineoplastic agent |
| GO:0006936 | 0.00212 | 1.97249 | 13 | 25 | 289 | muscle contraction |
| GO:0002032 | 0.00214 | Inf | 0 | 2 | 2 | desensitization of G protein-coupled receptor signaling pathway by arrestin |
| GO:0002380 | 0.00214 | Inf | 0 | 2 | 2 | immunoglobulin secretion involved in immune response |
| GO:0003366 | 0.00214 | Inf | 0 | 2 | 2 | cell-matrix adhesion involved in ameboidal cell migration |
| GO:0015882 | 0.00214 | Inf | 0 | 2 | 2 | L-ascorbic acid transmembrane transport |
| GO:0032701 | 0.00214 | Inf | 0 | 2 | 2 | negative regulation of interleukin-18 production |
| GO:0034125 | 0.00214 | Inf | 0 | 2 | 2 | negative regulation of MyD88-dependent toll-like receptor signaling pathway |
| GO:0034178 | 0.00214 | Inf | 0 | 2 | 2 | toll-like receptor 13 signaling pathway |
| GO:0045659 | 0.00214 | Inf | 0 | 2 | 2 | negative regulation of neutrophil differentiation |
| GO:0061017 | 0.00214 | Inf | 0 | 2 | 2 | hepatoblast differentiation |
| GO:0070904 | 0.00214 | Inf | 0 | 2 | 2 | transepithelial L-ascorbic acid transport |
| GO:0071226 | 0.00214 | Inf | 0 | 2 | 2 | cellular response to molecule of fungal origin |
| GO:0071460 | 0.00214 | Inf | 0 | 2 | 2 | cellular response to cell-matrix adhesion |
| GO:0072564 | 0.00214 | Inf | 0 | 2 | 2 | blood microparticle formation |
| GO:0090634 | 0.00214 | Inf | 0 | 2 | 2 | microglial cell mediated cytotoxicity |
| GO:1900220 | 0.00214 | Inf | 0 | 2 | 2 | semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis |
| GO:1902159 | 0.00214 | Inf | 0 | 2 | 2 | regulation of cyclic nucleotide-gated ion channel activity |
| GO:1904149 | 0.00214 | Inf | 0 | 2 | 2 | regulation of microglial cell mediated cytotoxicity |
| GO:1904151 | 0.00214 | Inf | 0 | 2 | 2 | positive regulation of microglial cell mediated cytotoxicity |
| GO:1905704 | 0.00214 | Inf | 0 | 2 | 2 | positive regulation of inhibitory synapse assembly |
| GO:2000332 | 0.00214 | Inf | 0 | 2 | 2 | regulation of blood microparticle formation |
| GO:2000334 | 0.00214 | Inf | 0 | 2 | 2 | positive regulation of blood microparticle formation |
| GO:2000521 | 0.00214 | Inf | 0 | 2 | 2 | negative regulation of immunological synapse formation |
| GO:2000522 | 0.00214 | Inf | 0 | 2 | 2 | positive regulation of immunological synapse formation |
| GO:2001189 | 0.00214 | Inf | 0 | 2 | 2 | negative regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell |
| GO:0050768 | 0.00216 | 1.88898 | 16 | 28 | 337 | negative regulation of neurogenesis |
| GO:0045786 | 0.00219 | 1.75274 | 21 | 35 | 452 | negative regulation of cell cycle |
| GO:0032620 | 0.00219 | 4.38980 | 2 | 7 | 40 | interleukin-17 production |
| GO:0045911 | 0.00219 | 4.38980 | 2 | 7 | 40 | positive regulation of DNA recombination |
| GO:0001952 | 0.00221 | 2.69732 | 5 | 13 | 113 | regulation of cell-matrix adhesion |
| GO:2000778 | 0.00222 | 5.17095 | 1 | 6 | 30 | positive regulation of interleukin-6 secretion |
| GO:0070252 | 0.00223 | 3.00070 | 4 | 11 | 87 | actin-mediated cell contraction |
| GO:0048640 | 0.00229 | 2.57153 | 6 | 14 | 127 | negative regulation of developmental growth |
| GO:0046165 | 0.00231 | 2.47181 | 7 | 15 | 141 | alcohol biosynthetic process |
| GO:0036303 | 0.00231 | 6.45999 | 1 | 5 | 21 | lymph vessel morphogenesis |
| GO:0042535 | 0.00231 | 6.45999 | 1 | 5 | 21 | positive regulation of tumor necrosis factor biosynthetic process |
| GO:0048569 | 0.00231 | 6.45999 | 1 | 5 | 21 | post-embryonic animal organ development |
| GO:0051023 | 0.00231 | 6.45999 | 1 | 5 | 21 | regulation of immunoglobulin secretion |
| GO:1901017 | 0.00231 | 6.45999 | 1 | 5 | 21 | negative regulation of potassium ion transmembrane transporter activity |
| GO:0097191 | 0.00232 | 2.10036 | 11 | 21 | 229 | extrinsic apoptotic signaling pathway |
| GO:1901617 | 0.00232 | 2.10036 | 11 | 21 | 229 | organic hydroxy compound biosynthetic process |
| GO:0006857 | 0.00234 | 9.18187 | 1 | 4 | 13 | oligopeptide transport |
| GO:0060670 | 0.00234 | 9.18187 | 1 | 4 | 13 | branching involved in labyrinthine layer morphogenesis |
| GO:0090594 | 0.00234 | 9.18187 | 1 | 4 | 13 | inflammatory response to wounding |
| GO:1903587 | 0.00234 | 9.18187 | 1 | 4 | 13 | regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis |
| GO:1903817 | 0.00234 | 9.18187 | 1 | 4 | 13 | negative regulation of voltage-gated potassium channel activity |
| GO:0060563 | 0.00234 | 3.18815 | 3 | 10 | 75 | neuroepithelial cell differentiation |
| GO:0046890 | 0.00238 | 2.30855 | 8 | 17 | 170 | regulation of lipid biosynthetic process |
| GO:0043534 | 0.00239 | 2.67049 | 5 | 13 | 114 | blood vessel endothelial cell migration |
| GO:0032386 | 0.00241 | 1.75682 | 20 | 34 | 438 | regulation of intracellular transport |
| GO:0015672 | 0.00244 | 1.73998 | 21 | 35 | 455 | monovalent inorganic cation transport |
| GO:0001764 | 0.00244 | 2.24012 | 9 | 18 | 185 | neuron migration |
| GO:1903035 | 0.00245 | 2.96160 | 4 | 11 | 88 | negative regulation of response to wounding |
| GO:0036293 | 0.00245 | 2.09022 | 11 | 21 | 230 | response to decreased oxygen levels |
| GO:0051348 | 0.00253 | 2.04366 | 11 | 22 | 246 | negative regulation of transferase activity |
| GO:2001222 | 0.00253 | 3.76434 | 2 | 8 | 52 | regulation of neuron migration |
| GO:0002832 | 0.00253 | 4.26049 | 2 | 7 | 41 | negative regulation of response to biotic stimulus |
| GO:0007431 | 0.00253 | 4.26049 | 2 | 7 | 41 | salivary gland development |
| GO:2000008 | 0.00253 | 4.26049 | 2 | 7 | 41 | regulation of protein localization to cell surface |
| GO:2001258 | 0.00253 | 4.26049 | 2 | 7 | 41 | negative regulation of cation channel activity |
| GO:0051656 | 0.00254 | 1.72038 | 22 | 36 | 473 | establishment of organelle localization |
| GO:0048666 | 0.00255 | 1.43551 | 57 | 78 | 1222 | neuron development |
| GO:1901576 | 0.00257 | 1.23036 | 233 | 271 | 5031 | organic substance biosynthetic process |
| GO:0060348 | 0.00258 | 2.08017 | 11 | 21 | 231 | bone development |
| GO:1903305 | 0.00259 | 2.22669 | 9 | 18 | 186 | regulation of regulated secretory pathway |
| GO:0019229 | 0.00259 | 3.13971 | 4 | 10 | 76 | regulation of vasoconstriction |
| GO:0030168 | 0.00259 | 3.13971 | 4 | 10 | 76 | platelet activation |
| GO:0048844 | 0.00259 | 3.13971 | 4 | 10 | 76 | artery morphogenesis |
| GO:0042306 | 0.00264 | 3.38939 | 3 | 9 | 64 | regulation of protein import into nucleus |
| GO:0010574 | 0.00265 | 4.96389 | 1 | 6 | 31 | regulation of vascular endothelial growth factor production |
| GO:0019884 | 0.00265 | 4.96389 | 1 | 6 | 31 | antigen processing and presentation of exogenous antigen |
| GO:0033081 | 0.00265 | 4.96389 | 1 | 6 | 31 | regulation of T cell differentiation in thymus |
| GO:0042036 | 0.00265 | 4.96389 | 1 | 6 | 31 | negative regulation of cytokine biosynthetic process |
| GO:0045932 | 0.00265 | 4.96389 | 1 | 6 | 31 | negative regulation of muscle contraction |
| GO:0099560 | 0.00265 | 4.96389 | 1 | 6 | 31 | synaptic membrane adhesion |
| GO:0097435 | 0.00266 | 1.58762 | 32 | 48 | 681 | supramolecular fiber organization |
| GO:0051897 | 0.00266 | 2.76513 | 5 | 12 | 102 | positive regulation of protein kinase B signaling |
| GO:1905477 | 0.00266 | 2.76513 | 5 | 12 | 102 | positive regulation of protein localization to membrane |
| GO:0060415 | 0.00268 | 2.92350 | 4 | 11 | 89 | muscle tissue morphogenesis |
| GO:0061180 | 0.00285 | 3.09271 | 4 | 10 | 77 | mammary gland epithelium development |
| GO:0034764 | 0.00286 | 2.06036 | 11 | 21 | 233 | positive regulation of transmembrane transport |
| GO:0120035 | 0.00286 | 1.54467 | 36 | 53 | 772 | regulation of plasma membrane bounded cell projection organization |
| GO:0031644 | 0.00286 | 2.26384 | 8 | 17 | 173 | regulation of neurological system process |
| GO:0002204 | 0.00286 | 3.68052 | 2 | 8 | 53 | somatic recombination of immunoglobulin genes involved in immune response |
| GO:0002208 | 0.00286 | 3.68052 | 2 | 8 | 53 | somatic diversification of immunoglobulins involved in immune response |
| GO:0045190 | 0.00286 | 3.68052 | 2 | 8 | 53 | isotype switching |
| GO:0045214 | 0.00286 | 3.68052 | 2 | 8 | 53 | sarcomere organization |
| GO:0071715 | 0.00286 | 3.68052 | 2 | 8 | 53 | icosanoid transport |
| GO:1901571 | 0.00286 | 3.68052 | 2 | 8 | 53 | fatty acid derivative transport |
| GO:0051875 | 0.00288 | 6.07971 | 1 | 5 | 22 | pigment granule localization |
| GO:0097205 | 0.00288 | 6.07971 | 1 | 5 | 22 | renal filtration |
| GO:1904469 | 0.00288 | 6.07971 | 1 | 5 | 22 | positive regulation of tumor necrosis factor secretion |
| GO:1990778 | 0.00289 | 1.84654 | 16 | 28 | 344 | protein localization to cell periphery |
| GO:0002823 | 0.00292 | 4.13858 | 2 | 7 | 42 | negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains |
| GO:0030866 | 0.00292 | 4.13858 | 2 | 7 | 42 | cortical actin cytoskeleton organization |
| GO:0042770 | 0.00293 | 2.88636 | 4 | 11 | 90 | signal transduction in response to DNA damage |
| GO:0043535 | 0.00293 | 2.88636 | 4 | 11 | 90 | regulation of blood vessel endothelial cell migration |
| GO:0016445 | 0.00294 | 3.32872 | 3 | 9 | 65 | somatic diversification of immunoglobulins |
| GO:0060425 | 0.00294 | 3.32872 | 3 | 9 | 65 | lung morphogenesis |
| GO:0042552 | 0.00296 | 2.32355 | 7 | 16 | 159 | myelination |
| GO:0006813 | 0.00301 | 2.05059 | 11 | 21 | 234 | potassium ion transport |
| GO:0002576 | 0.00301 | 15.48344 | 0 | 3 | 7 | platelet degranulation |
| GO:0009635 | 0.00301 | 15.48344 | 0 | 3 | 7 | response to herbicide |
| GO:0032493 | 0.00301 | 15.48344 | 0 | 3 | 7 | response to bacterial lipoprotein |
| GO:0033634 | 0.00301 | 15.48344 | 0 | 3 | 7 | positive regulation of cell-cell adhesion mediated by integrin |
| GO:0034141 | 0.00301 | 15.48344 | 0 | 3 | 7 | positive regulation of toll-like receptor 3 signaling pathway |
| GO:0045409 | 0.00301 | 15.48344 | 0 | 3 | 7 | negative regulation of interleukin-6 biosynthetic process |
| GO:0045630 | 0.00301 | 15.48344 | 0 | 3 | 7 | positive regulation of T-helper 2 cell differentiation |
| GO:1903003 | 0.00301 | 15.48344 | 0 | 3 | 7 | positive regulation of protein deubiquitination |
| GO:0007420 | 0.00313 | 1.59818 | 29 | 45 | 634 | brain development |
| GO:0016049 | 0.00313 | 1.67097 | 24 | 38 | 513 | cell growth |
| GO:0045672 | 0.00313 | 4.77276 | 1 | 6 | 32 | positive regulation of osteoclast differentiation |
| GO:0051180 | 0.00313 | 4.77276 | 1 | 6 | 32 | vitamin transport |
| GO:0060561 | 0.00313 | 4.77276 | 1 | 6 | 32 | apoptotic process involved in morphogenesis |
| GO:0060669 | 0.00313 | 4.77276 | 1 | 6 | 32 | embryonic placenta morphogenesis |
| GO:0060706 | 0.00313 | 4.77276 | 1 | 6 | 32 | cell differentiation involved in embryonic placenta development |
| GO:0042136 | 0.00313 | 2.70477 | 5 | 12 | 104 | neurotransmitter biosynthetic process |
| GO:0002260 | 0.00314 | 3.04709 | 4 | 10 | 78 | lymphocyte homeostasis |
| GO:0002885 | 0.00315 | 8.26331 | 1 | 4 | 14 | positive regulation of hypersensitivity |
| GO:0030213 | 0.00315 | 8.26331 | 1 | 4 | 14 | hyaluronan biosynthetic process |
| GO:0030949 | 0.00315 | 8.26331 | 1 | 4 | 14 | positive regulation of vascular endothelial growth factor receptor signaling pathway |
| GO:0032736 | 0.00315 | 8.26331 | 1 | 4 | 14 | positive regulation of interleukin-13 production |
| GO:0042362 | 0.00315 | 8.26331 | 1 | 4 | 14 | fat-soluble vitamin biosynthetic process |
| GO:0071850 | 0.00315 | 8.26331 | 1 | 4 | 14 | mitotic cell cycle arrest |
| GO:1901550 | 0.00315 | 8.26331 | 1 | 4 | 14 | regulation of endothelial cell development |
| GO:1903140 | 0.00315 | 8.26331 | 1 | 4 | 14 | regulation of establishment of endothelial barrier |
| GO:2000047 | 0.00315 | 8.26331 | 1 | 4 | 14 | regulation of cell-cell adhesion mediated by cadherin |
| GO:0014009 | 0.00323 | 3.60034 | 3 | 8 | 54 | glial cell proliferation |
| GO:0019751 | 0.00324 | 2.56829 | 5 | 13 | 118 | polyol metabolic process |
| GO:0001508 | 0.00327 | 2.46200 | 6 | 14 | 132 | action potential |
| GO:0034394 | 0.00327 | 3.27017 | 3 | 9 | 66 | protein localization to cell surface |
| GO:1904377 | 0.00327 | 3.27017 | 3 | 9 | 66 | positive regulation of protein localization to cell periphery |
| GO:0032535 | 0.00335 | 1.76611 | 18 | 31 | 397 | regulation of cellular component size |
| GO:0042307 | 0.00335 | 4.02343 | 2 | 7 | 43 | positive regulation of protein import into nucleus |
| GO:0038127 | 0.00339 | 2.67557 | 5 | 12 | 105 | ERBB signaling pathway |
| GO:0038034 | 0.00345 | 3.00279 | 4 | 10 | 79 | signal transduction in absence of ligand |
| GO:0097192 | 0.00345 | 3.00279 | 4 | 10 | 79 | extrinsic apoptotic signaling pathway in absence of ligand |
| GO:0043280 | 0.00349 | 2.54395 | 6 | 13 | 119 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic process |
| GO:0002093 | 0.00354 | 5.74169 | 1 | 5 | 23 | auditory receptor cell morphogenesis |
| GO:0007272 | 0.00357 | 2.27550 | 8 | 16 | 162 | ensheathment of neurons |
| GO:0008366 | 0.00357 | 2.27550 | 8 | 16 | 162 | axon ensheathment |
| GO:0060688 | 0.00362 | 3.21364 | 3 | 9 | 67 | regulation of morphogenesis of a branching structure |
| GO:0002548 | 0.00363 | 3.52358 | 3 | 8 | 55 | monocyte chemotaxis |
| GO:0035315 | 0.00363 | 3.52358 | 3 | 8 | 55 | hair cell differentiation |
| GO:0006470 | 0.00367 | 2.01243 | 11 | 21 | 238 | protein dephosphorylation |
| GO:0060840 | 0.00367 | 2.64698 | 5 | 12 | 106 | artery development |
| GO:0002691 | 0.00368 | 4.59578 | 2 | 6 | 33 | regulation of cellular extravasation |
| GO:0010543 | 0.00368 | 4.59578 | 2 | 6 | 33 | regulation of platelet activation |
| GO:0032660 | 0.00368 | 4.59578 | 2 | 6 | 33 | regulation of interleukin-17 production |
| GO:0086091 | 0.00368 | 4.59578 | 2 | 6 | 33 | regulation of heart rate by cardiac conduction |
| GO:1904467 | 0.00368 | 4.59578 | 2 | 6 | 33 | regulation of tumor necrosis factor secretion |
| GO:0051928 | 0.00375 | 2.42075 | 6 | 14 | 134 | positive regulation of calcium ion transport |
| GO:0002027 | 0.00378 | 2.78038 | 4 | 11 | 93 | regulation of heart rate |
| GO:0032410 | 0.00378 | 2.95976 | 4 | 10 | 80 | negative regulation of transporter activity |
| GO:1904064 | 0.00379 | 2.25992 | 8 | 16 | 163 | positive regulation of cation transmembrane transport |
| GO:0001569 | 0.00383 | 3.91452 | 2 | 7 | 44 | branching involved in blood vessel morphogenesis |
| GO:0070527 | 0.00383 | 3.91452 | 2 | 7 | 44 | platelet aggregation |
| GO:0010951 | 0.00384 | 2.19304 | 8 | 17 | 178 | negative regulation of endopeptidase activity |
| GO:0015850 | 0.00385 | 2.00310 | 11 | 21 | 239 | organic hydroxy compound transport |
| GO:0050728 | 0.00392 | 2.32339 | 7 | 15 | 149 | negative regulation of inflammatory response |
| GO:0072331 | 0.00401 | 2.40064 | 6 | 14 | 135 | signal transduction by p53 class mediator |
| GO:1905517 | 0.00406 | 3.45002 | 3 | 8 | 56 | macrophage migration |
| GO:0001659 | 0.00407 | 2.17940 | 8 | 17 | 179 | temperature homeostasis |
| GO:0022414 | 0.00411 | 1.37314 | 68 | 90 | 1471 | reproductive process |
| GO:0009890 | 0.00412 | 1.36840 | 70 | 92 | 1509 | negative regulation of biosynthetic process |
| GO:0015693 | 0.00414 | 7.51176 | 1 | 4 | 15 | magnesium ion transport |
| GO:0030656 | 0.00414 | 7.51176 | 1 | 4 | 15 | regulation of vitamin metabolic process |
| GO:0042033 | 0.00414 | 7.51176 | 1 | 4 | 15 | chemokine biosynthetic process |
| GO:0042953 | 0.00414 | 7.51176 | 1 | 4 | 15 | lipoprotein transport |
| GO:0044872 | 0.00414 | 7.51176 | 1 | 4 | 15 | lipoprotein localization |
| GO:0045073 | 0.00414 | 7.51176 | 1 | 4 | 15 | regulation of chemokine biosynthetic process |
| GO:0051044 | 0.00414 | 7.51176 | 1 | 4 | 15 | positive regulation of membrane protein ectodomain proteolysis |
| GO:0071404 | 0.00414 | 7.51176 | 1 | 4 | 15 | cellular response to low-density lipoprotein particle stimulus |
| GO:0051098 | 0.00417 | 1.73715 | 19 | 31 | 403 | regulation of binding |
| GO:0014013 | 0.00417 | 2.30608 | 7 | 15 | 150 | regulation of gliogenesis |
| GO:0000003 | 0.00419 | 1.37208 | 68 | 90 | 1472 | reproduction |
| GO:0044255 | 0.00423 | 1.46865 | 43 | 61 | 932 | cellular lipid metabolic process |
| GO:0045732 | 0.00423 | 2.06715 | 10 | 19 | 210 | positive regulation of protein catabolic process |
| GO:0003205 | 0.00429 | 2.11260 | 9 | 18 | 195 | cardiac chamber development |
| GO:0033032 | 0.00430 | 4.43144 | 2 | 6 | 34 | regulation of myeloid cell apoptotic process |
| GO:0099068 | 0.00430 | 4.43144 | 2 | 6 | 34 | postsynapse assembly |
| GO:0072643 | 0.00430 | 5.43925 | 1 | 5 | 24 | interferon-gamma secretion |
| GO:0072677 | 0.00430 | 5.43925 | 1 | 5 | 24 | eosinophil migration |
| GO:0097186 | 0.00430 | 5.43925 | 1 | 5 | 24 | amelogenesis |
| GO:0032814 | 0.00436 | 3.81133 | 2 | 7 | 45 | regulation of natural killer cell activation |
| GO:0042987 | 0.00436 | 3.81133 | 2 | 7 | 45 | amyloid precursor protein catabolic process |
| GO:1902893 | 0.00436 | 3.81133 | 2 | 7 | 45 | regulation of pri-miRNA transcription by RNA polymerase II |
| GO:0009059 | 0.00437 | 1.23187 | 191 | 224 | 4121 | macromolecule biosynthetic process |
| GO:1903670 | 0.00442 | 3.10624 | 3 | 9 | 69 | regulation of sprouting angiogenesis |
| GO:1904589 | 0.00442 | 3.10624 | 3 | 9 | 69 | regulation of protein import |
| GO:0007173 | 0.00446 | 2.71394 | 4 | 11 | 95 | epidermal growth factor receptor signaling pathway |
| GO:0090630 | 0.00453 | 2.87728 | 4 | 10 | 82 | activation of GTPase activity |
| GO:0009058 | 0.00453 | 1.21251 | 237 | 273 | 5125 | biosynthetic process |
| GO:0042551 | 0.00454 | 3.37945 | 3 | 8 | 57 | neuron maturation |
| GO:0048260 | 0.00454 | 3.37945 | 3 | 8 | 57 | positive regulation of receptor-mediated endocytosis |
| GO:0048259 | 0.00461 | 2.56477 | 5 | 12 | 109 | regulation of receptor-mediated endocytosis |
| GO:0061061 | 0.00462 | 1.53756 | 32 | 48 | 701 | muscle structure development |
| GO:0010638 | 0.00463 | 1.58678 | 28 | 42 | 595 | positive regulation of organelle organization |
| GO:0031665 | 0.00466 | 12.38619 | 0 | 3 | 8 | negative regulation of lipopolysaccharide-mediated signaling pathway |
| GO:0038089 | 0.00466 | 12.38619 | 0 | 3 | 8 | positive regulation of cell migration by vascular endothelial growth factor signaling pathway |
| GO:0055009 | 0.00466 | 12.38619 | 0 | 3 | 8 | atrial cardiac muscle tissue morphogenesis |
| GO:0070314 | 0.00466 | 12.38619 | 0 | 3 | 8 | G1 to G0 transition |
| GO:0080135 | 0.00469 | 1.55129 | 31 | 46 | 666 | regulation of cellular response to stress |
| GO:0051726 | 0.00470 | 1.45588 | 44 | 62 | 955 | regulation of cell cycle |
| GO:0007611 | 0.00491 | 1.86321 | 14 | 24 | 292 | learning or memory |
| GO:0045665 | 0.00492 | 1.92222 | 12 | 22 | 260 | negative regulation of neuron differentiation |
| GO:0043029 | 0.00494 | 3.71344 | 2 | 7 | 46 | T cell homeostasis |
| GO:0050798 | 0.00494 | 3.71344 | 2 | 7 | 46 | activated T cell proliferation |
| GO:0001539 | 0.00499 | 4.27844 | 2 | 6 | 35 | cilium or flagellum-dependent cell motility |
| GO:0002701 | 0.00499 | 4.27844 | 2 | 6 | 35 | negative regulation of production of molecular mediator of immune response |
| GO:0051567 | 0.00499 | 4.27844 | 2 | 6 | 35 | histone H3-K9 methylation |
| GO:0060285 | 0.00499 | 4.27844 | 2 | 6 | 35 | cilium-dependent cell motility |
| GO:1990774 | 0.00499 | 4.27844 | 2 | 6 | 35 | tumor necrosis factor secretion |
| GO:2000249 | 0.00499 | 4.27844 | 2 | 6 | 35 | regulation of actin cytoskeleton reorganization |
| GO:0043903 | 0.00502 | 2.07711 | 9 | 18 | 198 | regulation of symbiosis, encompassing mutualism through parasitism |
| GO:0045664 | 0.00503 | 1.50323 | 36 | 52 | 776 | regulation of neuron differentiation |
| GO:0016447 | 0.00506 | 3.31172 | 3 | 8 | 58 | somatic recombination of immunoglobulin gene segments |
| GO:0061337 | 0.00506 | 3.31172 | 3 | 8 | 58 | cardiac conduction |
| GO:0070231 | 0.00506 | 3.31172 | 3 | 8 | 58 | T cell apoptotic process |
| GO:0001516 | 0.00517 | 5.16706 | 1 | 5 | 25 | prostaglandin biosynthetic process |
| GO:0002478 | 0.00517 | 5.16706 | 1 | 5 | 25 | antigen processing and presentation of exogenous peptide antigen |
| GO:0003351 | 0.00517 | 5.16706 | 1 | 5 | 25 | epithelial cilium movement |
| GO:0010742 | 0.00517 | 5.16706 | 1 | 5 | 25 | macrophage derived foam cell differentiation |
| GO:0030194 | 0.00517 | 5.16706 | 1 | 5 | 25 | positive regulation of blood coagulation |
| GO:0045737 | 0.00517 | 5.16706 | 1 | 5 | 25 | positive regulation of cyclin-dependent protein serine/threonine kinase activity |
| GO:0046457 | 0.00517 | 5.16706 | 1 | 5 | 25 | prostanoid biosynthetic process |
| GO:0055094 | 0.00517 | 5.16706 | 1 | 5 | 25 | response to lipoprotein particle |
| GO:0071677 | 0.00517 | 5.16706 | 1 | 5 | 25 | positive regulation of mononuclear cell migration |
| GO:0072606 | 0.00517 | 5.16706 | 1 | 5 | 25 | interleukin-8 secretion |
| GO:0120033 | 0.00517 | 5.16706 | 1 | 5 | 25 | negative regulation of plasma membrane bounded cell projection assembly |
| GO:0150077 | 0.00517 | 5.16706 | 1 | 5 | 25 | regulation of neuroinflammatory response |
| GO:1900048 | 0.00517 | 5.16706 | 1 | 5 | 25 | positive regulation of hemostasis |
| GO:0030216 | 0.00520 | 2.32339 | 6 | 14 | 139 | keratinocyte differentiation |
| GO:0062012 | 0.00520 | 1.76165 | 17 | 28 | 359 | regulation of small molecule metabolic process |
| GO:0010595 | 0.00522 | 2.65058 | 4 | 11 | 97 | positive regulation of endothelial cell migration |
| GO:0048644 | 0.00522 | 2.65058 | 4 | 11 | 97 | muscle organ morphogenesis |
| GO:0002830 | 0.00533 | 6.88547 | 1 | 4 | 16 | positive regulation of type 2 immune response |
| GO:0002866 | 0.00533 | 6.88547 | 1 | 4 | 16 | positive regulation of acute inflammatory response to antigenic stimulus |
| GO:0007512 | 0.00533 | 6.88547 | 1 | 4 | 16 | adult heart development |
| GO:0042359 | 0.00533 | 6.88547 | 1 | 4 | 16 | vitamin D metabolic process |
| GO:0043923 | 0.00533 | 6.88547 | 1 | 4 | 16 | positive regulation by host of viral transcription |
| GO:0045779 | 0.00533 | 6.88547 | 1 | 4 | 16 | negative regulation of bone resorption |
| GO:0090196 | 0.00533 | 6.88547 | 1 | 4 | 16 | regulation of chemokine secretion |
| GO:1902414 | 0.00533 | 6.88547 | 1 | 4 | 16 | protein localization to cell junction |
| GO:0006937 | 0.00533 | 2.23931 | 7 | 15 | 154 | regulation of muscle contraction |
| GO:0071248 | 0.00533 | 2.23931 | 7 | 15 | 154 | cellular response to metal ion |
| GO:0048524 | 0.00538 | 2.79926 | 4 | 10 | 84 | positive regulation of viral process |
| GO:0044249 | 0.00548 | 1.20966 | 229 | 263 | 4938 | cellular biosynthetic process |
| GO:0002820 | 0.00558 | 3.62044 | 2 | 7 | 47 | negative regulation of adaptive immune response |
| GO:0032309 | 0.00558 | 3.62044 | 2 | 7 | 47 | icosanoid secretion |
| GO:0045907 | 0.00558 | 3.62044 | 2 | 7 | 47 | positive regulation of vasoconstriction |
| GO:0060711 | 0.00562 | 3.24663 | 3 | 8 | 59 | labyrinthine layer development |
| GO:1901016 | 0.00562 | 3.24663 | 3 | 8 | 59 | regulation of potassium ion transmembrane transporter activity |
| GO:0070227 | 0.00564 | 2.62000 | 5 | 11 | 98 | lymphocyte apoptotic process |
| GO:0042692 | 0.00570 | 1.71226 | 18 | 30 | 395 | muscle cell differentiation |
| GO:0046822 | 0.00573 | 2.48749 | 5 | 12 | 112 | regulation of nucleocytoplasmic transport |
| GO:0070528 | 0.00576 | 4.13564 | 2 | 6 | 36 | protein kinase C signaling |
| GO:0071604 | 0.00576 | 4.13564 | 2 | 6 | 36 | transforming growth factor beta production |
| GO:1902991 | 0.00576 | 4.13564 | 2 | 6 | 36 | regulation of amyloid precursor protein catabolic process |
| GO:0031327 | 0.00580 | 1.35546 | 68 | 89 | 1471 | negative regulation of cellular biosynthetic process |
| GO:0000079 | 0.00588 | 2.95792 | 3 | 9 | 72 | regulation of cyclin-dependent protein serine/threonine kinase activity |
| GO:0051592 | 0.00607 | 2.36456 | 6 | 13 | 127 | response to calcium ion |
| GO:0006807 | 0.00609 | 1.17499 | 413 | 453 | 8923 | nitrogen compound metabolic process |
| GO:0032528 | 0.00616 | 4.92078 | 1 | 5 | 26 | microvillus organization |
| GO:0033688 | 0.00616 | 4.92078 | 1 | 5 | 26 | regulation of osteoblast proliferation |
| GO:0050927 | 0.00616 | 4.92078 | 1 | 5 | 26 | positive regulation of positive chemotaxis |
| GO:0070168 | 0.00616 | 4.92078 | 1 | 5 | 26 | negative regulation of biomineral tissue development |
| GO:0090077 | 0.00616 | 4.92078 | 1 | 5 | 26 | foam cell differentiation |
| GO:0098901 | 0.00616 | 4.92078 | 1 | 5 | 26 | regulation of cardiac muscle cell action potential |
| GO:1903010 | 0.00616 | 4.92078 | 1 | 5 | 26 | regulation of bone development |
| GO:0009894 | 0.00623 | 1.47345 | 38 | 54 | 821 | regulation of catabolic process |
| GO:0002485 | 0.00623 | 41.25629 | 0 | 2 | 3 | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent |
| GO:0002540 | 0.00623 | 41.25629 | 0 | 2 | 3 | leukotriene production involved in inflammatory response |
| GO:0002554 | 0.00623 | 41.25629 | 0 | 2 | 3 | serotonin secretion by platelet |
| GO:0002652 | 0.00623 | 41.25629 | 0 | 2 | 3 | regulation of tolerance induction dependent upon immune response |
| GO:0002856 | 0.00623 | 41.25629 | 0 | 2 | 3 | negative regulation of natural killer cell mediated immune response to tumor cell |
| GO:0002859 | 0.00623 | 41.25629 | 0 | 2 | 3 | negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target |
| GO:0005997 | 0.00623 | 41.25629 | 0 | 2 | 3 | xylulose metabolic process |
| GO:0010979 | 0.00623 | 41.25629 | 0 | 2 | 3 | regulation of vitamin D 24-hydroxylase activity |
| GO:0010980 | 0.00623 | 41.25629 | 0 | 2 | 3 | positive regulation of vitamin D 24-hydroxylase activity |
| GO:0031580 | 0.00623 | 41.25629 | 0 | 2 | 3 | membrane raft distribution |
| GO:0034155 | 0.00623 | 41.25629 | 0 | 2 | 3 | regulation of toll-like receptor 7 signaling pathway |
| GO:0034157 | 0.00623 | 41.25629 | 0 | 2 | 3 | positive regulation of toll-like receptor 7 signaling pathway |
| GO:0034769 | 0.00623 | 41.25629 | 0 | 2 | 3 | basement membrane disassembly |
| GO:0045082 | 0.00623 | 41.25629 | 0 | 2 | 3 | positive regulation of interleukin-10 biosynthetic process |
| GO:0045658 | 0.00623 | 41.25629 | 0 | 2 | 3 | regulation of neutrophil differentiation |
| GO:0060557 | 0.00623 | 41.25629 | 0 | 2 | 3 | positive regulation of vitamin D biosynthetic process |
| GO:0060559 | 0.00623 | 41.25629 | 0 | 2 | 3 | positive regulation of calcidiol 1-monooxygenase activity |
| GO:0060584 | 0.00623 | 41.25629 | 0 | 2 | 3 | regulation of prostaglandin-endoperoxide synthase activity |
| GO:0060585 | 0.00623 | 41.25629 | 0 | 2 | 3 | positive regulation of prostaglandin-endoperoxide synthase activity |
| GO:0060671 | 0.00623 | 41.25629 | 0 | 2 | 3 | epithelial cell differentiation involved in embryonic placenta development |
| GO:0060672 | 0.00623 | 41.25629 | 0 | 2 | 3 | epithelial cell morphogenesis involved in placental branching |
| GO:0070488 | 0.00623 | 41.25629 | 0 | 2 | 3 | neutrophil aggregation |
| GO:0071613 | 0.00623 | 41.25629 | 0 | 2 | 3 | granzyme B production |
| GO:0071661 | 0.00623 | 41.25629 | 0 | 2 | 3 | regulation of granzyme B production |
| GO:0071663 | 0.00623 | 41.25629 | 0 | 2 | 3 | positive regulation of granzyme B production |
| GO:0072708 | 0.00623 | 41.25629 | 0 | 2 | 3 | response to sorbitol |
| GO:0110088 | 0.00623 | 41.25629 | 0 | 2 | 3 | hippocampal neuron apoptotic process |
| GO:0110089 | 0.00623 | 41.25629 | 0 | 2 | 3 | regulation of hippocampal neuron apoptotic process |
| GO:1902523 | 0.00623 | 41.25629 | 0 | 2 | 3 | positive regulation of protein K63-linked ubiquitination |
| GO:1904158 | 0.00623 | 41.25629 | 0 | 2 | 3 | axonemal central apparatus assembly |
| GO:1904444 | 0.00623 | 41.25629 | 0 | 2 | 3 | regulation of establishment of Sertoli cell barrier |
| GO:1905702 | 0.00623 | 41.25629 | 0 | 2 | 3 | regulation of inhibitory synapse assembly |
| GO:2001188 | 0.00623 | 41.25629 | 0 | 2 | 3 | regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell |
| GO:0034101 | 0.00627 | 2.26863 | 7 | 14 | 142 | erythrocyte homeostasis |
| GO:0050680 | 0.00627 | 2.26863 | 7 | 14 | 142 | negative regulation of epithelial cell proliferation |
| GO:0007157 | 0.00627 | 3.53197 | 2 | 7 | 48 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules |
| GO:0042088 | 0.00627 | 3.53197 | 2 | 7 | 48 | T-helper 1 type immune response |
| GO:0050873 | 0.00627 | 3.53197 | 2 | 7 | 48 | brown fat cell differentiation |
| GO:1904591 | 0.00627 | 3.53197 | 2 | 7 | 48 | positive regulation of protein import |
| GO:0030258 | 0.00630 | 1.98333 | 10 | 19 | 218 | lipid modification |
| GO:0050807 | 0.00641 | 1.87443 | 12 | 22 | 266 | regulation of synapse organization |
| GO:0006644 | 0.00642 | 1.75078 | 16 | 27 | 348 | phospholipid metabolic process |
| GO:0009790 | 0.00650 | 1.38188 | 57 | 76 | 1231 | embryo development |
| GO:0001782 | 0.00661 | 4.00205 | 2 | 6 | 37 | B cell homeostasis |
| GO:0007435 | 0.00661 | 4.00205 | 2 | 6 | 37 | salivary gland morphogenesis |
| GO:0033028 | 0.00661 | 4.00205 | 2 | 6 | 37 | myeloid cell apoptotic process |
| GO:0042092 | 0.00661 | 4.00205 | 2 | 6 | 37 | type 2 immune response |
| GO:0019233 | 0.00666 | 2.25094 | 7 | 14 | 143 | sensory perception of pain |
| GO:1901991 | 0.00666 | 2.25094 | 7 | 14 | 143 | negative regulation of mitotic cell cycle phase transition |
| GO:0001820 | 0.00671 | 6.35553 | 1 | 4 | 17 | serotonin secretion |
| GO:0002883 | 0.00671 | 6.35553 | 1 | 4 | 17 | regulation of hypersensitivity |
| GO:0009886 | 0.00671 | 6.35553 | 1 | 4 | 17 | post-embryonic animal morphogenesis |
| GO:0015701 | 0.00671 | 6.35553 | 1 | 4 | 17 | bicarbonate transport |
| GO:0030033 | 0.00671 | 6.35553 | 1 | 4 | 17 | microvillus assembly |
| GO:0032740 | 0.00671 | 6.35553 | 1 | 4 | 17 | positive regulation of interleukin-17 production |
| GO:0045064 | 0.00671 | 6.35553 | 1 | 4 | 17 | T-helper 2 cell differentiation |
| GO:0045579 | 0.00671 | 6.35553 | 1 | 4 | 17 | positive regulation of B cell differentiation |
| GO:0045793 | 0.00671 | 6.35553 | 1 | 4 | 17 | positive regulation of cell size |
| GO:0070886 | 0.00671 | 6.35553 | 1 | 4 | 17 | positive regulation of calcineurin-NFAT signaling cascade |
| GO:0071071 | 0.00671 | 6.35553 | 1 | 4 | 17 | regulation of phospholipid biosynthetic process |
| GO:0090195 | 0.00671 | 6.35553 | 1 | 4 | 17 | chemokine secretion |
| GO:0106058 | 0.00671 | 6.35553 | 1 | 4 | 17 | positive regulation of calcineurin-mediated signaling |
| GO:1902713 | 0.00671 | 6.35553 | 1 | 4 | 17 | regulation of interferon-gamma secretion |
| GO:1904889 | 0.00671 | 6.35553 | 1 | 4 | 17 | regulation of excitatory synapse assembly |
| GO:0006941 | 0.00673 | 2.17628 | 7 | 15 | 158 | striated muscle contraction |
| GO:0002604 | 0.00675 | 10.32136 | 0 | 3 | 9 | regulation of dendritic cell antigen processing and presentation |
| GO:0003228 | 0.00675 | 10.32136 | 0 | 3 | 9 | atrial cardiac muscle tissue development |
| GO:0008354 | 0.00675 | 10.32136 | 0 | 3 | 9 | germ cell migration |
| GO:0031622 | 0.00675 | 10.32136 | 0 | 3 | 9 | positive regulation of fever generation |
| GO:0032817 | 0.00675 | 10.32136 | 0 | 3 | 9 | regulation of natural killer cell proliferation |
| GO:0034139 | 0.00675 | 10.32136 | 0 | 3 | 9 | regulation of toll-like receptor 3 signaling pathway |
| GO:0035234 | 0.00675 | 10.32136 | 0 | 3 | 9 | ectopic germ cell programmed cell death |
| GO:0043320 | 0.00675 | 10.32136 | 0 | 3 | 9 | natural killer cell degranulation |
| GO:0070944 | 0.00675 | 10.32136 | 0 | 3 | 9 | neutrophil mediated killing of bacterium |
| GO:1900125 | 0.00675 | 10.32136 | 0 | 3 | 9 | regulation of hyaluronan biosynthetic process |
| GO:1903589 | 0.00675 | 10.32136 | 0 | 3 | 9 | positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis |
| GO:0031032 | 0.00681 | 2.00955 | 9 | 18 | 204 | actomyosin structure organization |
| GO:0046488 | 0.00690 | 2.32358 | 6 | 13 | 129 | phosphatidylinositol metabolic process |
| GO:0045165 | 0.00691 | 1.83231 | 13 | 23 | 284 | cell fate commitment |
| GO:0006911 | 0.00697 | 2.05176 | 9 | 17 | 189 | phagocytosis, engulfment |
| GO:0032368 | 0.00705 | 2.41471 | 5 | 12 | 115 | regulation of lipid transport |
| GO:0051099 | 0.00715 | 1.99871 | 9 | 18 | 205 | positive regulation of binding |
| GO:0018105 | 0.00724 | 1.77491 | 15 | 25 | 318 | peptidyl-serine phosphorylation |
| GO:0002335 | 0.00728 | 4.69690 | 1 | 5 | 27 | mature B cell differentiation |
| GO:0030212 | 0.00728 | 4.69690 | 1 | 5 | 27 | hyaluronan metabolic process |
| GO:0045830 | 0.00728 | 4.69690 | 1 | 5 | 27 | positive regulation of isotype switching |
| GO:0050926 | 0.00728 | 4.69690 | 1 | 5 | 27 | regulation of positive chemotaxis |
| GO:0023061 | 0.00728 | 1.58784 | 24 | 37 | 523 | signal release |
| GO:0051149 | 0.00746 | 2.65523 | 4 | 10 | 88 | positive regulation of muscle cell differentiation |
| GO:0010977 | 0.00747 | 2.08822 | 8 | 16 | 175 | negative regulation of neuron projection development |
| GO:1902115 | 0.00751 | 1.98799 | 10 | 18 | 206 | regulation of organelle assembly |
| GO:1901988 | 0.00753 | 2.14606 | 7 | 15 | 160 | negative regulation of cell cycle phase transition |
| GO:0006636 | 0.00754 | 3.87681 | 2 | 6 | 38 | unsaturated fatty acid biosynthetic process |
| GO:0043368 | 0.00754 | 3.87681 | 2 | 6 | 38 | positive T cell selection |
| GO:1904645 | 0.00754 | 3.87681 | 2 | 6 | 38 | response to amyloid-beta |
| GO:0030858 | 0.00759 | 3.06585 | 3 | 8 | 62 | positive regulation of epithelial cell differentiation |
| GO:0086003 | 0.00759 | 3.06585 | 3 | 8 | 62 | cardiac muscle cell contraction |
| GO:0045444 | 0.00765 | 1.90591 | 11 | 20 | 238 | fat cell differentiation |
| GO:0002200 | 0.00767 | 2.82309 | 3 | 9 | 75 | somatic diversification of immune receptors |
| GO:0030218 | 0.00783 | 2.28399 | 6 | 13 | 131 | erythrocyte differentiation |
| GO:0090316 | 0.00783 | 2.28399 | 6 | 13 | 131 | positive regulation of intracellular protein transport |
| GO:0030865 | 0.00786 | 3.36739 | 2 | 7 | 50 | cortical cytoskeleton organization |
| GO:0071675 | 0.00786 | 3.36739 | 2 | 7 | 50 | regulation of mononuclear cell migration |
| GO:0042391 | 0.00794 | 1.63791 | 20 | 32 | 439 | regulation of membrane potential |
| GO:0009896 | 0.00799 | 1.65129 | 20 | 31 | 422 | positive regulation of catabolic process |
| GO:0031667 | 0.00802 | 1.69908 | 17 | 28 | 371 | response to nutrient levels |
| GO:0017015 | 0.00816 | 2.47705 | 5 | 11 | 103 | regulation of transforming growth factor beta receptor signaling pathway |
| GO:1903426 | 0.00816 | 2.47705 | 5 | 11 | 103 | regulation of reactive oxygen species biosynthetic process |
| GO:0008016 | 0.00830 | 2.06209 | 8 | 16 | 177 | regulation of heart contraction |
| GO:0002524 | 0.00832 | 5.90129 | 1 | 4 | 18 | hypersensitivity |
| GO:0032700 | 0.00832 | 5.90129 | 1 | 4 | 18 | negative regulation of interleukin-17 production |
| GO:0035089 | 0.00832 | 5.90129 | 1 | 4 | 18 | establishment of apical/basal cell polarity |
| GO:0046851 | 0.00832 | 5.90129 | 1 | 4 | 18 | negative regulation of bone remodeling |
| GO:0051904 | 0.00832 | 5.90129 | 1 | 4 | 18 | pigment granule transport |
| GO:0060841 | 0.00832 | 5.90129 | 1 | 4 | 18 | venous blood vessel development |
| GO:0072148 | 0.00832 | 5.90129 | 1 | 4 | 18 | epithelial cell fate commitment |
| GO:2000319 | 0.00832 | 5.90129 | 1 | 4 | 18 | regulation of T-helper 17 cell differentiation |
| GO:2000810 | 0.00832 | 5.90129 | 1 | 4 | 18 | regulation of bicellular tight junction assembly |
| GO:0030330 | 0.00835 | 3.00997 | 3 | 8 | 63 | DNA damage response, signal transduction by p53 class mediator |
| GO:1904029 | 0.00835 | 2.78082 | 4 | 9 | 76 | regulation of cyclin-dependent protein kinase activity |
| GO:0071356 | 0.00841 | 2.11667 | 8 | 15 | 162 | cellular response to tumor necrosis factor |
| GO:0008643 | 0.00843 | 2.18285 | 7 | 14 | 147 | carbohydrate transport |
| GO:0006929 | 0.00853 | 4.49248 | 1 | 5 | 28 | substrate-dependent cell migration |
| GO:0044003 | 0.00853 | 4.49248 | 1 | 5 | 28 | modification by symbiont of host morphology or physiology |
| GO:0050820 | 0.00853 | 4.49248 | 1 | 5 | 28 | positive regulation of coagulation |
| GO:0060444 | 0.00853 | 4.49248 | 1 | 5 | 28 | branching involved in mammary gland duct morphogenesis |
| GO:0098698 | 0.00853 | 4.49248 | 1 | 5 | 28 | postsynaptic specialization assembly |
| GO:1904031 | 0.00853 | 4.49248 | 1 | 5 | 28 | positive regulation of cyclin-dependent protein kinase activity |
| GO:1904861 | 0.00853 | 4.49248 | 1 | 5 | 28 | excitatory synapse assembly |
| GO:2000178 | 0.00853 | 4.49248 | 1 | 5 | 28 | negative regulation of neural precursor cell proliferation |
| GO:0031640 | 0.00857 | 3.75916 | 2 | 6 | 39 | killing of cells of other organism |
| GO:0044364 | 0.00857 | 3.75916 | 2 | 6 | 39 | disruption of cells of other organism |
| GO:0046885 | 0.00857 | 3.75916 | 2 | 6 | 39 | regulation of hormone biosynthetic process |
| GO:0060251 | 0.00857 | 3.75916 | 2 | 6 | 39 | regulation of glial cell proliferation |
| GO:0090049 | 0.00857 | 3.75916 | 2 | 6 | 39 | regulation of cell migration involved in sprouting angiogenesis |
| GO:0061024 | 0.00858 | 1.46244 | 36 | 51 | 780 | membrane organization |
| GO:0045833 | 0.00870 | 2.58862 | 4 | 10 | 90 | negative regulation of lipid metabolic process |
| GO:0001974 | 0.00875 | 3.29071 | 2 | 7 | 51 | blood vessel remodeling |
| GO:0001501 | 0.00891 | 1.56479 | 25 | 37 | 530 | skeletal system development |
| GO:0003206 | 0.00893 | 2.16646 | 7 | 14 | 148 | cardiac chamber morphogenesis |
| GO:0031669 | 0.00896 | 1.99335 | 9 | 17 | 194 | cellular response to nutrient levels |
| GO:0048598 | 0.00897 | 1.51101 | 30 | 43 | 637 | embryonic morphogenesis |
| GO:0045926 | 0.00905 | 1.84092 | 12 | 21 | 258 | negative regulation of growth |
| GO:0050688 | 0.00908 | 2.73981 | 4 | 9 | 77 | regulation of defense response to virus |
| GO:0051785 | 0.00908 | 2.73981 | 4 | 9 | 77 | positive regulation of nuclear division |
| GO:0033157 | 0.00908 | 1.94622 | 10 | 18 | 210 | regulation of intracellular protein transport |
| GO:0010948 | 0.00913 | 1.90598 | 10 | 19 | 226 | negative regulation of cell cycle process |
| GO:0046824 | 0.00917 | 2.95609 | 3 | 8 | 64 | positive regulation of nucleocytoplasmic transport |
| GO:0034612 | 0.00920 | 2.03660 | 8 | 16 | 179 | response to tumor necrosis factor |
| GO:0002318 | 0.00931 | 8.84648 | 0 | 3 | 10 | myeloid progenitor cell differentiation |
| GO:0002420 | 0.00931 | 8.84648 | 0 | 3 | 10 | natural killer cell mediated cytotoxicity directed against tumor cell target |
| GO:0002645 | 0.00931 | 8.84648 | 0 | 3 | 10 | positive regulation of tolerance induction |
| GO:0002858 | 0.00931 | 8.84648 | 0 | 3 | 10 | regulation of natural killer cell mediated cytotoxicity directed against tumor cell target |
| GO:0002934 | 0.00931 | 8.84648 | 0 | 3 | 10 | desmosome organization |
| GO:0030854 | 0.00931 | 8.84648 | 0 | 3 | 10 | positive regulation of granulocyte differentiation |
| GO:0031620 | 0.00931 | 8.84648 | 0 | 3 | 10 | regulation of fever generation |
| GO:0033029 | 0.00931 | 8.84648 | 0 | 3 | 10 | regulation of neutrophil apoptotic process |
| GO:0033085 | 0.00931 | 8.84648 | 0 | 3 | 10 | negative regulation of T cell differentiation in thymus |
| GO:0035744 | 0.00931 | 8.84648 | 0 | 3 | 10 | T-helper 1 cell cytokine production |
| GO:0040009 | 0.00931 | 8.84648 | 0 | 3 | 10 | regulation of growth rate |
| GO:0044793 | 0.00931 | 8.84648 | 0 | 3 | 10 | negative regulation by host of viral process |
| GO:0048671 | 0.00931 | 8.84648 | 0 | 3 | 10 | negative regulation of collateral sprouting |
| GO:0060297 | 0.00931 | 8.84648 | 0 | 3 | 10 | regulation of sarcomere organization |
| GO:0070391 | 0.00931 | 8.84648 | 0 | 3 | 10 | response to lipoteichoic acid |
| GO:0070673 | 0.00931 | 8.84648 | 0 | 3 | 10 | response to interleukin-18 |
| GO:0071223 | 0.00931 | 8.84648 | 0 | 3 | 10 | cellular response to lipoteichoic acid |
| GO:0071635 | 0.00931 | 8.84648 | 0 | 3 | 10 | negative regulation of transforming growth factor beta production |
| GO:0072610 | 0.00931 | 8.84648 | 0 | 3 | 10 | interleukin-12 secretion |
| GO:0097119 | 0.00931 | 8.84648 | 0 | 3 | 10 | postsynaptic density protein 95 clustering |
| GO:1903011 | 0.00931 | 8.84648 | 0 | 3 | 10 | negative regulation of bone development |
| GO:2000318 | 0.00931 | 8.84648 | 0 | 3 | 10 | positive regulation of T-helper 17 type immune response |
| GO:1903844 | 0.00939 | 2.42412 | 5 | 11 | 105 | regulation of cellular response to transforming growth factor beta stimulus |
| GO:0016064 | 0.00943 | 1.83310 | 12 | 21 | 259 | immunoglobulin mediated immune response |
| GO:0006814 | 0.00951 | 1.93605 | 10 | 18 | 211 | sodium ion transport |
| GO:0060047 | 0.00951 | 1.93605 | 10 | 18 | 211 | heart contraction |
| GO:0050803 | 0.00968 | 1.79981 | 13 | 22 | 276 | regulation of synapse structure or activity |
| GO:0006692 | 0.00970 | 3.64843 | 2 | 6 | 40 | prostanoid metabolic process |
| GO:0006693 | 0.00970 | 3.64843 | 2 | 6 | 40 | prostaglandin metabolic process |
| GO:0038179 | 0.00970 | 3.64843 | 2 | 6 | 40 | neurotrophin signaling pathway |
| GO:0060603 | 0.00970 | 3.64843 | 2 | 6 | 40 | mammary gland duct morphogenesis |
| GO:0110111 | 0.00970 | 3.64843 | 2 | 6 | 40 | negative regulation of animal organ morphogenesis |
| GO:0061614 | 0.00972 | 3.21744 | 2 | 7 | 52 | pri-miRNA transcription by RNA polymerase II |
| GO:0050890 | 0.00975 | 1.72710 | 15 | 25 | 326 | cognition |
| GO:0007179 | 0.00988 | 2.07406 | 8 | 15 | 165 | transforming growth factor beta receptor signaling pathway |
| GO:1901615 | 0.00992 | 1.58467 | 22 | 34 | 481 | organic hydroxy compound metabolic process |
| GO:0002230 | 0.00992 | 4.30510 | 1 | 5 | 29 | positive regulation of defense response to virus by host |
| GO:0060117 | 0.00992 | 4.30510 | 1 | 5 | 29 | auditory receptor cell development |
| GO:0043647 | 0.01004 | 2.90409 | 3 | 8 | 65 | inositol phosphate metabolic process |
| GO:1904894 | 0.01005 | 2.39850 | 5 | 11 | 106 | positive regulation of STAT cascade |
| GO:0010467 | 0.01009 | 1.19240 | 223 | 254 | 4814 | gene expression |
| GO:0043009 | 0.01013 | 1.43699 | 38 | 53 | 824 | chordate embryonic development |
| GO:0030502 | 0.01016 | 5.50763 | 1 | 4 | 19 | negative regulation of bone mineralization |
| GO:0032695 | 0.01016 | 5.50763 | 1 | 4 | 19 | negative regulation of interleukin-12 production |
| GO:0045953 | 0.01016 | 5.50763 | 1 | 4 | 19 | negative regulation of natural killer cell mediated cytotoxicity |
| GO:0050860 | 0.01016 | 5.50763 | 1 | 4 | 19 | negative regulation of T cell receptor signaling pathway |
| GO:0051905 | 0.01016 | 5.50763 | 1 | 4 | 19 | establishment of pigment granule localization |
| GO:1900424 | 0.01016 | 5.50763 | 1 | 4 | 19 | regulation of defense response to bacterium |
| GO:1902259 | 0.01016 | 5.50763 | 1 | 4 | 19 | regulation of delayed rectifier potassium channel activity |
| GO:1905874 | 0.01016 | 5.50763 | 1 | 4 | 19 | regulation of postsynaptic density organization |
| GO:0050853 | 0.01017 | 2.01173 | 8 | 16 | 181 | B cell receptor signaling pathway |
| GO:0007423 | 0.01017 | 1.51379 | 28 | 41 | 606 | sensory organ development |
| GO:0045931 | 0.01041 | 2.06023 | 8 | 15 | 166 | positive regulation of mitotic cell cycle |
| GO:0001558 | 0.01062 | 1.61347 | 20 | 31 | 431 | regulation of cell growth |
| GO:0048663 | 0.01068 | 2.66128 | 4 | 9 | 79 | neuron fate commitment |
| GO:0016331 | 0.01069 | 1.99952 | 8 | 16 | 182 | morphogenesis of embryonic epithelium |
| GO:0120032 | 0.01069 | 1.99952 | 8 | 16 | 182 | regulation of plasma membrane bounded cell projection assembly |
| GO:0030219 | 0.01076 | 3.14735 | 2 | 7 | 53 | megakaryocyte differentiation |
| GO:0098815 | 0.01076 | 3.14735 | 2 | 7 | 53 | modulation of excitatory postsynaptic potential |
| GO:0009743 | 0.01085 | 1.94894 | 9 | 17 | 198 | response to carbohydrate |
| GO:0099024 | 0.01085 | 1.94894 | 9 | 17 | 198 | plasma membrane invagination |
| GO:0046889 | 0.01087 | 2.49471 | 4 | 10 | 93 | positive regulation of lipid biosynthetic process |
| GO:0001937 | 0.01093 | 3.54403 | 2 | 6 | 41 | negative regulation of endothelial cell proliferation |
| GO:0033059 | 0.01093 | 3.54403 | 2 | 6 | 41 | cellular pigmentation |
| GO:0046627 | 0.01093 | 3.54403 | 2 | 6 | 41 | negative regulation of insulin receptor signaling pathway |
| GO:0060122 | 0.01093 | 3.54403 | 2 | 6 | 41 | inner ear receptor cell stereocilium organization |
| GO:1901184 | 0.01097 | 2.85389 | 3 | 8 | 66 | regulation of ERBB signaling pathway |
| GO:0019724 | 0.01110 | 1.80247 | 12 | 21 | 263 | B cell mediated immunity |
| GO:0001701 | 0.01113 | 1.53923 | 25 | 37 | 538 | in utero embryonic development |
| GO:0050792 | 0.01123 | 1.98746 | 8 | 16 | 183 | regulation of viral process |
| GO:0010558 | 0.01125 | 1.32593 | 65 | 84 | 1414 | negative regulation of macromolecule biosynthetic process |
| GO:0050871 | 0.01141 | 1.89639 | 10 | 18 | 215 | positive regulation of B cell activation |
| GO:0002438 | 0.01146 | 4.13271 | 1 | 5 | 30 | acute inflammatory response to antigenic stimulus |
| GO:0002825 | 0.01146 | 4.13271 | 1 | 5 | 30 | regulation of T-helper 1 type immune response |
| GO:0032692 | 0.01146 | 4.13271 | 1 | 5 | 30 | negative regulation of interleukin-1 production |
| GO:0034110 | 0.01146 | 4.13271 | 1 | 5 | 30 | regulation of homotypic cell-cell adhesion |
| GO:0060143 | 0.01146 | 4.13271 | 1 | 5 | 30 | positive regulation of syncytium formation by plasma membrane fusion |
| GO:0061082 | 0.01146 | 4.13271 | 1 | 5 | 30 | myeloid leukocyte cytokine production |
| GO:0070306 | 0.01146 | 4.13271 | 1 | 5 | 30 | lens fiber cell differentiation |
| GO:1902003 | 0.01146 | 4.13271 | 1 | 5 | 30 | regulation of amyloid-beta formation |
| GO:2001257 | 0.01154 | 2.03311 | 8 | 15 | 168 | regulation of cation channel activity |
| GO:0010923 | 0.01155 | 2.62368 | 4 | 9 | 80 | negative regulation of phosphatase activity |
| GO:0050805 | 0.01155 | 2.62368 | 4 | 9 | 80 | negative regulation of synaptic transmission |
| GO:0060113 | 0.01155 | 2.62368 | 4 | 9 | 80 | inner ear receptor cell differentiation |
| GO:0006066 | 0.01160 | 1.72014 | 15 | 24 | 314 | alcohol metabolic process |
| GO:0046879 | 0.01166 | 1.66143 | 17 | 27 | 365 | hormone secretion |
| GO:0060491 | 0.01179 | 1.97554 | 9 | 16 | 184 | regulation of cell projection assembly |
| GO:0006665 | 0.01179 | 2.23986 | 6 | 12 | 123 | sphingolipid metabolic process |
| GO:0007050 | 0.01186 | 2.15540 | 6 | 13 | 138 | cell cycle arrest |
| GO:0032350 | 0.01189 | 3.08025 | 3 | 7 | 54 | regulation of hormone metabolic process |
| GO:0035272 | 0.01189 | 3.08025 | 3 | 7 | 54 | exocrine system development |
| GO:0045687 | 0.01189 | 3.08025 | 3 | 7 | 54 | positive regulation of glial cell differentiation |
| GO:0002562 | 0.01197 | 2.80539 | 3 | 8 | 67 | somatic diversification of immune receptors via germline recombination within a single locus |
| GO:0006940 | 0.01197 | 2.80539 | 3 | 8 | 67 | regulation of smooth muscle contraction |
| GO:0016444 | 0.01197 | 2.80539 | 3 | 8 | 67 | somatic cell DNA recombination |
| GO:0050771 | 0.01197 | 2.80539 | 3 | 8 | 67 | negative regulation of axonogenesis |
| GO:0045787 | 0.01208 | 1.67375 | 16 | 26 | 349 | positive regulation of cell cycle |
| GO:0002378 | 0.01208 | 20.62721 | 0 | 2 | 4 | immunoglobulin biosynthetic process |
| GO:0002408 | 0.01208 | 20.62721 | 0 | 2 | 4 | myeloid dendritic cell chemotaxis |
| GO:0002424 | 0.01208 | 20.62721 | 0 | 2 | 4 | T cell mediated immune response to tumor cell |
| GO:0002538 | 0.01208 | 20.62721 | 0 | 2 | 4 | arachidonic acid metabolite production involved in inflammatory response |
| GO:0002840 | 0.01208 | 20.62721 | 0 | 2 | 4 | regulation of T cell mediated immune response to tumor cell |
| GO:0002924 | 0.01208 | 20.62721 | 0 | 2 | 4 | negative regulation of humoral immune response mediated by circulating immunoglobulin |
| GO:0003104 | 0.01208 | 20.62721 | 0 | 2 | 4 | positive regulation of glomerular filtration |
| GO:0032672 | 0.01208 | 20.62721 | 0 | 2 | 4 | regulation of interleukin-3 production |
| GO:0033326 | 0.01208 | 20.62721 | 0 | 2 | 4 | cerebrospinal fluid secretion |
| GO:0034124 | 0.01208 | 20.62721 | 0 | 2 | 4 | regulation of MyD88-dependent toll-like receptor signaling pathway |
| GO:0034635 | 0.01208 | 20.62721 | 0 | 2 | 4 | glutathione transport |
| GO:0038156 | 0.01208 | 20.62721 | 0 | 2 | 4 | interleukin-3-mediated signaling pathway |
| GO:0042938 | 0.01208 | 20.62721 | 0 | 2 | 4 | dipeptide transport |
| GO:0042939 | 0.01208 | 20.62721 | 0 | 2 | 4 | tripeptide transport |
| GO:0043378 | 0.01208 | 20.62721 | 0 | 2 | 4 | positive regulation of CD8-positive, alpha-beta T cell differentiation |
| GO:0046136 | 0.01208 | 20.62721 | 0 | 2 | 4 | positive regulation of vitamin metabolic process |
| GO:0051665 | 0.01208 | 20.62721 | 0 | 2 | 4 | membrane raft localization |
| GO:0060214 | 0.01208 | 20.62721 | 0 | 2 | 4 | endocardium formation |
| GO:0061218 | 0.01208 | 20.62721 | 0 | 2 | 4 | negative regulation of mesonephros development |
| GO:0061884 | 0.01208 | 20.62721 | 0 | 2 | 4 | regulation of mini excitatory postsynaptic potential |
| GO:0070164 | 0.01208 | 20.62721 | 0 | 2 | 4 | negative regulation of adiponectin secretion |
| GO:0071072 | 0.01208 | 20.62721 | 0 | 2 | 4 | negative regulation of phospholipid biosynthetic process |
| GO:0071724 | 0.01208 | 20.62721 | 0 | 2 | 4 | response to diacyl bacterial lipopeptide |
| GO:0071726 | 0.01208 | 20.62721 | 0 | 2 | 4 | cellular response to diacyl bacterial lipopeptide |
| GO:0097029 | 0.01208 | 20.62721 | 0 | 2 | 4 | mature conventional dendritic cell differentiation |
| GO:0097118 | 0.01208 | 20.62721 | 0 | 2 | 4 | neuroligin clustering involved in postsynaptic membrane assembly |
| GO:0098816 | 0.01208 | 20.62721 | 0 | 2 | 4 | mini excitatory postsynaptic potential |
| GO:0098904 | 0.01208 | 20.62721 | 0 | 2 | 4 | regulation of AV node cell action potential |
| GO:1900126 | 0.01208 | 20.62721 | 0 | 2 | 4 | negative regulation of hyaluronan biosynthetic process |
| GO:1901491 | 0.01208 | 20.62721 | 0 | 2 | 4 | negative regulation of lymphangiogenesis |
| GO:1902566 | 0.01208 | 20.62721 | 0 | 2 | 4 | regulation of eosinophil activation |
| GO:1903903 | 0.01208 | 20.62721 | 0 | 2 | 4 | regulation of establishment of T cell polarity |
| GO:1903936 | 0.01208 | 20.62721 | 0 | 2 | 4 | cellular response to sodium arsenite |
| GO:2000173 | 0.01208 | 20.62721 | 0 | 2 | 4 | negative regulation of branching morphogenesis of a nerve |
| GO:2000566 | 0.01208 | 20.62721 | 0 | 2 | 4 | positive regulation of CD8-positive, alpha-beta T cell proliferation |
| GO:0090068 | 0.01222 | 1.81345 | 12 | 20 | 249 | positive regulation of cell cycle process |
| GO:0002577 | 0.01224 | 5.16317 | 1 | 4 | 20 | regulation of antigen processing and presentation |
| GO:0002716 | 0.01224 | 5.16317 | 1 | 4 | 20 | negative regulation of natural killer cell mediated immunity |
| GO:0033033 | 0.01224 | 5.16317 | 1 | 4 | 20 | negative regulation of myeloid cell apoptotic process |
| GO:0034143 | 0.01224 | 5.16317 | 1 | 4 | 20 | regulation of toll-like receptor 4 signaling pathway |
| GO:0043011 | 0.01224 | 5.16317 | 1 | 4 | 20 | myeloid dendritic cell differentiation |
| GO:0045986 | 0.01224 | 5.16317 | 1 | 4 | 20 | negative regulation of smooth muscle contraction |
| GO:0048245 | 0.01224 | 5.16317 | 1 | 4 | 20 | eosinophil chemotaxis |
| GO:0050434 | 0.01224 | 5.16317 | 1 | 4 | 20 | positive regulation of viral transcription |
| GO:0061162 | 0.01224 | 5.16317 | 1 | 4 | 20 | establishment of monopolar cell polarity |
| GO:1902993 | 0.01224 | 5.16317 | 1 | 4 | 20 | positive regulation of amyloid precursor protein catabolic process |
| GO:0006687 | 0.01226 | 3.44543 | 2 | 6 | 42 | glycosphingolipid metabolic process |
| GO:0050691 | 0.01226 | 3.44543 | 2 | 6 | 42 | regulation of defense response to virus by host |
| GO:1902742 | 0.01226 | 3.44543 | 2 | 6 | 42 | apoptotic process involved in development |
| GO:0044271 | 0.01227 | 1.19987 | 185 | 213 | 3993 | cellular nitrogen compound biosynthetic process |
| GO:0001574 | 0.01236 | 7.74032 | 1 | 3 | 11 | ganglioside biosynthetic process |
| GO:0001865 | 0.01236 | 7.74032 | 1 | 3 | 11 | NK T cell differentiation |
| GO:0002423 | 0.01236 | 7.74032 | 1 | 3 | 11 | natural killer cell mediated immune response to tumor cell |
| GO:0002855 | 0.01236 | 7.74032 | 1 | 3 | 11 | regulation of natural killer cell mediated immune response to tumor cell |
| GO:0010744 | 0.01236 | 7.74032 | 1 | 3 | 11 | positive regulation of macrophage derived foam cell differentiation |
| GO:0010872 | 0.01236 | 7.74032 | 1 | 3 | 11 | regulation of cholesterol esterification |
| GO:0033327 | 0.01236 | 7.74032 | 1 | 3 | 11 | Leydig cell differentiation |
| GO:0034135 | 0.01236 | 7.74032 | 1 | 3 | 11 | regulation of toll-like receptor 2 signaling pathway |
| GO:0036005 | 0.01236 | 7.74032 | 1 | 3 | 11 | response to macrophage colony-stimulating factor |
| GO:0036006 | 0.01236 | 7.74032 | 1 | 3 | 11 | cellular response to macrophage colony-stimulating factor stimulus |
| GO:0043619 | 0.01236 | 7.74032 | 1 | 3 | 11 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress |
| GO:0045416 | 0.01236 | 7.74032 | 1 | 3 | 11 | positive regulation of interleukin-8 biosynthetic process |
| GO:0048563 | 0.01236 | 7.74032 | 1 | 3 | 11 | post-embryonic animal organ morphogenesis |
| GO:0048845 | 0.01236 | 7.74032 | 1 | 3 | 11 | venous blood vessel morphogenesis |
| GO:0060693 | 0.01236 | 7.74032 | 1 | 3 | 11 | regulation of branching involved in salivary gland morphogenesis |
| GO:0070278 | 0.01236 | 7.74032 | 1 | 3 | 11 | extracellular matrix constituent secretion |
| GO:0070943 | 0.01236 | 7.74032 | 1 | 3 | 11 | neutrophil mediated killing of symbiont cell |
| GO:0090043 | 0.01236 | 7.74032 | 1 | 3 | 11 | regulation of tubulin deacetylation |
| GO:1904862 | 0.01236 | 7.74032 | 1 | 3 | 11 | inhibitory synapse assembly |
| GO:0008154 | 0.01246 | 1.91690 | 9 | 17 | 201 | actin polymerization or depolymerization |
| GO:0031646 | 0.01248 | 2.58712 | 4 | 9 | 81 | positive regulation of neurological system process |
| GO:0032479 | 0.01248 | 2.58712 | 4 | 9 | 81 | regulation of type I interferon production |
| GO:0060048 | 0.01252 | 2.21976 | 6 | 12 | 124 | cardiac muscle contraction |
| GO:1905475 | 0.01297 | 1.95212 | 9 | 16 | 186 | regulation of protein localization to membrane |
| GO:0001843 | 0.01306 | 2.30117 | 5 | 11 | 110 | neural tube closure |
| GO:0002042 | 0.01309 | 3.01594 | 3 | 7 | 55 | cell migration involved in sprouting angiogenesis |
| GO:0035306 | 0.01309 | 3.01594 | 3 | 7 | 55 | positive regulation of dephosphorylation |
| GO:0042531 | 0.01309 | 3.01594 | 3 | 7 | 55 | positive regulation of tyrosine phosphorylation of STAT protein |
| GO:0010758 | 0.01316 | 3.97358 | 1 | 5 | 31 | regulation of macrophage chemotaxis |
| GO:0048011 | 0.01316 | 3.97358 | 1 | 5 | 31 | neurotrophin TRK receptor signaling pathway |
| GO:0072089 | 0.01327 | 2.12127 | 6 | 13 | 140 | stem cell proliferation |
| GO:0120162 | 0.01341 | 2.40736 | 4 | 10 | 96 | positive regulation of cold-induced thermogenesis |
| GO:0051899 | 0.01346 | 2.55157 | 4 | 9 | 82 | membrane depolarization |
| GO:0043277 | 0.01371 | 3.35216 | 2 | 6 | 43 | apoptotic cell clearance |
| GO:0120039 | 0.01384 | 1.45331 | 32 | 45 | 691 | plasma membrane bounded cell projection morphogenesis |
| GO:0015749 | 0.01391 | 2.27805 | 5 | 11 | 111 | monosaccharide transmembrane transport |
| GO:0060606 | 0.01391 | 2.27805 | 5 | 11 | 111 | tube closure |
| GO:0071560 | 0.01426 | 1.88589 | 9 | 17 | 204 | cellular response to transforming growth factor beta stimulus |
| GO:0070167 | 0.01436 | 2.37958 | 4 | 10 | 97 | regulation of biomineral tissue development |
| GO:0031641 | 0.01438 | 2.95425 | 3 | 7 | 56 | regulation of myelination |
| GO:0043536 | 0.01438 | 2.95425 | 3 | 7 | 56 | positive regulation of blood vessel endothelial cell migration |
| GO:0003094 | 0.01458 | 4.85923 | 1 | 4 | 21 | glomerular filtration |
| GO:0010743 | 0.01458 | 4.85923 | 1 | 4 | 21 | regulation of macrophage derived foam cell differentiation |
| GO:0031579 | 0.01458 | 4.85923 | 1 | 4 | 21 | membrane raft organization |
| GO:0032400 | 0.01458 | 4.85923 | 1 | 4 | 21 | melanosome localization |
| GO:0032682 | 0.01458 | 4.85923 | 1 | 4 | 21 | negative regulation of chemokine production |
| GO:0061339 | 0.01458 | 4.85923 | 1 | 4 | 21 | establishment or maintenance of monopolar cell polarity |
| GO:0070230 | 0.01458 | 4.85923 | 1 | 4 | 21 | positive regulation of lymphocyte apoptotic process |
| GO:0090050 | 0.01458 | 4.85923 | 1 | 4 | 21 | positive regulation of cell migration involved in sprouting angiogenesis |
| GO:0097107 | 0.01458 | 4.85923 | 1 | 4 | 21 | postsynaptic density assembly |
| GO:2000482 | 0.01458 | 4.85923 | 1 | 4 | 21 | regulation of interleukin-8 secretion |
| GO:2001224 | 0.01458 | 4.85923 | 1 | 4 | 21 | positive regulation of neuron migration |
| GO:0009792 | 0.01459 | 1.40487 | 39 | 53 | 841 | embryo development ending in birth or egg hatching |
| GO:0001505 | 0.01464 | 1.62720 | 17 | 27 | 372 | regulation of neurotransmitter levels |
| GO:0035296 | 0.01479 | 1.96832 | 8 | 15 | 173 | regulation of tube diameter |
| GO:0050880 | 0.01479 | 1.96832 | 8 | 15 | 173 | regulation of blood vessel size |
| GO:0097746 | 0.01479 | 1.96832 | 8 | 15 | 173 | regulation of blood vessel diameter |
| GO:0003015 | 0.01479 | 1.83984 | 10 | 18 | 221 | heart process |
| GO:0008630 | 0.01480 | 2.25540 | 5 | 11 | 112 | intrinsic apoptotic signaling pathway in response to DNA damage |
| GO:0034219 | 0.01480 | 2.25540 | 5 | 11 | 112 | carbohydrate transmembrane transport |
| GO:0010324 | 0.01491 | 1.87577 | 9 | 17 | 205 | membrane invagination |
| GO:0009628 | 0.01500 | 1.36274 | 48 | 63 | 1030 | response to abiotic stimulus |
| GO:0040036 | 0.01502 | 3.82624 | 1 | 5 | 32 | regulation of fibroblast growth factor receptor signaling pathway |
| GO:0043243 | 0.01502 | 3.82624 | 1 | 5 | 32 | positive regulation of protein complex disassembly |
| GO:0045616 | 0.01502 | 3.82624 | 1 | 5 | 32 | regulation of keratinocyte differentiation |
| GO:0051642 | 0.01502 | 3.82624 | 1 | 5 | 32 | centrosome localization |
| GO:0060306 | 0.01502 | 3.82624 | 1 | 5 | 32 | regulation of membrane repolarization |
| GO:0070286 | 0.01502 | 3.82624 | 1 | 5 | 32 | axonemal dynein complex assembly |
| GO:1904646 | 0.01502 | 3.82624 | 1 | 5 | 32 | cellular response to amyloid-beta |
| GO:2000191 | 0.01502 | 3.82624 | 1 | 5 | 32 | regulation of fatty acid transport |
| GO:0009914 | 0.01511 | 1.62242 | 17 | 27 | 373 | hormone transport |
| GO:0048812 | 0.01528 | 1.44967 | 31 | 44 | 677 | neuron projection morphogenesis |
| GO:0002090 | 0.01536 | 2.66929 | 3 | 8 | 70 | regulation of receptor internalization |
| GO:0051057 | 0.01536 | 2.66929 | 3 | 8 | 70 | positive regulation of small GTPase mediated signal transduction |
| GO:0030041 | 0.01552 | 1.95586 | 8 | 15 | 174 | actin filament polymerization |
| GO:0035150 | 0.01552 | 1.95586 | 8 | 15 | 174 | regulation of tube size |
| GO:0048858 | 0.01552 | 1.44181 | 32 | 45 | 696 | cell projection morphogenesis |
| GO:0007178 | 0.01573 | 1.63270 | 17 | 26 | 357 | transmembrane receptor protein serine/threonine kinase signaling pathway |
| GO:0050994 | 0.01576 | 2.89504 | 3 | 7 | 57 | regulation of lipid catabolic process |
| GO:0099172 | 0.01576 | 2.89504 | 3 | 7 | 57 | presynapse organization |
| GO:0016042 | 0.01589 | 1.68817 | 14 | 23 | 306 | lipid catabolic process |
| GO:0003012 | 0.01590 | 1.59952 | 18 | 28 | 392 | muscle system process |
| GO:0001781 | 0.01592 | 6.87998 | 1 | 3 | 12 | neutrophil apoptotic process |
| GO:0001787 | 0.01592 | 6.87998 | 1 | 3 | 12 | natural killer cell proliferation |
| GO:0002921 | 0.01592 | 6.87998 | 1 | 3 | 12 | negative regulation of humoral immune response |
| GO:0032026 | 0.01592 | 6.87998 | 1 | 3 | 12 | response to magnesium ion |
| GO:0032308 | 0.01592 | 6.87998 | 1 | 3 | 12 | positive regulation of prostaglandin secretion |
| GO:0034392 | 0.01592 | 6.87998 | 1 | 3 | 12 | negative regulation of smooth muscle cell apoptotic process |
| GO:0045080 | 0.01592 | 6.87998 | 1 | 3 | 12 | positive regulation of chemokine biosynthetic process |
| GO:0045217 | 0.01592 | 6.87998 | 1 | 3 | 12 | cell-cell junction maintenance |
| GO:0060430 | 0.01592 | 6.87998 | 1 | 3 | 12 | lung saccule development |
| GO:0070444 | 0.01592 | 6.87998 | 1 | 3 | 12 | oligodendrocyte progenitor proliferation |
| GO:0070445 | 0.01592 | 6.87998 | 1 | 3 | 12 | regulation of oligodendrocyte progenitor proliferation |
| GO:0072540 | 0.01592 | 6.87998 | 1 | 3 | 12 | T-helper 17 cell lineage commitment |
| GO:0086013 | 0.01592 | 6.87998 | 1 | 3 | 12 | membrane repolarization during cardiac muscle cell action potential |
| GO:1900272 | 0.01592 | 6.87998 | 1 | 3 | 12 | negative regulation of long-term synaptic potentiation |
| GO:1900426 | 0.01592 | 6.87998 | 1 | 3 | 12 | positive regulation of defense response to bacterium |
| GO:1904251 | 0.01592 | 6.87998 | 1 | 3 | 12 | regulation of bile acid metabolic process |
| GO:2000105 | 0.01592 | 6.87998 | 1 | 3 | 12 | positive regulation of DNA-dependent DNA replication |
| GO:0050804 | 0.01612 | 1.45071 | 31 | 43 | 661 | modulation of chemical synaptic transmission |
| GO:0071804 | 0.01633 | 1.89591 | 9 | 16 | 191 | cellular potassium ion transport |
| GO:0071805 | 0.01633 | 1.89591 | 9 | 16 | 191 | potassium ion transmembrane transport |
| GO:0010771 | 0.01639 | 2.32590 | 5 | 10 | 99 | negative regulation of cell morphogenesis involved in differentiation |
| GO:0007613 | 0.01646 | 2.05612 | 7 | 13 | 144 | memory |
| GO:0099177 | 0.01649 | 1.44830 | 31 | 43 | 662 | regulation of trans-synaptic signaling |
| GO:0140014 | 0.01674 | 1.75159 | 12 | 20 | 257 | mitotic nuclear division |
| GO:0032606 | 0.01675 | 2.45052 | 4 | 9 | 85 | type I interferon production |
| GO:0032990 | 0.01682 | 1.42779 | 33 | 46 | 718 | cell part morphogenesis |
| GO:0060135 | 0.01695 | 3.17997 | 2 | 6 | 45 | maternal process involved in female pregnancy |
| GO:0061647 | 0.01695 | 3.17997 | 2 | 6 | 45 | histone H3-K9 modification |
| GO:1900077 | 0.01695 | 3.17997 | 2 | 6 | 45 | negative regulation of cellular response to insulin stimulus |
| GO:0071559 | 0.01697 | 1.84606 | 10 | 17 | 208 | response to transforming growth factor beta |
| GO:0034142 | 0.01704 | 3.68942 | 2 | 5 | 33 | toll-like receptor 4 signaling pathway |
| GO:0060487 | 0.01704 | 3.68942 | 2 | 5 | 33 | lung epithelial cell differentiation |
| GO:0061842 | 0.01704 | 3.68942 | 2 | 5 | 33 | microtubule organizing center localization |
| GO:2000108 | 0.01704 | 3.68942 | 2 | 5 | 33 | positive regulation of leukocyte apoptotic process |
| GO:0002864 | 0.01718 | 4.58907 | 1 | 4 | 22 | regulation of acute inflammatory response to antigenic stimulus |
| GO:0009110 | 0.01718 | 4.58907 | 1 | 4 | 22 | vitamin biosynthetic process |
| GO:0010884 | 0.01718 | 4.58907 | 1 | 4 | 22 | positive regulation of lipid storage |
| GO:0032303 | 0.01718 | 4.58907 | 1 | 4 | 22 | regulation of icosanoid secretion |
| GO:0032691 | 0.01718 | 4.58907 | 1 | 4 | 22 | negative regulation of interleukin-1 beta production |
| GO:0033008 | 0.01718 | 4.58907 | 1 | 4 | 22 | positive regulation of mast cell activation involved in immune response |
| GO:0036314 | 0.01718 | 4.58907 | 1 | 4 | 22 | response to sterol |
| GO:0043306 | 0.01718 | 4.58907 | 1 | 4 | 22 | positive regulation of mast cell degranulation |
| GO:0045063 | 0.01718 | 4.58907 | 1 | 4 | 22 | T-helper 1 cell differentiation |
| GO:0051043 | 0.01718 | 4.58907 | 1 | 4 | 22 | regulation of membrane protein ectodomain proteolysis |
| GO:2000010 | 0.01718 | 4.58907 | 1 | 4 | 22 | positive regulation of protein localization to cell surface |
| GO:0060443 | 0.01723 | 2.83814 | 3 | 7 | 58 | mammary gland morphogenesis |
| GO:0010769 | 0.01746 | 1.63350 | 16 | 25 | 343 | regulation of cell morphogenesis involved in differentiation |
| GO:0018209 | 0.01746 | 1.63350 | 16 | 25 | 343 | peptidyl-serine modification |
| GO:0007584 | 0.01748 | 2.29995 | 5 | 10 | 100 | response to nutrient |
| GO:0032006 | 0.01748 | 2.29995 | 5 | 10 | 100 | regulation of TOR signaling |
| GO:0048667 | 0.01751 | 1.45557 | 29 | 41 | 628 | cell morphogenesis involved in neuron differentiation |
| GO:0007093 | 0.01766 | 2.10632 | 6 | 12 | 130 | mitotic cell cycle checkpoint |
| GO:0008361 | 0.01771 | 1.83636 | 10 | 17 | 209 | regulation of cell size |
| GO:0000187 | 0.01774 | 2.19004 | 5 | 11 | 115 | activation of MAPK activity |
| GO:1990138 | 0.01785 | 1.87432 | 9 | 16 | 193 | neuron projection extension |
| GO:0042490 | 0.01796 | 2.41858 | 4 | 9 | 86 | mechanoreceptor differentiation |
| GO:0030239 | 0.01798 | 2.58564 | 3 | 8 | 72 | myofibril assembly |
| GO:1901990 | 0.01805 | 1.73678 | 12 | 20 | 259 | regulation of mitotic cell cycle phase transition |
| GO:0042310 | 0.01862 | 2.27457 | 5 | 10 | 101 | vasoconstriction |
| GO:0099173 | 0.01865 | 1.86370 | 9 | 16 | 194 | postsynapse organization |
| GO:0000075 | 0.01870 | 1.90751 | 8 | 15 | 178 | cell cycle checkpoint |
| GO:0048588 | 0.01874 | 1.72946 | 12 | 20 | 260 | developmental cell growth |
| GO:0048738 | 0.01874 | 1.72946 | 12 | 20 | 260 | cardiac muscle tissue development |
| GO:0001941 | 0.01875 | 3.10033 | 2 | 6 | 46 | postsynaptic membrane organization |
| GO:0032007 | 0.01875 | 3.10033 | 2 | 6 | 46 | negative regulation of TOR signaling |
| GO:0008347 | 0.01879 | 2.78344 | 3 | 7 | 59 | glial cell migration |
| GO:0098739 | 0.01880 | 2.16908 | 5 | 11 | 116 | import across plasma membrane |
| GO:0051648 | 0.01886 | 1.70281 | 13 | 21 | 277 | vesicle localization |
| GO:0042133 | 0.01921 | 2.00982 | 7 | 13 | 147 | neurotransmitter metabolic process |
| GO:0001655 | 0.01922 | 1.61801 | 16 | 25 | 346 | urogenital system development |
| GO:0042832 | 0.01924 | 3.56204 | 2 | 5 | 34 | defense response to protozoan |
| GO:0060479 | 0.01924 | 3.56204 | 2 | 5 | 34 | lung cell differentiation |
| GO:0071634 | 0.01924 | 3.56204 | 2 | 5 | 34 | regulation of transforming growth factor beta production |
| GO:0010717 | 0.01924 | 2.38747 | 4 | 9 | 87 | regulation of epithelial to mesenchymal transition |
| GO:0072091 | 0.01924 | 2.38747 | 4 | 9 | 87 | regulation of stem cell proliferation |
| GO:0051155 | 0.01940 | 2.54574 | 3 | 8 | 73 | positive regulation of striated muscle cell differentiation |
| GO:1902905 | 0.01948 | 1.85321 | 9 | 16 | 195 | positive regulation of supramolecular fiber organization |
| GO:0030879 | 0.01950 | 1.94703 | 8 | 14 | 163 | mammary gland development |
| GO:0001915 | 0.01952 | 13.75085 | 0 | 2 | 5 | negative regulation of T cell mediated cytotoxicity |
| GO:0002282 | 0.01952 | 13.75085 | 0 | 2 | 5 | microglial cell activation involved in immune response |
| GO:0002784 | 0.01952 | 13.75085 | 0 | 2 | 5 | regulation of antimicrobial peptide production |
| GO:0002786 | 0.01952 | 13.75085 | 0 | 2 | 5 | regulation of antibacterial peptide production |
| GO:0003376 | 0.01952 | 13.75085 | 0 | 2 | 5 | sphingosine-1-phosphate receptor signaling pathway |
| GO:0006116 | 0.01952 | 13.75085 | 0 | 2 | 5 | NADH oxidation |
| GO:0006742 | 0.01952 | 13.75085 | 0 | 2 | 5 | NADP catabolic process |
| GO:0010641 | 0.01952 | 13.75085 | 0 | 2 | 5 | positive regulation of platelet-derived growth factor receptor signaling pathway |
| GO:0015712 | 0.01952 | 13.75085 | 0 | 2 | 5 | hexose phosphate transport |
| GO:0015727 | 0.01952 | 13.75085 | 0 | 2 | 5 | lactate transport |
| GO:0015760 | 0.01952 | 13.75085 | 0 | 2 | 5 | glucose-6-phosphate transport |
| GO:0030222 | 0.01952 | 13.75085 | 0 | 2 | 5 | eosinophil differentiation |
| GO:0031632 | 0.01952 | 13.75085 | 0 | 2 | 5 | positive regulation of synaptic vesicle fusion to presynaptic active zone membrane |
| GO:0032632 | 0.01952 | 13.75085 | 0 | 2 | 5 | interleukin-3 production |
| GO:0032687 | 0.01952 | 13.75085 | 0 | 2 | 5 | negative regulation of interferon-alpha production |
| GO:0032696 | 0.01952 | 13.75085 | 0 | 2 | 5 | negative regulation of interleukin-13 production |
| GO:0035873 | 0.01952 | 13.75085 | 0 | 2 | 5 | lactate transmembrane transport |
| GO:0035879 | 0.01952 | 13.75085 | 0 | 2 | 5 | plasma membrane lactate transport |
| GO:0038145 | 0.01952 | 13.75085 | 0 | 2 | 5 | macrophage colony-stimulating factor signaling pathway |
| GO:0055118 | 0.01952 | 13.75085 | 0 | 2 | 5 | negative regulation of cardiac muscle contraction |
| GO:0060762 | 0.01952 | 13.75085 | 0 | 2 | 5 | regulation of branching involved in mammary gland duct morphogenesis |
| GO:0070837 | 0.01952 | 13.75085 | 0 | 2 | 5 | dehydroascorbic acid transport |
| GO:0099502 | 0.01952 | 13.75085 | 0 | 2 | 5 | calcium-dependent activation of synaptic vesicle fusion |
| GO:1900425 | 0.01952 | 13.75085 | 0 | 2 | 5 | negative regulation of defense response to bacterium |
| GO:1901842 | 0.01952 | 13.75085 | 0 | 2 | 5 | negative regulation of high voltage-gated calcium channel activity |
| GO:1902412 | 0.01952 | 13.75085 | 0 | 2 | 5 | regulation of mitotic cytokinesis |
| GO:1903969 | 0.01952 | 13.75085 | 0 | 2 | 5 | regulation of response to macrophage colony-stimulating factor |
| GO:1903972 | 0.01952 | 13.75085 | 0 | 2 | 5 | regulation of cellular response to macrophage colony-stimulating factor stimulus |
| GO:1904502 | 0.01952 | 13.75085 | 0 | 2 | 5 | regulation of lipophagy |
| GO:1904504 | 0.01952 | 13.75085 | 0 | 2 | 5 | positive regulation of lipophagy |
| GO:0046427 | 0.01982 | 2.24974 | 5 | 10 | 102 | positive regulation of JAK-STAT cascade |
| GO:0014020 | 0.01992 | 2.14852 | 5 | 11 | 117 | primary neural tube formation |
| GO:0051054 | 0.01999 | 1.74423 | 11 | 19 | 245 | positive regulation of DNA metabolic process |
| GO:0001845 | 0.02000 | 6.19170 | 1 | 3 | 13 | phagolysosome assembly |
| GO:0002371 | 0.02000 | 6.19170 | 1 | 3 | 13 | dendritic cell cytokine production |
| GO:0002430 | 0.02000 | 6.19170 | 1 | 3 | 13 | complement receptor mediated signaling pathway |
| GO:0002638 | 0.02000 | 6.19170 | 1 | 3 | 13 | negative regulation of immunoglobulin production |
| GO:0003157 | 0.02000 | 6.19170 | 1 | 3 | 13 | endocardium development |
| GO:0030240 | 0.02000 | 6.19170 | 1 | 3 | 13 | skeletal muscle thin filament assembly |
| GO:0030948 | 0.02000 | 6.19170 | 1 | 3 | 13 | negative regulation of vascular endothelial growth factor receptor signaling pathway |
| GO:0031652 | 0.02000 | 6.19170 | 1 | 3 | 13 | positive regulation of heat generation |
| GO:0031953 | 0.02000 | 6.19170 | 1 | 3 | 13 | negative regulation of protein autophosphorylation |
| GO:0033280 | 0.02000 | 6.19170 | 1 | 3 | 13 | response to vitamin D |
| GO:0042482 | 0.02000 | 6.19170 | 1 | 3 | 13 | positive regulation of odontogenesis |
| GO:0045628 | 0.02000 | 6.19170 | 1 | 3 | 13 | regulation of T-helper 2 cell differentiation |
| GO:0070942 | 0.02000 | 6.19170 | 1 | 3 | 13 | neutrophil mediated cytotoxicity |
| GO:0090042 | 0.02000 | 6.19170 | 1 | 3 | 13 | tubulin deacetylation |
| GO:0090085 | 0.02000 | 6.19170 | 1 | 3 | 13 | regulation of protein deubiquitination |
| GO:1902715 | 0.02000 | 6.19170 | 1 | 3 | 13 | positive regulation of interferon-gamma secretion |
| GO:2000484 | 0.02000 | 6.19170 | 1 | 3 | 13 | positive regulation of interleukin-8 secretion |
| GO:2000650 | 0.02000 | 6.19170 | 1 | 3 | 13 | negative regulation of sodium ion transmembrane transporter activity |
| GO:2001054 | 0.02000 | 6.19170 | 1 | 3 | 13 | negative regulation of mesenchymal cell apoptotic process |
| GO:2001223 | 0.02000 | 6.19170 | 1 | 3 | 13 | negative regulation of neuron migration |
| GO:0002827 | 0.02005 | 4.34734 | 1 | 4 | 23 | positive regulation of T-helper 1 type immune response |
| GO:0006837 | 0.02005 | 4.34734 | 1 | 4 | 23 | serotonin transport |
| GO:0045056 | 0.02005 | 4.34734 | 1 | 4 | 23 | transcytosis |
| GO:0099149 | 0.02005 | 4.34734 | 1 | 4 | 23 | regulation of postsynaptic neurotransmitter receptor internalization |
| GO:2000316 | 0.02005 | 4.34734 | 1 | 4 | 23 | regulation of T-helper 17 type immune response |
| GO:0006643 | 0.02045 | 1.93396 | 8 | 14 | 164 | membrane lipid metabolic process |
| GO:0042982 | 0.02045 | 2.73080 | 3 | 7 | 60 | amyloid precursor protein metabolic process |
| GO:0045744 | 0.02045 | 2.73080 | 3 | 7 | 60 | negative regulation of G protein-coupled receptor signaling pathway |
| GO:0046847 | 0.02045 | 2.73080 | 3 | 7 | 60 | filopodium assembly |
| GO:0070098 | 0.02045 | 2.73080 | 3 | 7 | 60 | chemokine-mediated signaling pathway |
| GO:0071156 | 0.02045 | 2.73080 | 3 | 7 | 60 | regulation of cell cycle arrest |
| GO:1902903 | 0.02047 | 1.60784 | 16 | 25 | 348 | regulation of supramolecular fiber organization |
| GO:0007416 | 0.02047 | 1.88422 | 8 | 15 | 180 | synapse assembly |
| GO:0048638 | 0.02078 | 1.56028 | 19 | 28 | 401 | regulation of developmental growth |
| GO:0006919 | 0.02089 | 2.50706 | 3 | 8 | 74 | activation of cysteine-type endopeptidase activity involved in apoptotic process |
| GO:0000018 | 0.02107 | 2.22545 | 5 | 10 | 103 | regulation of DNA recombination |
| GO:0043255 | 0.02107 | 2.22545 | 5 | 10 | 103 | regulation of carbohydrate biosynthetic process |
| GO:0060759 | 0.02108 | 2.12835 | 5 | 11 | 118 | regulation of response to cytokine stimulus |
| GO:0008610 | 0.02122 | 1.47213 | 25 | 36 | 545 | lipid biosynthetic process |
| GO:0035909 | 0.02161 | 3.44315 | 2 | 5 | 35 | aorta morphogenesis |
| GO:0043114 | 0.02161 | 3.44315 | 2 | 5 | 35 | regulation of vascular permeability |
| GO:0060142 | 0.02161 | 3.44315 | 2 | 5 | 35 | regulation of syncytium formation by plasma membrane fusion |
| GO:1904707 | 0.02161 | 3.44315 | 2 | 5 | 35 | positive regulation of vascular smooth muscle cell proliferation |
| GO:0000041 | 0.02199 | 2.32757 | 4 | 9 | 89 | transition metal ion transport |
| GO:0010812 | 0.02221 | 2.68010 | 3 | 7 | 61 | negative regulation of cell-substrate adhesion |
| GO:0042058 | 0.02221 | 2.68010 | 3 | 7 | 61 | regulation of epidermal growth factor receptor signaling pathway |
| GO:0048286 | 0.02221 | 2.68010 | 3 | 7 | 61 | lung alveolus development |
| GO:0003073 | 0.02229 | 2.10854 | 6 | 11 | 119 | regulation of systemic arterial blood pressure |
| GO:0031929 | 0.02229 | 2.10854 | 6 | 11 | 119 | TOR signaling |
| GO:0035051 | 0.02237 | 1.86148 | 8 | 15 | 182 | cardiocyte differentiation |
| GO:0007009 | 0.02238 | 2.20168 | 5 | 10 | 104 | plasma membrane organization |
| GO:1903825 | 0.02238 | 2.20168 | 5 | 10 | 104 | organic acid transmembrane transport |
| GO:1905039 | 0.02238 | 2.20168 | 5 | 10 | 104 | carboxylic acid transmembrane transport |
| GO:0046626 | 0.02247 | 2.46953 | 3 | 8 | 75 | regulation of insulin receptor signaling pathway |
| GO:1900182 | 0.02247 | 2.46953 | 3 | 8 | 75 | positive regulation of protein localization to nucleus |
| GO:0070482 | 0.02248 | 1.66981 | 13 | 21 | 282 | response to oxygen levels |
| GO:0035265 | 0.02264 | 1.78023 | 10 | 17 | 215 | organ growth |
| GO:0030857 | 0.02273 | 2.95243 | 2 | 6 | 48 | negative regulation of epithelial cell differentiation |
| GO:0070534 | 0.02273 | 2.95243 | 2 | 6 | 48 | protein K63-linked ubiquitination |
| GO:0090311 | 0.02273 | 2.95243 | 2 | 6 | 48 | regulation of protein deacetylation |
| GO:0010564 | 0.02309 | 1.44621 | 27 | 38 | 585 | regulation of cell cycle process |
| GO:0019048 | 0.02320 | 4.12979 | 1 | 4 | 24 | modulation by virus of host morphology or physiology |
| GO:0032352 | 0.02320 | 4.12979 | 1 | 4 | 24 | positive regulation of hormone metabolic process |
| GO:0032770 | 0.02320 | 4.12979 | 1 | 4 | 24 | positive regulation of monooxygenase activity |
| GO:0033622 | 0.02320 | 4.12979 | 1 | 4 | 24 | integrin activation |
| GO:0043921 | 0.02320 | 4.12979 | 1 | 4 | 24 | modulation by host of viral transcription |
| GO:0048670 | 0.02320 | 4.12979 | 1 | 4 | 24 | regulation of collateral sprouting |
| GO:0050995 | 0.02320 | 4.12979 | 1 | 4 | 24 | negative regulation of lipid catabolic process |
| GO:0052312 | 0.02320 | 4.12979 | 1 | 4 | 24 | modulation of transcription in other organism involved in symbiotic interaction |
| GO:0052472 | 0.02320 | 4.12979 | 1 | 4 | 24 | modulation by host of symbiont transcription |
| GO:0060216 | 0.02320 | 4.12979 | 1 | 4 | 24 | definitive hemopoiesis |
| GO:0006606 | 0.02340 | 1.95121 | 7 | 13 | 151 | protein import into nucleus |
| GO:0044070 | 0.02355 | 2.08910 | 6 | 11 | 120 | regulation of anion transport |
| GO:0051208 | 0.02355 | 2.08910 | 6 | 11 | 120 | sequestering of calcium ion |
| GO:1901216 | 0.02355 | 2.08910 | 6 | 11 | 120 | positive regulation of neuron death |
| GO:0048562 | 0.02373 | 1.61861 | 15 | 23 | 318 | embryonic organ morphogenesis |
| GO:0071417 | 0.02380 | 1.45025 | 26 | 37 | 568 | cellular response to organonitrogen compound |
| GO:0030278 | 0.02388 | 1.73620 | 11 | 18 | 233 | regulation of ossification |
| GO:0090092 | 0.02388 | 1.73620 | 11 | 18 | 233 | regulation of transmembrane receptor protein serine/threonine kinase signaling pathway |
| GO:0007049 | 0.02396 | 1.26124 | 76 | 93 | 1639 | cell cycle |
| GO:0048008 | 0.02407 | 2.63126 | 3 | 7 | 62 | platelet-derived growth factor receptor signaling pathway |
| GO:0034205 | 0.02417 | 3.33193 | 2 | 5 | 36 | amyloid-beta formation |
| GO:0035886 | 0.02417 | 3.33193 | 2 | 5 | 36 | vascular smooth muscle cell differentiation |
| GO:0051482 | 0.02417 | 3.33193 | 2 | 5 | 36 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway |
| GO:0097553 | 0.02424 | 2.00385 | 6 | 12 | 136 | calcium ion transmembrane import into cytosol |
| GO:0014866 | 0.02459 | 5.62856 | 1 | 3 | 14 | skeletal myofibril assembly |
| GO:0016446 | 0.02459 | 5.62856 | 1 | 3 | 14 | somatic hypermutation of immunoglobulin genes |
| GO:0018119 | 0.02459 | 5.62856 | 1 | 3 | 14 | peptidyl-cysteine S-nitrosylation |
| GO:0032306 | 0.02459 | 5.62856 | 1 | 3 | 14 | regulation of prostaglandin secretion |
| GO:0032769 | 0.02459 | 5.62856 | 1 | 3 | 14 | negative regulation of monooxygenase activity |
| GO:0034116 | 0.02459 | 5.62856 | 1 | 3 | 14 | positive regulation of heterotypic cell-cell adhesion |
| GO:0034433 | 0.02459 | 5.62856 | 1 | 3 | 14 | steroid esterification |
| GO:0034434 | 0.02459 | 5.62856 | 1 | 3 | 14 | sterol esterification |
| GO:0034435 | 0.02459 | 5.62856 | 1 | 3 | 14 | cholesterol esterification |
| GO:0035745 | 0.02459 | 5.62856 | 1 | 3 | 14 | T-helper 2 cell cytokine production |
| GO:0042976 | 0.02459 | 5.62856 | 1 | 3 | 14 | activation of Janus kinase activity |
| GO:0044546 | 0.02459 | 5.62856 | 1 | 3 | 14 | NLRP3 inflammasome complex assembly |
| GO:0045618 | 0.02459 | 5.62856 | 1 | 3 | 14 | positive regulation of keratinocyte differentiation |
| GO:0045651 | 0.02459 | 5.62856 | 1 | 3 | 14 | positive regulation of macrophage differentiation |
| GO:0051152 | 0.02459 | 5.62856 | 1 | 3 | 14 | positive regulation of smooth muscle cell differentiation |
| GO:0051782 | 0.02459 | 5.62856 | 1 | 3 | 14 | negative regulation of cell division |
| GO:0070365 | 0.02459 | 5.62856 | 1 | 3 | 14 | hepatocyte differentiation |
| GO:0072537 | 0.02459 | 5.62856 | 1 | 3 | 14 | fibroblast activation |
| GO:0097066 | 0.02459 | 5.62856 | 1 | 3 | 14 | response to thyroid hormone |
| GO:0098911 | 0.02459 | 5.62856 | 1 | 3 | 14 | regulation of ventricular cardiac muscle cell action potential |
| GO:0099151 | 0.02459 | 5.62856 | 1 | 3 | 14 | regulation of postsynaptic density assembly |
| GO:1902306 | 0.02459 | 5.62856 | 1 | 3 | 14 | negative regulation of sodium ion transmembrane transport |
| GO:1903430 | 0.02459 | 5.62856 | 1 | 3 | 14 | negative regulation of cell maturation |
| GO:1905063 | 0.02459 | 5.62856 | 1 | 3 | 14 | regulation of vascular smooth muscle cell differentiation |
| GO:0072001 | 0.02473 | 1.63075 | 14 | 22 | 302 | renal system development |
| GO:1900180 | 0.02487 | 2.07002 | 6 | 11 | 121 | regulation of protein localization to nucleus |
| GO:0045666 | 0.02489 | 1.49883 | 21 | 31 | 461 | positive regulation of neuron differentiation |
| GO:0035088 | 0.02492 | 2.88363 | 2 | 6 | 49 | establishment or maintenance of apical/basal cell polarity |
| GO:0045646 | 0.02492 | 2.88363 | 2 | 6 | 49 | regulation of erythrocyte differentiation |
| GO:0046834 | 0.02492 | 2.88363 | 2 | 6 | 49 | lipid phosphorylation |
| GO:0061245 | 0.02492 | 2.88363 | 2 | 6 | 49 | establishment or maintenance of bipolar cell polarity |
| GO:0002028 | 0.02501 | 2.27059 | 4 | 9 | 91 | regulation of sodium ion transport |
| GO:0000302 | 0.02504 | 1.79261 | 9 | 16 | 201 | response to reactive oxygen species |
| GO:0032091 | 0.02518 | 2.15561 | 5 | 10 | 106 | negative regulation of protein binding |
| GO:0048661 | 0.02518 | 2.15561 | 5 | 10 | 106 | positive regulation of smooth muscle cell proliferation |
| GO:0055006 | 0.02518 | 2.15561 | 5 | 10 | 106 | cardiac cell development |
| GO:0044419 | 0.02533 | 1.53104 | 19 | 28 | 408 | interspecies interaction between organisms |
| GO:0051495 | 0.02548 | 1.75342 | 10 | 17 | 218 | positive regulation of cytoskeleton organization |
| GO:0031056 | 0.02574 | 1.92316 | 7 | 13 | 153 | regulation of histone modification |
| GO:0015918 | 0.02588 | 2.39773 | 4 | 8 | 77 | sterol transport |
| GO:0030301 | 0.02588 | 2.39773 | 4 | 8 | 77 | cholesterol transport |
| GO:0032088 | 0.02588 | 2.39773 | 4 | 8 | 77 | negative regulation of NF-kappaB transcription factor activity |
| GO:0071277 | 0.02588 | 2.39773 | 4 | 8 | 77 | cellular response to calcium ion |
| GO:0043388 | 0.02603 | 2.58415 | 3 | 7 | 63 | positive regulation of DNA binding |
| GO:0043462 | 0.02603 | 2.58415 | 3 | 7 | 63 | regulation of ATPase activity |
| GO:0046579 | 0.02603 | 2.58415 | 3 | 7 | 63 | positive regulation of Ras protein signal transduction |
| GO:0000280 | 0.02604 | 1.52695 | 19 | 28 | 409 | nuclear division |
| GO:0045892 | 0.02619 | 1.30163 | 55 | 69 | 1177 | negative regulation of transcription, DNA-templated |
| GO:0006817 | 0.02663 | 3.93295 | 1 | 4 | 25 | phosphate ion transport |
| GO:0006925 | 0.02663 | 3.93295 | 1 | 4 | 25 | inflammatory cell apoptotic process |
| GO:0010640 | 0.02663 | 3.93295 | 1 | 4 | 25 | regulation of platelet-derived growth factor receptor signaling pathway |
| GO:0034114 | 0.02663 | 3.93295 | 1 | 4 | 25 | regulation of heterotypic cell-cell adhesion |
| GO:0035024 | 0.02663 | 3.93295 | 1 | 4 | 25 | negative regulation of Rho protein signal transduction |
| GO:0071711 | 0.02663 | 3.93295 | 1 | 4 | 25 | basement membrane organization |
| GO:0085029 | 0.02663 | 3.93295 | 1 | 4 | 25 | extracellular matrix assembly |
| GO:0086019 | 0.02663 | 3.93295 | 1 | 4 | 25 | cell-cell signaling involved in cardiac conduction |
| GO:0090280 | 0.02663 | 3.93295 | 1 | 4 | 25 | positive regulation of calcium ion import |
| GO:0003014 | 0.02666 | 2.13329 | 5 | 10 | 107 | renal system process |
| GO:0097756 | 0.02666 | 2.13329 | 5 | 10 | 107 | negative regulation of blood vessel diameter |
| GO:0060401 | 0.02686 | 1.85907 | 8 | 14 | 170 | cytosolic calcium ion transport |
| GO:0002717 | 0.02691 | 3.22766 | 2 | 5 | 37 | positive regulation of natural killer cell mediated immunity |
| GO:0032885 | 0.02691 | 3.22766 | 2 | 5 | 37 | regulation of polysaccharide biosynthetic process |
| GO:0045191 | 0.02691 | 3.22766 | 2 | 5 | 37 | regulation of isotype switching |
| GO:0045954 | 0.02691 | 3.22766 | 2 | 5 | 37 | positive regulation of natural killer cell mediated cytotoxicity |
| GO:0050892 | 0.02691 | 3.22766 | 2 | 5 | 37 | intestinal absorption |
| GO:0071158 | 0.02691 | 3.22766 | 2 | 5 | 37 | positive regulation of cell cycle arrest |
| GO:0086065 | 0.02691 | 3.22766 | 2 | 5 | 37 | cell communication involved in cardiac conduction |
| GO:2000463 | 0.02691 | 3.22766 | 2 | 5 | 37 | positive regulation of excitatory postsynaptic potential |
| GO:0001838 | 0.02697 | 1.90943 | 7 | 13 | 154 | embryonic epithelial tube formation |
| GO:0050891 | 0.02725 | 2.81797 | 2 | 6 | 50 | multicellular organismal water homeostasis |
| GO:0051055 | 0.02725 | 2.81797 | 2 | 6 | 50 | negative regulation of lipid biosynthetic process |
| GO:0090329 | 0.02725 | 2.81797 | 2 | 6 | 50 | regulation of DNA-dependent DNA replication |
| GO:0099054 | 0.02725 | 2.81797 | 2 | 6 | 50 | presynapse assembly |
| GO:0065003 | 0.02781 | 1.24603 | 80 | 97 | 1729 | protein-containing complex assembly |
| GO:1903507 | 0.02790 | 1.29670 | 55 | 69 | 1181 | negative regulation of nucleic acid-templated transcription |
| GO:0044774 | 0.02810 | 2.53870 | 3 | 7 | 64 | mitotic DNA integrity checkpoint |
| GO:0001959 | 0.02821 | 2.11143 | 5 | 10 | 108 | regulation of cytokine-mediated signaling pathway |
| GO:0035725 | 0.02821 | 2.11143 | 5 | 10 | 108 | sodium ion transmembrane transport |
| GO:0051170 | 0.02824 | 1.89590 | 7 | 13 | 155 | import into nucleus |
| GO:0035305 | 0.02832 | 2.21633 | 4 | 9 | 93 | negative regulation of dephosphorylation |
| GO:1902679 | 0.02835 | 1.29548 | 55 | 69 | 1182 | negative regulation of RNA biosynthetic process |
| GO:1901699 | 0.02835 | 1.40883 | 29 | 40 | 631 | cellular response to nitrogen compound |
| GO:0001705 | 0.02839 | 10.31267 | 0 | 2 | 6 | ectoderm formation |
| GO:0002023 | 0.02839 | 10.31267 | 0 | 2 | 6 | reduction of food intake in response to dietary excess |
| GO:0002248 | 0.02839 | 10.31267 | 0 | 2 | 6 | connective tissue replacement involved in inflammatory response wound healing |
| GO:0002461 | 0.02839 | 10.31267 | 0 | 2 | 6 | tolerance induction dependent upon immune response |
| GO:0002513 | 0.02839 | 10.31267 | 0 | 2 | 6 | tolerance induction to self antigen |
| GO:0002606 | 0.02839 | 10.31267 | 0 | 2 | 6 | positive regulation of dendritic cell antigen processing and presentation |
| GO:0009756 | 0.02839 | 10.31267 | 0 | 2 | 6 | carbohydrate mediated signaling |
| GO:0009757 | 0.02839 | 10.31267 | 0 | 2 | 6 | hexose mediated signaling |
| GO:0009912 | 0.02839 | 10.31267 | 0 | 2 | 6 | auditory receptor cell fate commitment |
| GO:0010182 | 0.02839 | 10.31267 | 0 | 2 | 6 | sugar mediated signaling pathway |
| GO:0010255 | 0.02839 | 10.31267 | 0 | 2 | 6 | glucose mediated signaling pathway |
| GO:0019364 | 0.02839 | 10.31267 | 0 | 2 | 6 | pyridine nucleotide catabolic process |
| GO:0032741 | 0.02839 | 10.31267 | 0 | 2 | 6 | positive regulation of interleukin-18 production |
| GO:0032762 | 0.02839 | 10.31267 | 0 | 2 | 6 | mast cell cytokine production |
| GO:0032782 | 0.02839 | 10.31267 | 0 | 2 | 6 | bile acid secretion |
| GO:0034165 | 0.02839 | 10.31267 | 0 | 2 | 6 | positive regulation of toll-like receptor 9 signaling pathway |
| GO:0034773 | 0.02839 | 10.31267 | 0 | 2 | 6 | histone H4-K20 trimethylation |
| GO:0035166 | 0.02839 | 10.31267 | 0 | 2 | 6 | post-embryonic hemopoiesis |
| GO:0035509 | 0.02839 | 10.31267 | 0 | 2 | 6 | negative regulation of myosin-light-chain-phosphatase activity |
| GO:0035655 | 0.02839 | 10.31267 | 0 | 2 | 6 | interleukin-18-mediated signaling pathway |
| GO:0042695 | 0.02839 | 10.31267 | 0 | 2 | 6 | thelarche |
| GO:0043305 | 0.02839 | 10.31267 | 0 | 2 | 6 | negative regulation of mast cell degranulation |
| GO:0043307 | 0.02839 | 10.31267 | 0 | 2 | 6 | eosinophil activation |
| GO:0043376 | 0.02839 | 10.31267 | 0 | 2 | 6 | regulation of CD8-positive, alpha-beta T cell differentiation |
| GO:0045650 | 0.02839 | 10.31267 | 0 | 2 | 6 | negative regulation of macrophage differentiation |
| GO:0048597 | 0.02839 | 10.31267 | 0 | 2 | 6 | post-embryonic camera-type eye morphogenesis |
| GO:0050722 | 0.02839 | 10.31267 | 0 | 2 | 6 | regulation of interleukin-1 beta biosynthetic process |
| GO:0050725 | 0.02839 | 10.31267 | 0 | 2 | 6 | positive regulation of interleukin-1 beta biosynthetic process |
| GO:0051182 | 0.02839 | 10.31267 | 0 | 2 | 6 | coenzyme transport |
| GO:0051661 | 0.02839 | 10.31267 | 0 | 2 | 6 | maintenance of centrosome location |
| GO:0052173 | 0.02839 | 10.31267 | 0 | 2 | 6 | response to defenses of other organism involved in symbiotic interaction |
| GO:0052200 | 0.02839 | 10.31267 | 0 | 2 | 6 | response to host defenses |
| GO:0060120 | 0.02839 | 10.31267 | 0 | 2 | 6 | inner ear receptor cell fate commitment |
| GO:0060744 | 0.02839 | 10.31267 | 0 | 2 | 6 | mammary gland branching involved in thelarche |
| GO:0060751 | 0.02839 | 10.31267 | 0 | 2 | 6 | branch elongation involved in mammary gland duct branching |
| GO:0061724 | 0.02839 | 10.31267 | 0 | 2 | 6 | lipophagy |
| GO:0070162 | 0.02839 | 10.31267 | 0 | 2 | 6 | adiponectin secretion |
| GO:0070163 | 0.02839 | 10.31267 | 0 | 2 | 6 | regulation of adiponectin secretion |
| GO:0075136 | 0.02839 | 10.31267 | 0 | 2 | 6 | response to host |
| GO:0097114 | 0.02839 | 10.31267 | 0 | 2 | 6 | NMDA glutamate receptor clustering |
| GO:0099576 | 0.02839 | 10.31267 | 0 | 2 | 6 | regulation of protein catabolic process at postsynapse, modulating synaptic transmission |
| GO:1900028 | 0.02839 | 10.31267 | 0 | 2 | 6 | negative regulation of ruffle assembly |
| GO:1900194 | 0.02839 | 10.31267 | 0 | 2 | 6 | negative regulation of oocyte maturation |
| GO:1901552 | 0.02839 | 10.31267 | 0 | 2 | 6 | positive regulation of endothelial cell development |
| GO:1902075 | 0.02839 | 10.31267 | 0 | 2 | 6 | cellular response to salt |
| GO:1903142 | 0.02839 | 10.31267 | 0 | 2 | 6 | positive regulation of establishment of endothelial barrier |
| GO:1903935 | 0.02839 | 10.31267 | 0 | 2 | 6 | response to sodium arsenite |
| GO:1904238 | 0.02839 | 10.31267 | 0 | 2 | 6 | pericyte cell differentiation |
| GO:1904428 | 0.02839 | 10.31267 | 0 | 2 | 6 | negative regulation of tubulin deacetylation |
| GO:1905065 | 0.02839 | 10.31267 | 0 | 2 | 6 | positive regulation of vascular smooth muscle cell differentiation |
| GO:2000416 | 0.02839 | 10.31267 | 0 | 2 | 6 | regulation of eosinophil migration |
| GO:2000427 | 0.02839 | 10.31267 | 0 | 2 | 6 | positive regulation of apoptotic cell clearance |
| GO:2000491 | 0.02839 | 10.31267 | 0 | 2 | 6 | positive regulation of hepatic stellate cell activation |
| GO:2000554 | 0.02839 | 10.31267 | 0 | 2 | 6 | regulation of T-helper 1 cell cytokine production |
| GO:2000556 | 0.02839 | 10.31267 | 0 | 2 | 6 | positive regulation of T-helper 1 cell cytokine production |
| GO:2000664 | 0.02839 | 10.31267 | 0 | 2 | 6 | positive regulation of interleukin-5 secretion |
| GO:2000977 | 0.02839 | 10.31267 | 0 | 2 | 6 | regulation of forebrain neuron differentiation |
| GO:0044283 | 0.02862 | 1.40155 | 30 | 41 | 650 | small molecule biosynthetic process |
| GO:0110053 | 0.02874 | 1.66956 | 12 | 19 | 255 | regulation of actin filament organization |
| GO:0033138 | 0.02912 | 2.01479 | 6 | 11 | 124 | positive regulation of peptidyl-serine phosphorylation |
| GO:1901987 | 0.02936 | 1.61956 | 13 | 21 | 290 | regulation of cell cycle phase transition |
| GO:0006694 | 0.02955 | 1.88255 | 7 | 13 | 156 | steroid biosynthetic process |
| GO:0043525 | 0.02963 | 2.32998 | 4 | 8 | 79 | positive regulation of neuron apoptotic process |
| GO:0002566 | 0.02970 | 5.15928 | 1 | 3 | 15 | somatic diversification of immune receptors via somatic mutation |
| GO:0006978 | 0.02970 | 5.15928 | 1 | 3 | 15 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator |
| GO:0010878 | 0.02970 | 5.15928 | 1 | 3 | 15 | cholesterol storage |
| GO:0010935 | 0.02970 | 5.15928 | 1 | 3 | 15 | regulation of macrophage cytokine production |
| GO:0017014 | 0.02970 | 5.15928 | 1 | 3 | 15 | protein nitrosylation |
| GO:0031268 | 0.02970 | 5.15928 | 1 | 3 | 15 | pseudopodium organization |
| GO:0031650 | 0.02970 | 5.15928 | 1 | 3 | 15 | regulation of heat generation |
| GO:0035461 | 0.02970 | 5.15928 | 1 | 3 | 15 | vitamin transmembrane transport |
| GO:0036159 | 0.02970 | 5.15928 | 1 | 3 | 15 | inner dynein arm assembly |
| GO:0042095 | 0.02970 | 5.15928 | 1 | 3 | 15 | interferon-gamma biosynthetic process |
| GO:0043117 | 0.02970 | 5.15928 | 1 | 3 | 15 | positive regulation of vascular permeability |
| GO:0045414 | 0.02970 | 5.15928 | 1 | 3 | 15 | regulation of interleukin-8 biosynthetic process |
| GO:0050872 | 0.02970 | 5.15928 | 1 | 3 | 15 | white fat cell differentiation |
| GO:0051712 | 0.02970 | 5.15928 | 1 | 3 | 15 | positive regulation of killing of cells of other organism |
| GO:0070234 | 0.02970 | 5.15928 | 1 | 3 | 15 | positive regulation of T cell apoptotic process |
| GO:0070307 | 0.02970 | 5.15928 | 1 | 3 | 15 | lens fiber cell development |
| GO:0072567 | 0.02970 | 5.15928 | 1 | 3 | 15 | chemokine (C-X-C motif) ligand 2 production |
| GO:0086014 | 0.02970 | 5.15928 | 1 | 3 | 15 | atrial cardiac muscle cell action potential |
| GO:0086026 | 0.02970 | 5.15928 | 1 | 3 | 15 | atrial cardiac muscle cell to AV node cell signaling |
| GO:0086066 | 0.02970 | 5.15928 | 1 | 3 | 15 | atrial cardiac muscle cell to AV node cell communication |
| GO:0090197 | 0.02970 | 5.15928 | 1 | 3 | 15 | positive regulation of chemokine secretion |
| GO:2001256 | 0.02970 | 5.15928 | 1 | 3 | 15 | regulation of store-operated calcium entry |
| GO:0045912 | 0.02972 | 2.75522 | 2 | 6 | 51 | negative regulation of carbohydrate metabolic process |
| GO:0070542 | 0.02972 | 2.75522 | 2 | 6 | 51 | response to fatty acid |
| GO:0090257 | 0.02978 | 1.68860 | 11 | 18 | 239 | regulation of muscle system process |
| GO:1903076 | 0.02983 | 2.09001 | 5 | 10 | 109 | regulation of protein localization to plasma membrane |
| GO:0001562 | 0.02985 | 3.12971 | 2 | 5 | 38 | response to protozoan |
| GO:0001953 | 0.02985 | 3.12971 | 2 | 5 | 38 | negative regulation of cell-matrix adhesion |
| GO:0046854 | 0.02985 | 3.12971 | 2 | 5 | 38 | phosphatidylinositol phosphorylation |
| GO:0044403 | 0.02990 | 1.56168 | 16 | 24 | 343 | symbiont process |
| GO:0051125 | 0.03035 | 3.75401 | 1 | 4 | 26 | regulation of actin nucleation |
| GO:0051570 | 0.03035 | 3.75401 | 1 | 4 | 26 | regulation of histone H3-K9 methylation |
| GO:0051767 | 0.03035 | 3.75401 | 1 | 4 | 26 | nitric-oxide synthase biosynthetic process |
| GO:0051769 | 0.03035 | 3.75401 | 1 | 4 | 26 | regulation of nitric-oxide synthase biosynthetic process |
| GO:0072574 | 0.03035 | 3.75401 | 1 | 4 | 26 | hepatocyte proliferation |
| GO:0072575 | 0.03035 | 3.75401 | 1 | 4 | 26 | epithelial cell proliferation involved in liver morphogenesis |
| GO:2000311 | 0.03035 | 3.75401 | 1 | 4 | 26 | regulation of AMPA receptor activity |
| GO:0043393 | 0.03086 | 1.68092 | 11 | 18 | 240 | regulation of protein binding |
| GO:0060402 | 0.03091 | 1.86940 | 7 | 13 | 157 | calcium ion transport into cytosol |
| GO:0090100 | 0.03150 | 2.06901 | 5 | 10 | 110 | positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway |
| GO:0030500 | 0.03164 | 2.29751 | 4 | 8 | 80 | regulation of bone mineralization |
| GO:0045682 | 0.03164 | 2.29751 | 4 | 8 | 80 | regulation of epidermis development |
| GO:0055001 | 0.03171 | 1.73583 | 10 | 16 | 207 | muscle cell development |
| GO:0046916 | 0.03192 | 2.16459 | 4 | 9 | 95 | cellular transition metal ion homeostasis |
| GO:0055076 | 0.03224 | 1.97957 | 6 | 11 | 126 | transition metal ion homeostasis |
| GO:0001954 | 0.03233 | 2.69520 | 2 | 6 | 52 | positive regulation of cell-matrix adhesion |
| GO:0035924 | 0.03233 | 2.69520 | 2 | 6 | 52 | cellular response to vascular endothelial growth factor stimulus |
| GO:0043268 | 0.03233 | 2.69520 | 2 | 6 | 52 | positive regulation of potassium ion transport |
| GO:0021915 | 0.03255 | 1.76557 | 9 | 15 | 191 | neural tube development |
| GO:0051253 | 0.03265 | 1.27550 | 59 | 73 | 1269 | negative regulation of RNA metabolic process |
| GO:0007257 | 0.03298 | 3.03752 | 2 | 5 | 39 | activation of JUN kinase activity |
| GO:1902692 | 0.03298 | 3.03752 | 2 | 5 | 39 | regulation of neuroblast proliferation |
| GO:0043583 | 0.03310 | 1.66576 | 11 | 18 | 242 | ear development |
| GO:0071241 | 0.03311 | 1.69387 | 10 | 17 | 225 | cellular response to inorganic substance |
| GO:0031570 | 0.03324 | 2.04844 | 5 | 10 | 111 | DNA integrity checkpoint |
| GO:0071901 | 0.03324 | 2.04844 | 5 | 10 | 111 | negative regulation of protein serine/threonine kinase activity |
| GO:0099537 | 0.03331 | 1.33311 | 40 | 52 | 865 | trans-synaptic signaling |
| GO:0031329 | 0.03349 | 1.37289 | 32 | 43 | 695 | regulation of cellular catabolic process |
| GO:0044839 | 0.03388 | 1.96241 | 6 | 11 | 127 | cell cycle G2/M phase transition |
| GO:0061387 | 0.03388 | 1.96241 | 6 | 11 | 127 | regulation of extent of cell growth |
| GO:0055007 | 0.03400 | 1.89617 | 7 | 12 | 143 | cardiac muscle cell differentiation |
| GO:0072073 | 0.03400 | 1.89617 | 7 | 12 | 143 | kidney epithelium development |
| GO:2000027 | 0.03420 | 1.71768 | 10 | 16 | 209 | regulation of animal organ morphogenesis |
| GO:0003085 | 0.03436 | 3.59063 | 1 | 4 | 27 | negative regulation of systemic arterial blood pressure |
| GO:0010460 | 0.03436 | 3.59063 | 1 | 4 | 27 | positive regulation of heart rate |
| GO:0021533 | 0.03436 | 3.59063 | 1 | 4 | 27 | cell differentiation in hindbrain |
| GO:0045780 | 0.03436 | 3.59063 | 1 | 4 | 27 | positive regulation of bone resorption |
| GO:0046852 | 0.03436 | 3.59063 | 1 | 4 | 27 | positive regulation of bone remodeling |
| GO:0048843 | 0.03436 | 3.59063 | 1 | 4 | 27 | negative regulation of axon extension involved in axon guidance |
| GO:0050996 | 0.03436 | 3.59063 | 1 | 4 | 27 | positive regulation of lipid catabolic process |
| GO:0051354 | 0.03436 | 3.59063 | 1 | 4 | 27 | negative regulation of oxidoreductase activity |
| GO:0061099 | 0.03436 | 3.59063 | 1 | 4 | 27 | negative regulation of protein tyrosine kinase activity |
| GO:2000727 | 0.03436 | 3.59063 | 1 | 4 | 27 | positive regulation of cardiac muscle cell differentiation |
| GO:0008064 | 0.03465 | 1.78973 | 8 | 14 | 176 | regulation of actin polymerization or depolymerization |
| GO:0035148 | 0.03465 | 1.78973 | 8 | 14 | 176 | tube formation |
| GO:0048285 | 0.03466 | 1.46297 | 21 | 30 | 456 | organelle fission |
| GO:0034645 | 0.03476 | 1.15967 | 186 | 209 | 4022 | cellular macromolecule biosynthetic process |
| GO:0000768 | 0.03498 | 2.41144 | 3 | 7 | 67 | syncytium formation by plasma membrane fusion |
| GO:0048678 | 0.03498 | 2.41144 | 3 | 7 | 67 | response to axon injury |
| GO:0140253 | 0.03498 | 2.41144 | 3 | 7 | 67 | cell-cell fusion |
| GO:2000179 | 0.03498 | 2.41144 | 3 | 7 | 67 | positive regulation of neural precursor cell proliferation |
| GO:0006939 | 0.03505 | 2.02826 | 5 | 10 | 112 | smooth muscle contraction |
| GO:0006023 | 0.03508 | 2.63774 | 2 | 6 | 53 | aminoglycan biosynthetic process |
| GO:1904705 | 0.03508 | 2.63774 | 2 | 6 | 53 | regulation of vascular smooth muscle cell proliferation |
| GO:1990874 | 0.03508 | 2.63774 | 2 | 6 | 53 | vascular smooth muscle cell proliferation |
| GO:0031214 | 0.03526 | 1.83100 | 7 | 13 | 160 | biomineral tissue development |
| GO:0043433 | 0.03526 | 1.83100 | 7 | 13 | 160 | negative regulation of DNA-binding transcription factor activity |
| GO:0001886 | 0.03533 | 4.76220 | 1 | 3 | 16 | endothelial cell morphogenesis |
| GO:0002295 | 0.03533 | 4.76220 | 1 | 3 | 16 | T-helper cell lineage commitment |
| GO:0002431 | 0.03533 | 4.76220 | 1 | 3 | 16 | Fc receptor mediated stimulatory signaling pathway |
| GO:0002467 | 0.03533 | 4.76220 | 1 | 3 | 16 | germinal center formation |
| GO:0002544 | 0.03533 | 4.76220 | 1 | 3 | 16 | chronic inflammatory response |
| GO:0002739 | 0.03533 | 4.76220 | 1 | 3 | 16 | regulation of cytokine secretion involved in immune response |
| GO:0006968 | 0.03533 | 4.76220 | 1 | 3 | 16 | cellular defense response |
| GO:0010875 | 0.03533 | 4.76220 | 1 | 3 | 16 | positive regulation of cholesterol efflux |
| GO:0016045 | 0.03533 | 4.76220 | 1 | 3 | 16 | detection of bacterium |
| GO:0032252 | 0.03533 | 4.76220 | 1 | 3 | 16 | secretory granule localization |
| GO:0042228 | 0.03533 | 4.76220 | 1 | 3 | 16 | interleukin-8 biosynthetic process |
| GO:0042772 | 0.03533 | 4.76220 | 1 | 3 | 16 | DNA damage response, signal transduction resulting in transcription |
| GO:0045059 | 0.03533 | 4.76220 | 1 | 3 | 16 | positive thymic T cell selection |
| GO:0045655 | 0.03533 | 4.76220 | 1 | 3 | 16 | regulation of monocyte differentiation |
| GO:0051709 | 0.03533 | 4.76220 | 1 | 3 | 16 | regulation of killing of cells of other organism |
| GO:0051852 | 0.03533 | 4.76220 | 1 | 3 | 16 | disruption by host of symbiont cells |
| GO:0051873 | 0.03533 | 4.76220 | 1 | 3 | 16 | killing by host of symbiont cells |
| GO:0071498 | 0.03533 | 4.76220 | 1 | 3 | 16 | cellular response to fluid shear stress |
| GO:0090128 | 0.03533 | 4.76220 | 1 | 3 | 16 | regulation of synapse maturation |
| GO:0097284 | 0.03533 | 4.76220 | 1 | 3 | 16 | hepatocyte apoptotic process |
| GO:0098543 | 0.03533 | 4.76220 | 1 | 3 | 16 | detection of other organism |
| GO:1901881 | 0.03533 | 4.76220 | 1 | 3 | 16 | positive regulation of protein depolymerization |
| GO:1902004 | 0.03533 | 4.76220 | 1 | 3 | 16 | positive regulation of amyloid-beta formation |
| GO:1902337 | 0.03533 | 4.76220 | 1 | 3 | 16 | regulation of apoptotic process involved in morphogenesis |
| GO:1904996 | 0.03533 | 4.76220 | 1 | 3 | 16 | positive regulation of leukocyte adhesion to vascular endothelial cell |
| GO:2001053 | 0.03533 | 4.76220 | 1 | 3 | 16 | regulation of mesenchymal cell apoptotic process |
| GO:0045861 | 0.03555 | 1.53243 | 16 | 24 | 349 | negative regulation of proteolysis |
| GO:0015748 | 0.03593 | 2.23521 | 4 | 8 | 82 | organophosphate ester transport |
| GO:0002323 | 0.03630 | 2.95060 | 2 | 5 | 40 | natural killer cell activation involved in immune response |
| GO:0003009 | 0.03630 | 2.95060 | 2 | 5 | 40 | skeletal muscle contraction |
| GO:0034105 | 0.03630 | 2.95060 | 2 | 5 | 40 | positive regulation of tissue remodeling |
| GO:0035307 | 0.03630 | 2.95060 | 2 | 5 | 40 | positive regulation of protein dephosphorylation |
| GO:0045747 | 0.03630 | 2.95060 | 2 | 5 | 40 | positive regulation of Notch signaling pathway |
| GO:0006836 | 0.03658 | 1.57797 | 14 | 21 | 297 | neurotransmitter transport |
| GO:0030308 | 0.03660 | 1.73574 | 9 | 15 | 194 | negative regulation of cell growth |
| GO:1901214 | 0.03672 | 1.51270 | 17 | 25 | 368 | regulation of neuron death |
| GO:0072175 | 0.03680 | 1.81854 | 7 | 13 | 161 | epithelial tube formation |
| GO:0048839 | 0.03683 | 1.69991 | 10 | 16 | 211 | inner ear development |
| GO:0003007 | 0.03713 | 1.59497 | 13 | 20 | 280 | heart morphogenesis |
| GO:0055081 | 0.03750 | 2.37180 | 3 | 7 | 68 | anion homeostasis |
| GO:0007585 | 0.03798 | 2.58267 | 3 | 6 | 54 | respiratory gaseous exchange |
| GO:0043030 | 0.03798 | 2.58267 | 3 | 6 | 54 | regulation of macrophage activation |
| GO:0045604 | 0.03798 | 2.58267 | 3 | 6 | 54 | regulation of epidermal cell differentiation |
| GO:0050922 | 0.03798 | 2.58267 | 3 | 6 | 54 | negative regulation of chemotaxis |
| GO:2000351 | 0.03798 | 2.58267 | 3 | 6 | 54 | regulation of endothelial cell apoptotic process |
| GO:0051146 | 0.03815 | 1.55210 | 15 | 22 | 316 | striated muscle cell differentiation |
| GO:0001822 | 0.03831 | 1.58879 | 13 | 20 | 281 | kidney development |
| GO:0001955 | 0.03854 | 8.24977 | 0 | 2 | 7 | blood vessel maturation |
| GO:0002249 | 0.03854 | 8.24977 | 0 | 2 | 7 | lymphocyte anergy |
| GO:0002457 | 0.03854 | 8.24977 | 0 | 2 | 7 | T cell antigen processing and presentation |
| GO:0002667 | 0.03854 | 8.24977 | 0 | 2 | 7 | regulation of T cell anergy |
| GO:0002759 | 0.03854 | 8.24977 | 0 | 2 | 7 | regulation of antimicrobial humoral response |
| GO:0002775 | 0.03854 | 8.24977 | 0 | 2 | 7 | antimicrobial peptide production |
| GO:0002778 | 0.03854 | 8.24977 | 0 | 2 | 7 | antibacterial peptide production |
| GO:0002870 | 0.03854 | 8.24977 | 0 | 2 | 7 | T cell anergy |
| GO:0002911 | 0.03854 | 8.24977 | 0 | 2 | 7 | regulation of lymphocyte anergy |
| GO:0003160 | 0.03854 | 8.24977 | 0 | 2 | 7 | endocardium morphogenesis |
| GO:0003330 | 0.03854 | 8.24977 | 0 | 2 | 7 | regulation of extracellular matrix constituent secretion |
| GO:0010511 | 0.03854 | 8.24977 | 0 | 2 | 7 | regulation of phosphatidylinositol biosynthetic process |
| GO:0010533 | 0.03854 | 8.24977 | 0 | 2 | 7 | regulation of activation of Janus kinase activity |
| GO:0010760 | 0.03854 | 8.24977 | 0 | 2 | 7 | negative regulation of macrophage chemotaxis |
| GO:0010886 | 0.03854 | 8.24977 | 0 | 2 | 7 | positive regulation of cholesterol storage |
| GO:0030885 | 0.03854 | 8.24977 | 0 | 2 | 7 | regulation of myeloid dendritic cell activation |
| GO:0032819 | 0.03854 | 8.24977 | 0 | 2 | 7 | positive regulation of natural killer cell proliferation |
| GO:0033292 | 0.03854 | 8.24977 | 0 | 2 | 7 | T-tubule organization |
| GO:0033629 | 0.03854 | 8.24977 | 0 | 2 | 7 | negative regulation of cell adhesion mediated by integrin |
| GO:0034137 | 0.03854 | 8.24977 | 0 | 2 | 7 | positive regulation of toll-like receptor 2 signaling pathway |
| GO:0035701 | 0.03854 | 8.24977 | 0 | 2 | 7 | hematopoietic stem cell migration |
| GO:0044828 | 0.03854 | 8.24977 | 0 | 2 | 7 | negative regulation by host of viral genome replication |
| GO:0048050 | 0.03854 | 8.24977 | 0 | 2 | 7 | post-embryonic eye morphogenesis |
| GO:0048069 | 0.03854 | 8.24977 | 0 | 2 | 7 | eye pigmentation |
| GO:0048170 | 0.03854 | 8.24977 | 0 | 2 | 7 | positive regulation of long-term neuronal synaptic plasticity |
| GO:0050720 | 0.03854 | 8.24977 | 0 | 2 | 7 | interleukin-1 beta biosynthetic process |
| GO:0050859 | 0.03854 | 8.24977 | 0 | 2 | 7 | negative regulation of B cell receptor signaling pathway |
| GO:0050904 | 0.03854 | 8.24977 | 0 | 2 | 7 | diapedesis |
| GO:0060158 | 0.03854 | 8.24977 | 0 | 2 | 7 | phospholipase C-activating dopamine receptor signaling pathway |
| GO:0060283 | 0.03854 | 8.24977 | 0 | 2 | 7 | negative regulation of oocyte development |
| GO:0060664 | 0.03854 | 8.24977 | 0 | 2 | 7 | epithelial cell proliferation involved in salivary gland morphogenesis |
| GO:0061074 | 0.03854 | 8.24977 | 0 | 2 | 7 | regulation of neural retina development |
| GO:0070309 | 0.03854 | 8.24977 | 0 | 2 | 7 | lens fiber cell morphogenesis |
| GO:0070945 | 0.03854 | 8.24977 | 0 | 2 | 7 | neutrophil mediated killing of gram-negative bacterium |
| GO:0071351 | 0.03854 | 8.24977 | 0 | 2 | 7 | cellular response to interleukin-18 |
| GO:0072603 | 0.03854 | 8.24977 | 0 | 2 | 7 | interleukin-5 secretion |
| GO:0086042 | 0.03854 | 8.24977 | 0 | 2 | 7 | cardiac muscle cell-cardiac muscle cell adhesion |
| GO:0098915 | 0.03854 | 8.24977 | 0 | 2 | 7 | membrane repolarization during ventricular cardiac muscle cell action potential |
| GO:0150094 | 0.03854 | 8.24977 | 0 | 2 | 7 | amyloid-beta clearance by cellular catabolic process |
| GO:1901490 | 0.03854 | 8.24977 | 0 | 2 | 7 | regulation of lymphangiogenesis |
| GO:1902732 | 0.03854 | 8.24977 | 0 | 2 | 7 | positive regulation of chondrocyte proliferation |
| GO:1903753 | 0.03854 | 8.24977 | 0 | 2 | 7 | negative regulation of p38MAPK cascade |
| GO:1903980 | 0.03854 | 8.24977 | 0 | 2 | 7 | positive regulation of microglial cell activation |
| GO:1905880 | 0.03854 | 8.24977 | 0 | 2 | 7 | negative regulation of oogenesis |
| GO:2000425 | 0.03854 | 8.24977 | 0 | 2 | 7 | regulation of apoptotic cell clearance |
| GO:2000553 | 0.03854 | 8.24977 | 0 | 2 | 7 | positive regulation of T-helper 2 cell cytokine production |
| GO:2000662 | 0.03854 | 8.24977 | 0 | 2 | 7 | regulation of interleukin-5 secretion |
| GO:2000665 | 0.03854 | 8.24977 | 0 | 2 | 7 | regulation of interleukin-13 secretion |
| GO:0002029 | 0.03867 | 3.44087 | 1 | 4 | 28 | desensitization of G protein-coupled receptor signaling pathway |
| GO:0010719 | 0.03867 | 3.44087 | 1 | 4 | 28 | negative regulation of epithelial to mesenchymal transition |
| GO:0022401 | 0.03867 | 3.44087 | 1 | 4 | 28 | negative adaptation of signaling pathway |
| GO:0032647 | 0.03867 | 3.44087 | 1 | 4 | 28 | regulation of interferon-alpha production |
| GO:0032891 | 0.03867 | 3.44087 | 1 | 4 | 28 | negative regulation of organic acid transport |
| GO:0033198 | 0.03867 | 3.44087 | 1 | 4 | 28 | response to ATP |
| GO:0044788 | 0.03867 | 3.44087 | 1 | 4 | 28 | modulation by host of viral process |
| GO:0072576 | 0.03867 | 3.44087 | 1 | 4 | 28 | liver morphogenesis |
| GO:1902668 | 0.03867 | 3.44087 | 1 | 4 | 28 | negative regulation of axon guidance |
| GO:2000113 | 0.03876 | 1.25284 | 64 | 78 | 1379 | negative regulation of cellular macromolecule biosynthetic process |
| GO:0043523 | 0.03883 | 1.60757 | 12 | 19 | 264 | regulation of neuron apoptotic process |
| GO:0048814 | 0.03887 | 1.98908 | 5 | 10 | 114 | regulation of dendrite morphogenesis |
| GO:0099536 | 0.03900 | 1.31795 | 40 | 52 | 874 | synaptic signaling |
| GO:0030832 | 0.03911 | 1.75695 | 8 | 14 | 179 | regulation of actin filament length |
| GO:0043933 | 0.03922 | 1.21274 | 91 | 107 | 1956 | protein-containing complex subunit organization |
| GO:0007268 | 0.03978 | 1.31967 | 40 | 51 | 856 | chemical synaptic transmission |
| GO:0098916 | 0.03978 | 1.31967 | 40 | 51 | 856 | anterograde trans-synaptic signaling |
| GO:0086009 | 0.03983 | 2.86851 | 2 | 5 | 41 | membrane repolarization |
| GO:0097484 | 0.03983 | 2.86851 | 2 | 5 | 41 | dendrite extension |
| GO:1903170 | 0.03983 | 2.86851 | 2 | 5 | 41 | negative regulation of calcium ion transmembrane transport |
| GO:1903672 | 0.03983 | 2.86851 | 2 | 5 | 41 | positive regulation of sprouting angiogenesis |
| GO:1905521 | 0.03983 | 2.86851 | 2 | 5 | 41 | regulation of macrophage migration |
| GO:0000278 | 0.04000 | 1.33082 | 37 | 48 | 799 | mitotic cell cycle |
| GO:0048660 | 0.04002 | 1.79413 | 8 | 13 | 163 | regulation of smooth muscle cell proliferation |
| GO:0006766 | 0.04013 | 2.33344 | 3 | 7 | 69 | vitamin metabolic process |
| GO:0006949 | 0.04013 | 2.33344 | 3 | 7 | 69 | syncytium formation |
| GO:0007492 | 0.04013 | 2.33344 | 3 | 7 | 69 | endoderm development |
| GO:0043407 | 0.04013 | 2.33344 | 3 | 7 | 69 | negative regulation of MAP kinase activity |
| GO:0061035 | 0.04013 | 2.33344 | 3 | 7 | 69 | regulation of cartilage development |
| GO:0051209 | 0.04088 | 1.97004 | 5 | 10 | 115 | release of sequestered calcium ion into cytosol |
| GO:1902275 | 0.04100 | 1.70690 | 9 | 15 | 197 | regulation of chromatin organization |
| GO:0035019 | 0.04102 | 2.52985 | 3 | 6 | 55 | somatic stem cell population maintenance |
| GO:0008202 | 0.04126 | 1.55515 | 14 | 21 | 301 | steroid metabolic process |
| GO:0002836 | 0.04146 | 4.42184 | 1 | 3 | 17 | positive regulation of response to tumor cell |
| GO:0002839 | 0.04146 | 4.42184 | 1 | 3 | 17 | positive regulation of immune response to tumor cell |
| GO:0007096 | 0.04146 | 4.42184 | 1 | 3 | 17 | regulation of exit from mitosis |
| GO:0007288 | 0.04146 | 4.42184 | 1 | 3 | 17 | sperm axoneme assembly |
| GO:0010919 | 0.04146 | 4.42184 | 1 | 3 | 17 | regulation of inositol phosphate biosynthetic process |
| GO:0010934 | 0.04146 | 4.42184 | 1 | 3 | 17 | macrophage cytokine production |
| GO:0032305 | 0.04146 | 4.42184 | 1 | 3 | 17 | positive regulation of icosanoid secretion |
| GO:0032402 | 0.04146 | 4.42184 | 1 | 3 | 17 | melanosome transport |
| GO:0034331 | 0.04146 | 4.42184 | 1 | 3 | 17 | cell junction maintenance |
| GO:0035313 | 0.04146 | 4.42184 | 1 | 3 | 17 | wound healing, spreading of epidermal cells |
| GO:0036124 | 0.04146 | 4.42184 | 1 | 3 | 17 | histone H3-K9 trimethylation |
| GO:0043373 | 0.04146 | 4.42184 | 1 | 3 | 17 | CD4-positive, alpha-beta T cell lineage commitment |
| GO:0044406 | 0.04146 | 4.42184 | 1 | 3 | 17 | adhesion of symbiont to host |
| GO:0045603 | 0.04146 | 4.42184 | 1 | 3 | 17 | positive regulation of endothelial cell differentiation |
| GO:0060081 | 0.04146 | 4.42184 | 1 | 3 | 17 | membrane hyperpolarization |
| GO:0070243 | 0.04146 | 4.42184 | 1 | 3 | 17 | regulation of thymocyte apoptotic process |
| GO:0090185 | 0.04146 | 4.42184 | 1 | 3 | 17 | negative regulation of kidney development |
| GO:0097152 | 0.04146 | 4.42184 | 1 | 3 | 17 | mesenchymal cell apoptotic process |
| GO:0099171 | 0.04146 | 4.42184 | 1 | 3 | 17 | presynaptic modulation of chemical synaptic transmission |
| GO:1904748 | 0.04146 | 4.42184 | 1 | 3 | 17 | regulation of apoptotic process involved in development |
| GO:2001028 | 0.04146 | 4.42184 | 1 | 3 | 17 | positive regulation of endothelial cell chemotaxis |
| GO:0031331 | 0.04196 | 1.50424 | 16 | 24 | 355 | positive regulation of cellular catabolic process |
| GO:0055013 | 0.04227 | 2.04519 | 5 | 9 | 100 | cardiac muscle cell development |
| GO:0110020 | 0.04227 | 2.04519 | 5 | 9 | 100 | regulation of actomyosin structure organization |
| GO:0098656 | 0.04230 | 1.73575 | 8 | 14 | 181 | anion transmembrane transport |
| GO:0010629 | 0.04259 | 1.21738 | 83 | 98 | 1783 | negative regulation of gene expression |
| GO:0046173 | 0.04289 | 2.29630 | 3 | 7 | 70 | polyol biosynthetic process |
| GO:0010927 | 0.04297 | 1.95137 | 5 | 10 | 116 | cellular component assembly involved in morphogenesis |
| GO:0030282 | 0.04297 | 1.95137 | 5 | 10 | 116 | bone mineralization |
| GO:0001841 | 0.04298 | 1.88090 | 6 | 11 | 132 | neural tube formation |
| GO:0048708 | 0.04308 | 2.14784 | 4 | 8 | 85 | astrocyte differentiation |
| GO:0098659 | 0.04308 | 2.14784 | 4 | 8 | 85 | inorganic cation import across plasma membrane |
| GO:0099587 | 0.04308 | 2.14784 | 4 | 8 | 85 | inorganic ion import across plasma membrane |
| GO:0003148 | 0.04327 | 3.30308 | 1 | 4 | 29 | outflow tract septum morphogenesis |
| GO:0034390 | 0.04327 | 3.30308 | 1 | 4 | 29 | smooth muscle cell apoptotic process |
| GO:0034391 | 0.04327 | 3.30308 | 1 | 4 | 29 | regulation of smooth muscle cell apoptotic process |
| GO:0099622 | 0.04327 | 3.30308 | 1 | 4 | 29 | cardiac muscle cell membrane repolarization |
| GO:0019827 | 0.04344 | 1.77036 | 8 | 13 | 165 | stem cell population maintenance |
| GO:0043901 | 0.04344 | 1.77036 | 8 | 13 | 165 | negative regulation of multi-organism process |
| GO:0010765 | 0.04355 | 2.79086 | 2 | 5 | 42 | positive regulation of sodium ion transport |
| GO:0010883 | 0.04355 | 2.79086 | 2 | 5 | 42 | regulation of lipid storage |
| GO:0032958 | 0.04355 | 2.79086 | 2 | 5 | 42 | inositol phosphate biosynthetic process |
| GO:0045740 | 0.04355 | 2.79086 | 2 | 5 | 42 | positive regulation of DNA replication |
| GO:1900015 | 0.04355 | 2.79086 | 2 | 5 | 42 | regulation of cytokine production involved in inflammatory response |
| GO:1903523 | 0.04355 | 2.79086 | 2 | 5 | 42 | negative regulation of blood circulation |
| GO:0031346 | 0.04402 | 1.42876 | 22 | 30 | 466 | positive regulation of cell projection organization |
| GO:0030104 | 0.04422 | 2.47914 | 3 | 6 | 56 | water homeostasis |
| GO:0044773 | 0.04422 | 2.47914 | 3 | 6 | 56 | mitotic DNA damage checkpoint |
| GO:0033559 | 0.04459 | 2.02287 | 5 | 9 | 101 | unsaturated fatty acid metabolic process |
| GO:0006886 | 0.04466 | 1.30476 | 41 | 52 | 882 | intracellular protein transport |
| GO:0051283 | 0.04512 | 1.93304 | 5 | 10 | 117 | negative regulation of sequestering of calcium ion |
| GO:0003281 | 0.04565 | 2.12020 | 4 | 8 | 86 | ventricular septum development |
| GO:0035304 | 0.04565 | 2.12020 | 4 | 8 | 86 | regulation of protein dephosphorylation |
| GO:0055072 | 0.04565 | 2.12020 | 4 | 8 | 86 | iron ion homeostasis |
| GO:0042509 | 0.04576 | 2.26031 | 3 | 7 | 71 | regulation of tyrosine phosphorylation of STAT protein |
| GO:0061045 | 0.04576 | 2.26031 | 3 | 7 | 71 | negative regulation of wound healing |
| GO:0008217 | 0.04576 | 1.67899 | 9 | 15 | 200 | regulation of blood pressure |
| GO:0051259 | 0.04601 | 1.36425 | 29 | 38 | 617 | protein complex oligomerization |
| GO:0034614 | 0.04629 | 1.79942 | 7 | 12 | 150 | cellular response to reactive oxygen species |
| GO:0001100 | 0.04632 | Inf | 0 | 1 | 1 | negative regulation of exit from mitosis |
| GO:0001300 | 0.04632 | Inf | 0 | 1 | 1 | chronological cell aging |
| GO:0002194 | 0.04632 | Inf | 0 | 1 | 1 | hepatocyte cell migration |
| GO:0002280 | 0.04632 | Inf | 0 | 1 | 1 | monocyte activation involved in immune response |
| GO:0002316 | 0.04632 | Inf | 0 | 1 | 1 | follicular B cell differentiation |
| GO:0002413 | 0.04632 | Inf | 0 | 1 | 1 | tolerance induction to tumor cell |
| GO:0002419 | 0.04632 | Inf | 0 | 1 | 1 | T cell mediated cytotoxicity directed against tumor cell target |
| GO:0002470 | 0.04632 | Inf | 0 | 1 | 1 | plasmacytoid dendritic cell antigen processing and presentation |
| GO:0002510 | 0.04632 | Inf | 0 | 1 | 1 | central B cell tolerance induction |
| GO:0002552 | 0.04632 | Inf | 0 | 1 | 1 | serotonin secretion by mast cell |
| GO:0002640 | 0.04632 | Inf | 0 | 1 | 1 | regulation of immunoglobulin biosynthetic process |
| GO:0002642 | 0.04632 | Inf | 0 | 1 | 1 | positive regulation of immunoglobulin biosynthetic process |
| GO:0002646 | 0.04632 | Inf | 0 | 1 | 1 | regulation of central tolerance induction |
| GO:0002648 | 0.04632 | Inf | 0 | 1 | 1 | positive regulation of central tolerance induction |
| GO:0002785 | 0.04632 | Inf | 0 | 1 | 1 | negative regulation of antimicrobial peptide production |
| GO:0002787 | 0.04632 | Inf | 0 | 1 | 1 | negative regulation of antibacterial peptide production |
| GO:0002805 | 0.04632 | Inf | 0 | 1 | 1 | regulation of antimicrobial peptide biosynthetic process |
| GO:0002807 | 0.04632 | Inf | 0 | 1 | 1 | positive regulation of antimicrobial peptide biosynthetic process |
| GO:0002808 | 0.04632 | Inf | 0 | 1 | 1 | regulation of antibacterial peptide biosynthetic process |
| GO:0002815 | 0.04632 | Inf | 0 | 1 | 1 | biosynthetic process of antibacterial peptides active against Gram-positive bacteria |
| GO:0002816 | 0.04632 | Inf | 0 | 1 | 1 | regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria |
| GO:0002841 | 0.04632 | Inf | 0 | 1 | 1 | negative regulation of T cell mediated immune response to tumor cell |
| GO:0002843 | 0.04632 | Inf | 0 | 1 | 1 | regulation of tolerance induction to tumor cell |
| GO:0002845 | 0.04632 | Inf | 0 | 1 | 1 | positive regulation of tolerance induction to tumor cell |
| GO:0002852 | 0.04632 | Inf | 0 | 1 | 1 | regulation of T cell mediated cytotoxicity directed against tumor cell target |
| GO:0002853 | 0.04632 | Inf | 0 | 1 | 1 | negative regulation of T cell mediated cytotoxicity directed against tumor cell target |
| GO:0002881 | 0.04632 | Inf | 0 | 1 | 1 | negative regulation of chronic inflammatory response to non-antigenic stimulus |
| GO:0002895 | 0.04632 | Inf | 0 | 1 | 1 | regulation of central B cell tolerance induction |
| GO:0002897 | 0.04632 | Inf | 0 | 1 | 1 | positive regulation of central B cell tolerance induction |
| GO:0003059 | 0.04632 | Inf | 0 | 1 | 1 | positive regulation of the force of heart contraction by epinephrine |
| GO:0003243 | 0.04632 | Inf | 0 | 1 | 1 | circumferential growth involved in left ventricle morphogenesis |
| GO:0006174 | 0.04632 | Inf | 0 | 1 | 1 | dADP phosphorylation |
| GO:0006186 | 0.04632 | Inf | 0 | 1 | 1 | dGDP phosphorylation |
| GO:0006218 | 0.04632 | Inf | 0 | 1 | 1 | uridine catabolic process |
| GO:0006963 | 0.04632 | Inf | 0 | 1 | 1 | positive regulation of antibacterial peptide biosynthetic process |
| GO:0006965 | 0.04632 | Inf | 0 | 1 | 1 | positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria |
| GO:0007185 | 0.04632 | Inf | 0 | 1 | 1 | transmembrane receptor protein tyrosine phosphatase signaling pathway |
| GO:0007522 | 0.04632 | Inf | 0 | 1 | 1 | visceral muscle development |
| GO:0008348 | 0.04632 | Inf | 0 | 1 | 1 | negative regulation of antimicrobial humoral response |
| GO:0009817 | 0.04632 | Inf | 0 | 1 | 1 | defense response to fungus, incompatible interaction |
| GO:0010335 | 0.04632 | Inf | 0 | 1 | 1 | response to non-ionic osmotic stress |
| GO:0010650 | 0.04632 | Inf | 0 | 1 | 1 | positive regulation of cell communication by electrical coupling |
| GO:0010879 | 0.04632 | Inf | 0 | 1 | 1 | cholesterol transport involved in cholesterol storage |
| GO:0010924 | 0.04632 | Inf | 0 | 1 | 1 | regulation of inositol-polyphosphate 5-phosphatase activity |
| GO:0010925 | 0.04632 | Inf | 0 | 1 | 1 | positive regulation of inositol-polyphosphate 5-phosphatase activity |
| GO:0014006 | 0.04632 | Inf | 0 | 1 | 1 | regulation of microglia differentiation |
| GO:0014008 | 0.04632 | Inf | 0 | 1 | 1 | positive regulation of microglia differentiation |
| GO:0014828 | 0.04632 | Inf | 0 | 1 | 1 | distal stomach smooth muscle contraction |
| GO:0014861 | 0.04632 | Inf | 0 | 1 | 1 | regulation of skeletal muscle contraction via regulation of action potential |
| GO:0015680 | 0.04632 | Inf | 0 | 1 | 1 | protein maturation by copper ion transfer |
| GO:0015794 | 0.04632 | Inf | 0 | 1 | 1 | glycerol-3-phosphate transmembrane transport |
| GO:0018917 | 0.04632 | Inf | 0 | 1 | 1 | fluorene metabolic process |
| GO:0018979 | 0.04632 | Inf | 0 | 1 | 1 | trichloroethylene metabolic process |
| GO:0030845 | 0.04632 | Inf | 0 | 1 | 1 | phospholipase C-inhibiting G protein-coupled receptor signaling pathway |
| GO:0031619 | 0.04632 | Inf | 0 | 1 | 1 | homologous chromosome orientation involved in meiotic metaphase I plate congression |
| GO:0032254 | 0.04632 | Inf | 0 | 1 | 1 | establishment of secretory granule localization |
| GO:0032498 | 0.04632 | Inf | 0 | 1 | 1 | detection of muramyl dipeptide |
| GO:0032599 | 0.04632 | Inf | 0 | 1 | 1 | protein transport out of membrane raft |
| GO:0032600 | 0.04632 | Inf | 0 | 1 | 1 | chemokine receptor transport out of membrane raft |
| GO:0032603 | 0.04632 | Inf | 0 | 1 | 1 | fractalkine production |
| GO:0032644 | 0.04632 | Inf | 0 | 1 | 1 | regulation of fractalkine production |
| GO:0032658 | 0.04632 | Inf | 0 | 1 | 1 | regulation of interleukin-15 production |
| GO:0032685 | 0.04632 | Inf | 0 | 1 | 1 | negative regulation of granulocyte macrophage colony-stimulating factor production |
| GO:0032712 | 0.04632 | Inf | 0 | 1 | 1 | negative regulation of interleukin-3 production |
| GO:0032724 | 0.04632 | Inf | 0 | 1 | 1 | positive regulation of fractalkine production |
| GO:0032738 | 0.04632 | Inf | 0 | 1 | 1 | positive regulation of interleukin-15 production |
| GO:0032771 | 0.04632 | Inf | 0 | 1 | 1 | regulation of monophenol monooxygenase activity |
| GO:0032773 | 0.04632 | Inf | 0 | 1 | 1 | positive regulation of monophenol monooxygenase activity |
| GO:0032913 | 0.04632 | Inf | 0 | 1 | 1 | negative regulation of transforming growth factor beta3 production |
| GO:0033343 | 0.04632 | Inf | 0 | 1 | 1 | positive regulation of collagen binding |
| GO:0033367 | 0.04632 | Inf | 0 | 1 | 1 | protein localization to mast cell secretory granule |
| GO:0033368 | 0.04632 | Inf | 0 | 1 | 1 | protease localization to mast cell secretory granule |
| GO:0033370 | 0.04632 | Inf | 0 | 1 | 1 | maintenance of protein location in mast cell secretory granule |
| GO:0033371 | 0.04632 | Inf | 0 | 1 | 1 | T cell secretory granule organization |
| GO:0033373 | 0.04632 | Inf | 0 | 1 | 1 | maintenance of protease location in mast cell secretory granule |
| GO:0033374 | 0.04632 | Inf | 0 | 1 | 1 | protein localization to T cell secretory granule |
| GO:0033375 | 0.04632 | Inf | 0 | 1 | 1 | protease localization to T cell secretory granule |
| GO:0033377 | 0.04632 | Inf | 0 | 1 | 1 | maintenance of protein location in T cell secretory granule |
| GO:0033379 | 0.04632 | Inf | 0 | 1 | 1 | maintenance of protease location in T cell secretory granule |
| GO:0033380 | 0.04632 | Inf | 0 | 1 | 1 | granzyme B localization to T cell secretory granule |
| GO:0033382 | 0.04632 | Inf | 0 | 1 | 1 | maintenance of granzyme B location in T cell secretory granule |
| GO:0033606 | 0.04632 | Inf | 0 | 1 | 1 | chemokine receptor transport within lipid bilayer |
| GO:0033955 | 0.04632 | Inf | 0 | 1 | 1 | mitochondrial DNA inheritance |
| GO:0034102 | 0.04632 | Inf | 0 | 1 | 1 | erythrocyte clearance |
| GO:0034106 | 0.04632 | Inf | 0 | 1 | 1 | regulation of erythrocyte clearance |
| GO:0034107 | 0.04632 | Inf | 0 | 1 | 1 | negative regulation of erythrocyte clearance |
| GO:0034119 | 0.04632 | Inf | 0 | 1 | 1 | negative regulation of erythrocyte aggregation |
| GO:0034179 | 0.04632 | Inf | 0 | 1 | 1 | regulation of toll-like receptor 13 signaling pathway |
| GO:0034181 | 0.04632 | Inf | 0 | 1 | 1 | positive regulation of toll-like receptor 13 signaling pathway |
| GO:0035128 | 0.04632 | Inf | 0 | 1 | 1 | post-embryonic forelimb morphogenesis |
| GO:0035504 | 0.04632 | Inf | 0 | 1 | 1 | regulation of myosin light chain kinase activity |
| GO:0035505 | 0.04632 | Inf | 0 | 1 | 1 | positive regulation of myosin light chain kinase activity |
| GO:0035565 | 0.04632 | Inf | 0 | 1 | 1 | regulation of pronephros size |
| GO:0035644 | 0.04632 | Inf | 0 | 1 | 1 | phosphoanandamide dephosphorylation |
| GO:0035664 | 0.04632 | Inf | 0 | 1 | 1 | TIRAP-dependent toll-like receptor signaling pathway |
| GO:0035665 | 0.04632 | Inf | 0 | 1 | 1 | TIRAP-dependent toll-like receptor 4 signaling pathway |
| GO:0035772 | 0.04632 | Inf | 0 | 1 | 1 | interleukin-13-mediated signaling pathway |
| GO:0036268 | 0.04632 | Inf | 0 | 1 | 1 | swimming |
| GO:0036323 | 0.04632 | Inf | 0 | 1 | 1 | vascular endothelial growth factor receptor-1 signaling pathway |
| GO:0038112 | 0.04632 | Inf | 0 | 1 | 1 | interleukin-8-mediated signaling pathway |
| GO:0038178 | 0.04632 | Inf | 0 | 1 | 1 | complement component C5a signaling pathway |
| GO:0042103 | 0.04632 | Inf | 0 | 1 | 1 | positive regulation of T cell homeostatic proliferation |
| GO:0042196 | 0.04632 | Inf | 0 | 1 | 1 | chlorinated hydrocarbon metabolic process |
| GO:0042197 | 0.04632 | Inf | 0 | 1 | 1 | halogenated hydrocarbon metabolic process |
| GO:0042313 | 0.04632 | Inf | 0 | 1 | 1 | protein kinase C deactivation |
| GO:0042441 | 0.04632 | Inf | 0 | 1 | 1 | eye pigment metabolic process |
| GO:0042669 | 0.04632 | Inf | 0 | 1 | 1 | regulation of inner ear auditory receptor cell fate specification |
| GO:0042696 | 0.04632 | Inf | 0 | 1 | 1 | menarche |
| GO:0043056 | 0.04632 | Inf | 0 | 1 | 1 | forward locomotion |
| GO:0043324 | 0.04632 | Inf | 0 | 1 | 1 | pigment metabolic process involved in developmental pigmentation |
| GO:0043474 | 0.04632 | Inf | 0 | 1 | 1 | pigment metabolic process involved in pigmentation |
| GO:0044651 | 0.04632 | Inf | 0 | 1 | 1 | adhesion of symbiont to host epithelial cell |
| GO:0045769 | 0.04632 | Inf | 0 | 1 | 1 | negative regulation of asymmetric cell division |
| GO:0046014 | 0.04632 | Inf | 0 | 1 | 1 | negative regulation of T cell homeostatic proliferation |
| GO:0046108 | 0.04632 | Inf | 0 | 1 | 1 | uridine metabolic process |
| GO:0046154 | 0.04632 | Inf | 0 | 1 | 1 | rhodopsin metabolic process |
| GO:0046551 | 0.04632 | Inf | 0 | 1 | 1 | retinal cone cell fate commitment |
| GO:0050751 | 0.04632 | Inf | 0 | 1 | 1 | fractalkine biosynthetic process |
| GO:0050752 | 0.04632 | Inf | 0 | 1 | 1 | regulation of fractalkine biosynthetic process |
| GO:0050754 | 0.04632 | Inf | 0 | 1 | 1 | positive regulation of fractalkine biosynthetic process |
| GO:0050756 | 0.04632 | Inf | 0 | 1 | 1 | fractalkine metabolic process |
| GO:0051796 | 0.04632 | Inf | 0 | 1 | 1 | negative regulation of timing of catagen |
| GO:0052031 | 0.04632 | Inf | 0 | 1 | 1 | modulation by symbiont of host defense response |
| GO:0052063 | 0.04632 | Inf | 0 | 1 | 1 | induction by symbiont of defense-related host nitric oxide production |
| GO:0052163 | 0.04632 | Inf | 0 | 1 | 1 | modulation by symbiont of defense-related host nitric oxide production |
| GO:0052251 | 0.04632 | Inf | 0 | 1 | 1 | induction by organism of defense response of other organism involved in symbiotic interaction |
| GO:0052255 | 0.04632 | Inf | 0 | 1 | 1 | modulation by organism of defense response of other organism involved in symbiotic interaction |
| GO:0052263 | 0.04632 | Inf | 0 | 1 | 1 | induction by organism of defense-related nitric oxide production in other organism involved in symbiotic interaction |
| GO:0052302 | 0.04632 | Inf | 0 | 1 | 1 | modulation by organism of defense-related nitric oxide production in other organism involved in symbiotic interaction |
| GO:0052345 | 0.04632 | Inf | 0 | 1 | 1 | positive regulation by organism of defense-related nitric oxide production in other organism involved in symbiotic interaction |
| GO:0052347 | 0.04632 | Inf | 0 | 1 | 1 | positive regulation by symbiont of defense-related host nitric oxide production |
| GO:0052509 | 0.04632 | Inf | 0 | 1 | 1 | positive regulation by symbiont of host defense response |
| GO:0052510 | 0.04632 | Inf | 0 | 1 | 1 | positive regulation by organism of defense response of other organism involved in symbiotic interaction |
| GO:0052552 | 0.04632 | Inf | 0 | 1 | 1 | modulation by organism of immune response of other organism involved in symbiotic interaction |
| GO:0052553 | 0.04632 | Inf | 0 | 1 | 1 | modulation by symbiont of host immune response |
| GO:0052555 | 0.04632 | Inf | 0 | 1 | 1 | positive regulation by organism of immune response of other organism involved in symbiotic interaction |
| GO:0052556 | 0.04632 | Inf | 0 | 1 | 1 | positive regulation by symbiont of host immune response |
| GO:0052558 | 0.04632 | Inf | 0 | 1 | 1 | induction by organism of immune response of other organism involved in symbiotic interaction |
| GO:0052559 | 0.04632 | Inf | 0 | 1 | 1 | induction by symbiont of host immune response |
| GO:0060010 | 0.04632 | Inf | 0 | 1 | 1 | Sertoli cell fate commitment |
| GO:0060034 | 0.04632 | Inf | 0 | 1 | 1 | notochord cell differentiation |
| GO:0060035 | 0.04632 | Inf | 0 | 1 | 1 | notochord cell development |
| GO:0060222 | 0.04632 | Inf | 0 | 1 | 1 | regulation of retinal cone cell fate commitment |
| GO:0060223 | 0.04632 | Inf | 0 | 1 | 1 | retinal rod cell fate commitment |
| GO:0060226 | 0.04632 | Inf | 0 | 1 | 1 | negative regulation of retinal cone cell fate commitment |
| GO:0060234 | 0.04632 | Inf | 0 | 1 | 1 | neuroblast delamination |
| GO:0060305 | 0.04632 | Inf | 0 | 1 | 1 | regulation of cell diameter |
| GO:0060668 | 0.04632 | Inf | 0 | 1 | 1 | regulation of branching involved in salivary gland morphogenesis by extracellular matrix-epithelial cell signaling |
| GO:0060901 | 0.04632 | Inf | 0 | 1 | 1 | regulation of hair cycle by canonical Wnt signaling pathway |
| GO:0061011 | 0.04632 | Inf | 0 | 1 | 1 | hepatic duct development |
| GO:0061048 | 0.04632 | Inf | 0 | 1 | 1 | negative regulation of branching involved in lung morphogenesis |
| GO:0061114 | 0.04632 | Inf | 0 | 1 | 1 | branching involved in pancreas morphogenesis |
| GO:0061163 | 0.04632 | Inf | 0 | 1 | 1 | endoplasmic reticulum polarization |
| GO:0061206 | 0.04632 | Inf | 0 | 1 | 1 | mesonephros morphogenesis |
| GO:0061215 | 0.04632 | Inf | 0 | 1 | 1 | mesonephric nephron development |
| GO:0061228 | 0.04632 | Inf | 0 | 1 | 1 | mesonephric nephron morphogenesis |
| GO:0061235 | 0.04632 | Inf | 0 | 1 | 1 | mesenchymal stem cell maintenance involved in mesonephric nephron morphogenesis |
| GO:0061295 | 0.04632 | Inf | 0 | 1 | 1 | regulation of mesenchymal cell apoptotic process involved in mesonephric nephron morphogenesis |
| GO:0061296 | 0.04632 | Inf | 0 | 1 | 1 | negative regulation of mesenchymal cell apoptotic process involved in mesonephric nephron morphogenesis |
| GO:0061485 | 0.04632 | Inf | 0 | 1 | 1 | memory T cell proliferation |
| GO:0061508 | 0.04632 | Inf | 0 | 1 | 1 | CDP phosphorylation |
| GO:0061565 | 0.04632 | Inf | 0 | 1 | 1 | dAMP phosphorylation |
| GO:0061566 | 0.04632 | Inf | 0 | 1 | 1 | CMP phosphorylation |
| GO:0061567 | 0.04632 | Inf | 0 | 1 | 1 | dCMP phosphorylation |
| GO:0061568 | 0.04632 | Inf | 0 | 1 | 1 | GDP phosphorylation |
| GO:0061569 | 0.04632 | Inf | 0 | 1 | 1 | UDP phosphorylation |
| GO:0061570 | 0.04632 | Inf | 0 | 1 | 1 | dCDP phosphorylation |
| GO:0061571 | 0.04632 | Inf | 0 | 1 | 1 | TDP phosphorylation |
| GO:0061573 | 0.04632 | Inf | 0 | 1 | 1 | actin filament bundle retrograde transport |
| GO:0061737 | 0.04632 | Inf | 0 | 1 | 1 | leukotriene signaling pathway |
| GO:0061886 | 0.04632 | Inf | 0 | 1 | 1 | negative regulation of mini excitatory postsynaptic potential |
| GO:0061901 | 0.04632 | Inf | 0 | 1 | 1 | regulation of 1-phosphatidylinositol-3-kinase activity |
| GO:0061903 | 0.04632 | Inf | 0 | 1 | 1 | positive regulation of 1-phosphatidylinositol-3-kinase activity |
| GO:0061914 | 0.04632 | Inf | 0 | 1 | 1 | negative regulation of growth plate cartilage chondrocyte proliferation |
| GO:0061921 | 0.04632 | Inf | 0 | 1 | 1 | peptidyl-lysine propionylation |
| GO:0061966 | 0.04632 | Inf | 0 | 1 | 1 | establishment of left/right asymmetry |
| GO:0061976 | 0.04632 | Inf | 0 | 1 | 1 | temporomandibular joint articular cartilage development |
| GO:0061978 | 0.04632 | Inf | 0 | 1 | 1 | mandibular condyle articular cartilage development |
| GO:0061986 | 0.04632 | Inf | 0 | 1 | 1 | negative regulation of transcription by glucose |
| GO:0061987 | 0.04632 | Inf | 0 | 1 | 1 | negative regulation of transcription from RNA polymerase II promoter by glucose |
| GO:0070543 | 0.04632 | Inf | 0 | 1 | 1 | response to linoleic acid |
| GO:0070962 | 0.04632 | Inf | 0 | 1 | 1 | positive regulation of neutrophil mediated killing of bacterium |
| GO:0070963 | 0.04632 | Inf | 0 | 1 | 1 | positive regulation of neutrophil mediated killing of gram-negative bacterium |
| GO:0071324 | 0.04632 | Inf | 0 | 1 | 1 | cellular response to disaccharide stimulus |
| GO:0071329 | 0.04632 | Inf | 0 | 1 | 1 | cellular response to sucrose stimulus |
| GO:0071471 | 0.04632 | Inf | 0 | 1 | 1 | cellular response to non-ionic osmotic stress |
| GO:0071629 | 0.04632 | Inf | 0 | 1 | 1 | cytoplasm protein quality control by the ubiquitin-proteasome system |
| GO:0071656 | 0.04632 | Inf | 0 | 1 | 1 | negative regulation of granulocyte colony-stimulating factor production |
| GO:0071976 | 0.04632 | Inf | 0 | 1 | 1 | cell gliding |
| GO:0072209 | 0.04632 | Inf | 0 | 1 | 1 | metanephric mesangial cell differentiation |
| GO:0072254 | 0.04632 | Inf | 0 | 1 | 1 | metanephric glomerular mesangial cell differentiation |
| GO:0072255 | 0.04632 | Inf | 0 | 1 | 1 | metanephric glomerular mesangial cell development |
| GO:0072264 | 0.04632 | Inf | 0 | 1 | 1 | metanephric glomerular endothelium development |
| GO:0072709 | 0.04632 | Inf | 0 | 1 | 1 | cellular response to sorbitol |
| GO:0072740 | 0.04632 | Inf | 0 | 1 | 1 | cellular response to anisomycin |
| GO:0086072 | 0.04632 | Inf | 0 | 1 | 1 | AV node cell-bundle of His cell adhesion involved in cell communication |
| GO:0090119 | 0.04632 | Inf | 0 | 1 | 1 | vesicle-mediated cholesterol transport |
| GO:0090126 | 0.04632 | Inf | 0 | 1 | 1 | protein-containing complex assembly involved in synapse maturation |
| GO:0090198 | 0.04632 | Inf | 0 | 1 | 1 | negative regulation of chemokine secretion |
| GO:0090251 | 0.04632 | Inf | 0 | 1 | 1 | protein localization involved in establishment of planar polarity |
| GO:0090318 | 0.04632 | Inf | 0 | 1 | 1 | regulation of chylomicron remodeling |
| GO:0090319 | 0.04632 | Inf | 0 | 1 | 1 | positive regulation of chylomicron remodeling |
| GO:0090321 | 0.04632 | Inf | 0 | 1 | 1 | positive regulation of chylomicron remnant clearance |
| GO:0090425 | 0.04632 | Inf | 0 | 1 | 1 | acinar cell differentiation |
| GO:0097291 | 0.04632 | Inf | 0 | 1 | 1 | renal phosphate ion absorption |
| GO:0097326 | 0.04632 | Inf | 0 | 1 | 1 | melanocyte adhesion |
| GO:0097393 | 0.04632 | Inf | 0 | 1 | 1 | telomeric repeat-containing RNA transcription |
| GO:0097394 | 0.04632 | Inf | 0 | 1 | 1 | telomeric repeat-containing RNA transcription by RNA polymerase II |
| GO:0097403 | 0.04632 | Inf | 0 | 1 | 1 | cellular response to raffinose |
| GO:0097510 | 0.04632 | Inf | 0 | 1 | 1 | base-excision repair, AP site formation via deaminated base removal |
| GO:0098737 | 0.04632 | Inf | 0 | 1 | 1 | protein insertion into plasma membrane |
| GO:0099606 | 0.04632 | Inf | 0 | 1 | 1 | microtubule plus-end directed mitotic chromosome migration |
| GO:0099607 | 0.04632 | Inf | 0 | 1 | 1 | lateral attachment of mitotic spindle microtubules to kinetochore |
| GO:0110090 | 0.04632 | Inf | 0 | 1 | 1 | positive regulation of hippocampal neuron apoptotic process |
| GO:0120064 | 0.04632 | Inf | 0 | 1 | 1 | stomach pylorus smooth muscle contraction |
| GO:0120065 | 0.04632 | Inf | 0 | 1 | 1 | pyloric antrum smooth muscle contraction |
| GO:0120071 | 0.04632 | Inf | 0 | 1 | 1 | regulation of pyloric antrum smooth muscle contraction |
| GO:0120072 | 0.04632 | Inf | 0 | 1 | 1 | positive regulation of pyloric antrum smooth muscle contraction |
| GO:0120117 | 0.04632 | Inf | 0 | 1 | 1 | T cell meandering migration |
| GO:0140067 | 0.04632 | Inf | 0 | 1 | 1 | peptidyl-lysine butyrylation |
| GO:0140075 | 0.04632 | Inf | 0 | 1 | 1 | regulation of lipoprotein transport |
| GO:0140077 | 0.04632 | Inf | 0 | 1 | 1 | positive regulation of lipoprotein transport |
| GO:0140205 | 0.04632 | Inf | 0 | 1 | 1 | oligopeptide import across plasma membrane |
| GO:0140206 | 0.04632 | Inf | 0 | 1 | 1 | dipeptide import across plasma membrane |
| GO:0150024 | 0.04632 | Inf | 0 | 1 | 1 | oxidised low-density lipoprotein particle clearance |
| GO:0150089 | 0.04632 | Inf | 0 | 1 | 1 | multiple spine synapse organization |
| GO:0150090 | 0.04632 | Inf | 0 | 1 | 1 | multiple spine synapse organization, single dendrite |
| GO:1900827 | 0.04632 | Inf | 0 | 1 | 1 | positive regulation of membrane depolarization during cardiac muscle cell action potential |
| GO:1901146 | 0.04632 | Inf | 0 | 1 | 1 | mesenchymal cell apoptotic process involved in mesonephric nephron morphogenesis |
| GO:1901148 | 0.04632 | Inf | 0 | 1 | 1 | gene expression involved in extracellular matrix organization |
| GO:1901246 | 0.04632 | Inf | 0 | 1 | 1 | regulation of lung ciliated cell differentiation |
| GO:1901248 | 0.04632 | Inf | 0 | 1 | 1 | positive regulation of lung ciliated cell differentiation |
| GO:1901257 | 0.04632 | Inf | 0 | 1 | 1 | negative regulation of macrophage colony-stimulating factor production |
| GO:1901494 | 0.04632 | Inf | 0 | 1 | 1 | regulation of cysteine metabolic process |
| GO:1901545 | 0.04632 | Inf | 0 | 1 | 1 | response to raffinose |
| GO:1901580 | 0.04632 | Inf | 0 | 1 | 1 | regulation of telomeric RNA transcription from RNA pol II promoter |
| GO:1901581 | 0.04632 | Inf | 0 | 1 | 1 | negative regulation of telomeric RNA transcription from RNA pol II promoter |
| GO:1901582 | 0.04632 | Inf | 0 | 1 | 1 | positive regulation of telomeric RNA transcription from RNA pol II promoter |
| GO:1902076 | 0.04632 | Inf | 0 | 1 | 1 | regulation of lateral motor column neuron migration |
| GO:1902078 | 0.04632 | Inf | 0 | 1 | 1 | positive regulation of lateral motor column neuron migration |
| GO:1902161 | 0.04632 | Inf | 0 | 1 | 1 | positive regulation of cyclic nucleotide-gated ion channel activity |
| GO:1902426 | 0.04632 | Inf | 0 | 1 | 1 | deactivation of mitotic spindle assembly checkpoint |
| GO:1902691 | 0.04632 | Inf | 0 | 1 | 1 | respiratory basal cell differentiation |
| GO:1902910 | 0.04632 | Inf | 0 | 1 | 1 | positive regulation of melanosome transport |
| GO:1903027 | 0.04632 | Inf | 0 | 1 | 1 | regulation of opsonization |
| GO:1903028 | 0.04632 | Inf | 0 | 1 | 1 | positive regulation of opsonization |
| GO:1903165 | 0.04632 | Inf | 0 | 1 | 1 | response to polycyclic arene |
| GO:1903166 | 0.04632 | Inf | 0 | 1 | 1 | cellular response to polycyclic arene |
| GO:1903435 | 0.04632 | Inf | 0 | 1 | 1 | positive regulation of constitutive secretory pathway |
| GO:1903450 | 0.04632 | Inf | 0 | 1 | 1 | regulation of G1 to G0 transition |
| GO:1903452 | 0.04632 | Inf | 0 | 1 | 1 | positive regulation of G1 to G0 transition |
| GO:1903584 | 0.04632 | Inf | 0 | 1 | 1 | regulation of histone deubiquitination |
| GO:1903586 | 0.04632 | Inf | 0 | 1 | 1 | positive regulation of histone deubiquitination |
| GO:1903769 | 0.04632 | Inf | 0 | 1 | 1 | negative regulation of cell proliferation in bone marrow |
| GO:1903904 | 0.04632 | Inf | 0 | 1 | 1 | negative regulation of establishment of T cell polarity |
| GO:1904140 | 0.04632 | Inf | 0 | 1 | 1 | negative regulation of microglial cell migration |
| GO:1904145 | 0.04632 | Inf | 0 | 1 | 1 | negative regulation of meiotic cell cycle process involved in oocyte maturation |
| GO:1904274 | 0.04632 | Inf | 0 | 1 | 1 | tricellular tight junction assembly |
| GO:1904445 | 0.04632 | Inf | 0 | 1 | 1 | negative regulation of establishment of Sertoli cell barrier |
| GO:1904451 | 0.04632 | Inf | 0 | 1 | 1 | regulation of potassium:proton exchanging ATPase activity |
| GO:1904453 | 0.04632 | Inf | 0 | 1 | 1 | positive regulation of potassium:proton exchanging ATPase activity |
| GO:1904472 | 0.04632 | Inf | 0 | 1 | 1 | positive regulation of endothelin secretion |
| GO:1904596 | 0.04632 | Inf | 0 | 1 | 1 | regulation of connective tissue replacement involved in inflammatory response wound healing |
| GO:1904597 | 0.04632 | Inf | 0 | 1 | 1 | negative regulation of connective tissue replacement involved in inflammatory response wound healing |
| GO:1904603 | 0.04632 | Inf | 0 | 1 | 1 | regulation of advanced glycation end-product receptor activity |
| GO:1904604 | 0.04632 | Inf | 0 | 1 | 1 | negative regulation of advanced glycation end-product receptor activity |
| GO:1904605 | 0.04632 | Inf | 0 | 1 | 1 | positive regulation of advanced glycation end-product receptor activity |
| GO:1904681 | 0.04632 | Inf | 0 | 1 | 1 | response to 3-methylcholanthrene |
| GO:1904682 | 0.04632 | Inf | 0 | 1 | 1 | cellular response to 3-methylcholanthrene |
| GO:1904799 | 0.04632 | Inf | 0 | 1 | 1 | regulation of neuron remodeling |
| GO:1904800 | 0.04632 | Inf | 0 | 1 | 1 | negative regulation of neuron remodeling |
| GO:1904897 | 0.04632 | Inf | 0 | 1 | 1 | regulation of hepatic stellate cell proliferation |
| GO:1904899 | 0.04632 | Inf | 0 | 1 | 1 | positive regulation of hepatic stellate cell proliferation |
| GO:1904999 | 0.04632 | Inf | 0 | 1 | 1 | positive regulation of leukocyte adhesion to arterial endothelial cell |
| GO:1905176 | 0.04632 | Inf | 0 | 1 | 1 | positive regulation of vascular smooth muscle cell dedifferentiation |
| GO:1905217 | 0.04632 | Inf | 0 | 1 | 1 | response to astaxanthin |
| GO:1905222 | 0.04632 | Inf | 0 | 1 | 1 | atrioventricular canal morphogenesis |
| GO:1905226 | 0.04632 | Inf | 0 | 1 | 1 | regulation of adhesion of symbiont to host epithelial cell |
| GO:1905239 | 0.04632 | Inf | 0 | 1 | 1 | regulation of canonical Wnt signaling pathway involved in osteoblast differentiation |
| GO:1905240 | 0.04632 | Inf | 0 | 1 | 1 | negative regulation of canonical Wnt signaling pathway involved in osteoblast differentiation |
| GO:1905313 | 0.04632 | Inf | 0 | 1 | 1 | transforming growth factor beta receptor signaling pathway involved in heart development |
| GO:1905341 | 0.04632 | Inf | 0 | 1 | 1 | negative regulation of protein localization to kinetochore |
| GO:1905404 | 0.04632 | Inf | 0 | 1 | 1 | positive regulation of activated CD8-positive, alpha-beta T cell apoptotic process |
| GO:1905483 | 0.04632 | Inf | 0 | 1 | 1 | regulation of motor neuron migration |
| GO:1905485 | 0.04632 | Inf | 0 | 1 | 1 | positive regulation of motor neuron migration |
| GO:1905535 | 0.04632 | Inf | 0 | 1 | 1 | regulation of eukaryotic translation initiation factor 4F complex assembly |
| GO:1905537 | 0.04632 | Inf | 0 | 1 | 1 | positive regulation of eukaryotic translation initiation factor 4F complex assembly |
| GO:1905610 | 0.04632 | Inf | 0 | 1 | 1 | regulation of mRNA cap binding |
| GO:1905612 | 0.04632 | Inf | 0 | 1 | 1 | positive regulation of mRNA cap binding |
| GO:1905872 | 0.04632 | Inf | 0 | 1 | 1 | negative regulation of protein localization to cell leading edge |
| GO:1990134 | 0.04632 | Inf | 0 | 1 | 1 | epithelial cell apoptotic process involved in palatal shelf morphogenesis |
| GO:1990402 | 0.04632 | Inf | 0 | 1 | 1 | embryonic liver development |
| GO:1990654 | 0.04632 | Inf | 0 | 1 | 1 | sebum secreting cell proliferation |
| GO:1990771 | 0.04632 | Inf | 0 | 1 | 1 | clathrin-dependent extracellular exosome endocytosis |
| GO:1990834 | 0.04632 | Inf | 0 | 1 | 1 | response to odorant |
| GO:1990922 | 0.04632 | Inf | 0 | 1 | 1 | hepatic stellate cell proliferation |
| GO:2000077 | 0.04632 | Inf | 0 | 1 | 1 | negative regulation of type B pancreatic cell development |
| GO:2000296 | 0.04632 | Inf | 0 | 1 | 1 | negative regulation of hydrogen peroxide catabolic process |
| GO:2000361 | 0.04632 | Inf | 0 | 1 | 1 | regulation of prostaglandin-E synthase activity |
| GO:2000363 | 0.04632 | Inf | 0 | 1 | 1 | positive regulation of prostaglandin-E synthase activity |
| GO:2000426 | 0.04632 | Inf | 0 | 1 | 1 | negative regulation of apoptotic cell clearance |
| GO:2000526 | 0.04632 | Inf | 0 | 1 | 1 | positive regulation of glycoprotein biosynthetic process involved in immunological synapse formation |
| GO:2000577 | 0.04632 | Inf | 0 | 1 | 1 | regulation of ATP-dependent microtubule motor activity, minus-end-directed |
| GO:2000578 | 0.04632 | Inf | 0 | 1 | 1 | negative regulation of ATP-dependent microtubule motor activity, minus-end-directed |
| GO:2000970 | 0.04632 | Inf | 0 | 1 | 1 | regulation of detection of glucose |
| GO:2000971 | 0.04632 | Inf | 0 | 1 | 1 | negative regulation of detection of glucose |
| GO:2000979 | 0.04632 | Inf | 0 | 1 | 1 | positive regulation of forebrain neuron differentiation |
| GO:2001246 | 0.04632 | Inf | 0 | 1 | 1 | negative regulation of phosphatidylcholine biosynthetic process |
| GO:2001295 | 0.04632 | Inf | 0 | 1 | 1 | malonyl-CoA biosynthetic process |
| GO:1904375 | 0.04705 | 1.85014 | 6 | 11 | 134 | regulation of protein localization to cell periphery |
| GO:0046620 | 0.04735 | 1.91506 | 5 | 10 | 118 | regulation of organ growth |
| GO:0031670 | 0.04748 | 2.71729 | 2 | 5 | 43 | cellular response to nutrient |
| GO:0042771 | 0.04748 | 2.71729 | 2 | 5 | 43 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator |
| GO:0045823 | 0.04748 | 2.71729 | 2 | 5 | 43 | positive regulation of heart contraction |
| GO:1901031 | 0.04748 | 2.71729 | 2 | 5 | 43 | regulation of response to reactive oxygen species |
| GO:1901381 | 0.04748 | 2.71729 | 2 | 5 | 43 | positive regulation of potassium ion transmembrane transport |
| GO:0006879 | 0.04757 | 2.43042 | 3 | 6 | 57 | cellular iron ion homeostasis |
| GO:0045071 | 0.04757 | 2.43042 | 3 | 6 | 57 | negative regulation of viral genome replication |
| GO:0072577 | 0.04757 | 2.43042 | 3 | 6 | 57 | endothelial cell apoptotic process |
| GO:0042176 | 0.04778 | 1.46918 | 18 | 25 | 378 | regulation of protein catabolic process |
| GO:0002076 | 0.04809 | 4.12687 | 1 | 3 | 18 | osteoblast development |
| GO:0007252 | 0.04809 | 4.12687 | 1 | 3 | 18 | I-kappaB phosphorylation |
| GO:0021542 | 0.04809 | 4.12687 | 1 | 3 | 18 | dentate gyrus development |
| GO:0030002 | 0.04809 | 4.12687 | 1 | 3 | 18 | cellular anion homeostasis |
| GO:0030320 | 0.04809 | 4.12687 | 1 | 3 | 18 | cellular monovalent inorganic anion homeostasis |
| GO:0032401 | 0.04809 | 4.12687 | 1 | 3 | 18 | establishment of melanosome localization |
| GO:0032793 | 0.04809 | 4.12687 | 1 | 3 | 18 | positive regulation of CREB transcription factor activity |
| GO:0072578 | 0.04809 | 4.12687 | 1 | 3 | 18 | neurotransmitter-gated ion channel clustering |
| GO:0086011 | 0.04809 | 4.12687 | 1 | 3 | 18 | membrane repolarization during action potential |
| GO:0097091 | 0.04809 | 4.12687 | 1 | 3 | 18 | synaptic vesicle clustering |
| GO:0099150 | 0.04809 | 4.12687 | 1 | 3 | 18 | regulation of postsynaptic specialization assembly |
| GO:0150052 | 0.04809 | 4.12687 | 1 | 3 | 18 | regulation of postsynapse assembly |
| GO:1903909 | 0.04809 | 4.12687 | 1 | 3 | 18 | regulation of receptor clustering |
| GO:0008608 | 0.04816 | 3.17590 | 1 | 4 | 30 | attachment of spindle microtubules to kinetochore |
| GO:0010922 | 0.04816 | 3.17590 | 1 | 4 | 30 | positive regulation of phosphatase activity |
| GO:0023058 | 0.04816 | 3.17590 | 1 | 4 | 30 | adaptation of signaling pathway |
| GO:0031297 | 0.04816 | 3.17590 | 1 | 4 | 30 | replication fork processing |
| GO:0032607 | 0.04816 | 3.17590 | 1 | 4 | 30 | interferon-alpha production |
| GO:0042481 | 0.04816 | 3.17590 | 1 | 4 | 30 | regulation of odontogenesis |
| GO:0097755 | 0.04875 | 2.22544 | 3 | 7 | 72 | positive regulation of blood vessel diameter |
| GO:0030509 | 0.04895 | 1.73586 | 8 | 13 | 168 | BMP signaling pathway |
| GO:0048659 | 0.04895 | 1.73586 | 8 | 13 | 168 | smooth muscle cell proliferation |
| GO:0061572 | 0.04895 | 1.73586 | 8 | 13 | 168 | actin filament bundle organization |
| GO:0030317 | 0.04946 | 1.97965 | 5 | 9 | 103 | flagellated sperm motility |
| GO:0051282 | 0.04965 | 1.89740 | 6 | 10 | 119 | regulation of sequestering of calcium ion |
| GO:0034504 | 0.04979 | 1.55617 | 13 | 19 | 272 | protein localization to nucleus |
| GO:0060485 | 0.04979 | 1.55617 | 13 | 19 | 272 | mesenchyme development |
| GO:0001812 | 0.04983 | 6.87450 | 0 | 2 | 8 | positive regulation of type I hypersensitivity |
| GO:0009415 | 0.04983 | 6.87450 | 0 | 2 | 8 | response to water |
| GO:0030643 | 0.04983 | 6.87450 | 0 | 2 | 8 | cellular phosphate ion homeostasis |
| GO:0031394 | 0.04983 | 6.87450 | 0 | 2 | 8 | positive regulation of prostaglandin biosynthetic process |
| GO:0033007 | 0.04983 | 6.87450 | 0 | 2 | 8 | negative regulation of mast cell activation involved in immune response |
| GO:0035507 | 0.04983 | 6.87450 | 0 | 2 | 8 | regulation of myosin-light-chain-phosphatase activity |
| GO:0035696 | 0.04983 | 6.87450 | 0 | 2 | 8 | monocyte extravasation |
| GO:0035740 | 0.04983 | 6.87450 | 0 | 2 | 8 | CD8-positive, alpha-beta T cell proliferation |
| GO:0035912 | 0.04983 | 6.87450 | 0 | 2 | 8 | dorsal aorta morphogenesis |
| GO:0036092 | 0.04983 | 6.87450 | 0 | 2 | 8 | phosphatidylinositol-3-phosphate biosynthetic process |
| GO:0042045 | 0.04983 | 6.87450 | 0 | 2 | 8 | epithelial fluid transport |
| GO:0043615 | 0.04983 | 6.87450 | 0 | 2 | 8 | astrocyte cell migration |
| GO:0045360 | 0.04983 | 6.87450 | 0 | 2 | 8 | regulation of interleukin-1 biosynthetic process |
| GO:0045362 | 0.04983 | 6.87450 | 0 | 2 | 8 | positive regulation of interleukin-1 biosynthetic process |
| GO:0045542 | 0.04983 | 6.87450 | 0 | 2 | 8 | positive regulation of cholesterol biosynthetic process |
| GO:0045842 | 0.04983 | 6.87450 | 0 | 2 | 8 | positive regulation of mitotic metaphase/anaphase transition |
| GO:0046602 | 0.04983 | 6.87450 | 0 | 2 | 8 | regulation of mitotic centrosome separation |
| GO:0051126 | 0.04983 | 6.87450 | 0 | 2 | 8 | negative regulation of actin nucleation |
| GO:0051136 | 0.04983 | 6.87450 | 0 | 2 | 8 | regulation of NK T cell differentiation |
| GO:0051388 | 0.04983 | 6.87450 | 0 | 2 | 8 | positive regulation of neurotrophin TRK receptor signaling pathway |
| GO:0060836 | 0.04983 | 6.87450 | 0 | 2 | 8 | lymphatic endothelial cell differentiation |
| GO:0070561 | 0.04983 | 6.87450 | 0 | 2 | 8 | vitamin D receptor signaling pathway |
| GO:0071578 | 0.04983 | 6.87450 | 0 | 2 | 8 | zinc ion import across plasma membrane |
| GO:0072501 | 0.04983 | 6.87450 | 0 | 2 | 8 | cellular divalent inorganic anion homeostasis |
| GO:0072502 | 0.04983 | 6.87450 | 0 | 2 | 8 | cellular trivalent inorganic anion homeostasis |
| GO:0072526 | 0.04983 | 6.87450 | 0 | 2 | 8 | pyridine-containing compound catabolic process |
| GO:0072611 | 0.04983 | 6.87450 | 0 | 2 | 8 | interleukin-13 secretion |
| GO:0090205 | 0.04983 | 6.87450 | 0 | 2 | 8 | positive regulation of cholesterol metabolic process |
| GO:0098883 | 0.04983 | 6.87450 | 0 | 2 | 8 | synapse pruning |
| GO:0106120 | 0.04983 | 6.87450 | 0 | 2 | 8 | positive regulation of sterol biosynthetic process |
| GO:0150078 | 0.04983 | 6.87450 | 0 | 2 | 8 | positive regulation of neuroinflammatory response |
| GO:1901970 | 0.04983 | 6.87450 | 0 | 2 | 8 | positive regulation of mitotic sister chromatid separation |
| GO:1902339 | 0.04983 | 6.87450 | 0 | 2 | 8 | positive regulation of apoptotic process involved in morphogenesis |
| GO:1902866 | 0.04983 | 6.87450 | 0 | 2 | 8 | regulation of retina development in camera-type eye |
| GO:1903726 | 0.04983 | 6.87450 | 0 | 2 | 8 | negative regulation of phospholipid metabolic process |
| GO:1904415 | 0.04983 | 6.87450 | 0 | 2 | 8 | regulation of xenophagy |
| GO:1904417 | 0.04983 | 6.87450 | 0 | 2 | 8 | positive regulation of xenophagy |
| GO:1904747 | 0.04983 | 6.87450 | 0 | 2 | 8 | positive regulation of apoptotic process involved in development |
| GO:2000564 | 0.04983 | 6.87450 | 0 | 2 | 8 | regulation of CD8-positive, alpha-beta T cell proliferation |
| GO:2001182 | 0.04983 | 6.87450 | 0 | 2 | 8 | regulation of interleukin-12 secretion |